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ABSTRACT 
Inter- and Intra-kingdom Signaling in Bacterial Chemotaxis, Biofilm Formation, and 
Virulence. (December 2011) 
Manjunath Narayan Hegde, B. Eng., R. V. College of Engineering, Bangalore, India 
Co-Chairs of Advisory Committee: Dr. Arul Jayaraman  
                                                             Dr. Thomas K. Wood 
 
 Cell-cell communication between bacteria, belonging to the same species or to 
different species (Intra-kingdom signaling), or communication between bacteria and 
their animal host (Inter-kingdom signaling) is mediated through different chemical 
signals that are synthesized and secreted by bacteria or the host and is crucial for the 
survival of bacteria inside their host. The overall goal of this work was to understand the 
role of inter- and intra-kingdom signaling in phenotypes such as chemotaxis, 
colonization and biofilm formation, and virulence that are associated with infections 
caused by the human gastrointestinal (GI) tract pathogens. A part of our work also aimed 
at developing microfluidics-based models to study inter- and intra-kingdom signaling in 
biofilm formation, inhibition, and dispersal.  
 We showed that norepinephrine (NE), an important host signal produced during 
stress, increases human opportunistic pathogen Pseudomonas aeruginosa growth, 
motility, attachment, and virulence, and also showed that the actions of NE are mediated 
primarily through the LasR, and not the RhlR QS system. We investigated the molecular 
mechanism underlying the chemo-sensing of the intra-kingdom signal autoinducer-2 
(AI-2) by pathogens Escherichia coli and Salmonella typhimurium by performing 
 iv 
different chemotaxis assays (capillary, microPlug and microFlow assays), and 
discovered that AI-2 is a potent attractant for E. coli and S. typhimurium, and that the Tsr 
chemoreceptor and periplasmic AI-2 binding protein LsrB are necessary for sensing AI-
2, although uptake of AI-2 into the cytoplasm is not required. We concluded that LsrB, 
when bound to AI-2, interacts directly with the periplasmic domain of Tsr primarily at 
the Thr-61 and Asp-63 residues of LsrB, making LsrB the first known periplasmic-
protein partner for Tsr.  
 We fabricated a simple user-friendly microfluidic flow cell (µBF) device that can 
precisely measure the effect of a wide range of concentrations of single or combinations 
of two or more soluble signals on bacterial biofilm formation and development. We also 
constructed a synthetic biofilm circuit that utilizes the Hha and BdcA dispersal proteins 
of E. coli along with a quorum sensing (QS) switch that works based on the 
accumulation of the signal N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-o-C12HSL) 
and implemented it in an upgraded µBF device. We showed that a QS system may be 
utilized with biofilm dispersal proteins to control consortial biofilm formation by 
removing an existing biofilm and then removing the biofilm that displaced the first one. 
These types of synthetic QS circuits may be used to pattern biofilms by facilitating the 
re-use of platforms and to create sophisticated reactor systems that will be used to form 
bio-refineries. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Background  
 Bacteria are found ubiquitously in most ecological niches, either as free planktonic 
cells or matrix-encased, complex surface-associated communities known as biofilms (1). 
No better example exists in the nature than the astounding numbers of bacteria harbored 
by the “human superorganism”(2). The number of microbial cells in and on the human 
body is approximately 10-times greater than that of the human host (3).  Particularly, the 
human distal gastrointestinal (GI) tract or gut, houses up to 1000 distinct bacterial 
species and an estimated excess of ~10
14
 resident microbes existing in homeostasis with 
the host's immune system (3). Therefore, the gut microbiome is one of the most complex 
microbial ecosystems, in which a diverse population of bacteria co-exists in with human 
cells (4).  
 The gut microbiome contains symbionts (or probiotics) that have known health-
promoting functions, commensals, that are permanent residents that provide no benefit 
or cause no harm to the host (5), and pathobionts (or pathogens) that have the potential 
to induce pathological changes in the human host (6). Symbiotic gut bacteria supply 
essential nutrients, metabolize compounds in the food, defend against colonization by 
foodborne pathogens and by opportunistic-pathogens, and contribute to the development 
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of overall health of humans (5).  
 The symbiosis between bacteria and the host is disturbed when there is an unnatural 
shift in composition of bacteria, either by a reduction in the numbers of probiotics and/or 
increase in the numbers of pathogens (6). Most of the pathogens that enter the GI tract 
are food or waterborne. Once in the GI tract, they migrate to and colonize specific 
regions within the small and large intestines, leading to the onset of infections (7). For 
example, common foodborne pathogens such as enterohaemorrhagic Escherichia coli 
(EHEC) O157:H7, Salmonella enterica, and Listeria monocytogenes enter the gut 
through consumption of contaminated foods, such as raw or undercooked ground meat 
products and raw unpasteurized milk (8).  Many incidences of pathogen outbreaks are 
also associated with the consumption of fruits and vegetables such as sprouts, lettuce, 
coleslaw, and salad which get contaminated due to contact with feces from domestic or 
wild animals (e.g., manure) at some stage during cultivation or handling (9). But it is not 
necessary that pathogens need to be food- or water-borne. In some cases, opportunistic 
pathogens are already resident inside the GI tract and cause infections when the right 
environmental conditions arise (i.e., such as when the host immune system is 
compromised). An example of a pathogen that opportunistically causes GI tract 
infections is Pseudomonas aeruginosa (10).  
 The lower and upper GI tract infections have been reported to occur through three 
key steps: a) recognition of the intestinal luminal environment and migration of a 
pathogen toward the epithelial cell lining in the gut that is covered by a layer of mucus, 
b) colonization and attachment of pathogens on the epithelium, and c) invasion of 
3 
 
 
3 
pathogens or translocation of their toxins into epithelial cells (11). The seriousness of 
these foodborne illnesses is apparent in the health-related costs attributed with them. The 
United States alone spends an estimated $152 billion annually in dealing with the 
healthcare, workplace, and other economic costs associated with acute foodborne 
illnesses (12).  Hence, it is important to identify environmental cues in the GI tract that 
help the incoming foodborne pathogen colonize specific regions in the gut and cause 
infections.  
 
1.2 Motivation 
 Infections caused by foodborne pathogens affect millions of people and kill 
thousands in the United States alone.  The Center for Disease Control (CDC) estimates 
for 2011 show that food-borne infections affect approximately 1 out of 6 Americans (or 
48 million people) every year, with 128,000 hospitalizations and 3,000 deaths (13). 
Foodborne pathogens such as Salmonella spp., EHEC, enteropathogenic E. coli (EPEC), 
Campylobacter spp., and Staphylococcus aureus are the most common causes of enteric 
infections. The symptoms of such enteric infections can range from diarrhea (sometimes 
bloody), cramping, abdominal pain, fever, and sometimes lead to infection in the 
systemic circulation and death. In United States, a significant health-related cost of ~152 
billion/year, estimated after considering the sum of medical costs (hospital services, 
physician services, and drugs), quality-of-life losses (deaths, pain, suffering, and 
functional disability), and costs to others in society (e.g. costs to insurance companies 
that pay medical expenses) is associated with foodborne illness alone (12). Some enteric 
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infections, such as the ones caused by EHEC, cannot be treated by antibiotics because of 
the possibility of aggravating the infection due to enhanced release of the shiga toxins 
that are critical for the infection  (14); this requires doctors to employ alternate treatment 
approaches such as fluid and electrolyte administration to limit the severity of symptoms 
(14, 15).  
 Other than infections caused by foodborne pathogens, severe illness also occur due 
to opportunistic GI pathogens that target individuals with compromised immune systems 
or chronic inflammation.  P. aeruginosa is present at clinically-undetectable levels in the 
gut of healthy individuals (10). However, in critically-ill and immuno-compromised 
patients, Pseudomonas sp. levels have been shown to increase by as much as 100-fold 
(16) leading to the expression of virulence determinants (e.g., PA-I lectin/adhesin) (10) 
that cause infection. P. aeruginosa has been shown to translocate from the GI tract into 
the systemic circulation following shock or injury (17), and the resultant sepsis rapidly 
leads to mortality (18). In fact, the mere presence of P. aeruginosa in the gastrointestinal 
(GI) tract of critically-ill surgical patients has been associated with nearly 70% mortality 
(10).   
   
1.3 Research importance, objectives, and novelty  
 Due to the close proximity of host cells and bacteria in the GI tract, a pathogen 
entering the GI tract is exposed to a wide range of molecules produced by both the host 
epithelium and commensal bacteria. It has been speculated that these molecules, in part, 
form an unique signature of the GI tract, which in turn, helps pathogens to identify the 
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microenvironment that is favorable for colonization and infection. These molecules 
include those used in bacterial quorum sensing or cell-cell communication and 
metabolites produced during normal bacterial growth. The quorum sensing signals 
include autoinducer-2 (AI-2) that is produced by ~55 different species of bacteria  (19)  
including E. coli, Helicobacter pylori, S. typhimurium, Streptococcus mutans, Vibrio 
cholera, and Vibrio harveyi, as well as acyl homoserine lactones produced at high 
concentrations by numerous Gram-negative bacteria including P. aeruginosa, Vibrio 
fischeri, Agrobacterium tumefaciens, and Rhodobacter sphaeroides (20). Bacterial 
metabolites that also function as signals include indole that is produced by E. coli, as 
well as derivatives of indole such as hydroxyindoles that are produced by other GI tract 
bacteria from indole (21) and have been shown to affect phenotypes such as motility, 
adhesion to epithelial cells, and biofilm formation in E. coli (22-24). Eukaryotic signals 
produced in situ in the intestine of the host include hormones such as norepinephrine 
(NE), epinephrine, dopamine, and serotonin (25) and small molecules such as adenosine 
(26). Importantly, it has been shown that molecules produced by bacteria and host cells 
in the GI tract are recognized by host cells and bacteria, respectively (25). The 
abundance of these molecules and their cross-recognition by cells belonging to different 
kingdoms leads to a signal-centric paradigm wherein signaling molecules are thought to 
be a major contributor to the initiation and development of pathogen infections in the GI 
tract. However, the molecular basis of this interaction and its effect on the different steps 
involved in infections are poorly understood. Therefore, understanding the role of 
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signals in GI tract infections will lead to the development of approaches to control 
bacterial infections of the GI tract.  
 The overall goal of this work was to investigate the role of prokaryotic (AI-2, indole, 
7-hydroxyindole, and isatin) and eukaryotic signals (NE) on specific phenotypes that 
promote infections - namely chemotaxis, colonization and invasion of epithelial cells, 
production of virulence factors, and biofilm formation. A major focus of this dissertation 
is on investigating the mechanism of chemotactic migration of E. coli and S. 
typhimurium toward AI-2. We also studied the effect of NE on phenotypes expressed by 
P. aeruginosa during gut-derived sepsis. Our work also involved developing 
microfluidics-based tools to study the effect of the bacterial signals indole and its 
derivatives on biofilm formation. 
 AI-2 has been reported to be a chemoattractant for E. coli (27) which has an AI-2 
uptake system similar to that of S. typhimurium. However, the receptor(s) involved in 
AI-2 sensing have not been identified. This work is novel because this is the first study 
that identifies the receptor involved in the chemo-sensing of AI-2 in E. coli and S. 
typhimurium. Because AI-2 is produced by so many types of bacteria, this work provides 
a basis for understanding how planktonic (free-swimming) bacteria are possibly 
recruited to form mixed-species bacterial communities or biofilms. In this study, we 
used the non-pathogenic lab strain E. coli RP437 as a model strain for investigating the 
chemotaxis of EHEC towards GI tract molecules, since both non-pathogenic E.  coli  and  
EHEC  possess  the  same  five chemoreceptors Tar, Tsr, Tap, Trg, and Aer with  a  high  
degree  of  gene and protein sequence  homology (28).   Conventional methods of 
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studying chemotaxis such as swarm plates and capillary assays, although widely used, 
have numerous drawbacks that limit their use in chemotaxis investigations (29). These 
include difficulties in quantitation (swarm plates), variability in the cell accumulation 
numbers between two similar runs (capillary assays), unsuitability for studying repellent 
taxis (capillary assays), temporally changing concentration gradients (capillary assays), 
and requirements for metabolizable chemoeffectors (swarm plates). These problems are 
elegantly addressed by microfluidic chemotaxis models. For example, the flow-based 
microfluidic chemotaxis model developed in this study allows generation of temporally 
and spatially stable concentration gradients of chemoeffectors of any gradient strength, 
is equally applicable for attractants and repellents, provides quantitative data, and is 
more sensitive than capillary assays or swarm plates.  
 Although there have been several cases of P. aeruginosa derived sepsis reported 
when patients are immune-compromised or undergoing conditions of chronic stress (10), 
there is no direct evidence of how stress conditions promotes P. aeruginosa virulence 
and infectivity. This is the first investigation on the effect of stress hormones such as NE 
on P. aeruginosa virulence phenotypes and gene expression. 
 Indole has been shown to decrease biofilm formation in E. coli (21), but indole 
derivatives such as 7-hydroxyindole and isatin have differential effect on E. coli biofilm 
formation, in that the former decreases and the latter increases biofilm formation (23) . 
These biofilm studies were performed with only a single concentration of indole or its 
derivatives using traditional macroflow cells. However, it is important to know the effect 
of wide range of concentrations of these signals on biofilm formation or inhibition, 
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which would be tedious and time consuming using macroflow cells. Moreover, flow 
cells have the disadvantages of requiring large volumes and are not suited for high-
throughput investigation, and do not facilitate spatial and temporal control of bacterial 
introduction and adhesion. These problems can be addressed in a microfluidic flow cell 
system. Micro flow cells developed previously (30-33) have several drawbacks such as 
disruption of fluid dynamics by biofouling of tubes used to seed bacterial cells and 
nutrient medium into the biofilm chamber, inability to carry out high-throughput 
investigations, and lack of customizable features. We developed a customizable 
microflow cell with eight separate microchambers for cultivating biofilms exposed to 
eight different concentrations of signals through a single gradient mixer. We also added 
a second layer of a gradient-mixer to this design to study the synthetic biofilm circuit in 
which we engineered cells that are able to displace an existing biofilm and then be 
removed on command allowing one to control consortial biofilm formation for various 
applications. 
The specific objectives were to: 
 Identify the chemoreceptor(s) in E. coli and S. typhimurium involved in AI-2 sensing 
and study how AI-2 interacts with the chemoreceptors to generate a chemoattractant 
response. 
 Study the changes in gene expression and virulence phenotypes of P. aeruginosa on 
exposure to NE. 
 Develop a microfluidic flow cell model for studying the interactions between two 
derivatives of the bacterial signal indole on biofilm formation by pathogenic E. coli. 
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 Develop a microfluidic biofilm circuit that combines the LasI/LasR QS module of P. 
aeruginosa with engineered Hha and BdcA biofilm dispersal proteins of E. coli to 
selectively remove one type of cell from an existing biofilm, and then remove the 
second biofilm for various engineering applications. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
10 
CHAPTER II 
LITERATURE REVIEW 
 
2.1 The human gut microbiota 
 The largest epithelial surface of the human body is the gastrointestinal (GI) tract, 
commonly known as the gut (3, 34). The upper gut consists of the esophagus, stomach, 
and duodenum, and the lower gut consists of the small and large intestine. Together, the 
organs that form the gut play dual roles in human physiology: digestion and uptake of 
nutrients and the more challenging task of maintaining immune homeostasis (i.e., 
protecting the body from potentially harmful microbes, while inducing tolerance to 
certain undesirable components in food, commensal micro flora, and self-antigens) (3). 
The gut could be considered the largest surface area of the body that is exposed to and 
interacts with both exogenous pathogens and intrinsic commensal microbes. The 
composition of the microflora in the gut is governed by age, diet, environment and 
phylogeny (i.e. co-evolution of the gut microbes with their host) and the ecosystem 
contains all three domains of life: bacteria, archaea and eukarya (fungi, yeasts and 
protozoa), with the largest community residing in the colon, which is a part of the large 
intestine (34). Although the gut is sterile during birth, microorganisms soon colonize the 
gut and other mucosal surfaces after birth. This colonization evolves into a highly 
diverse endogenous microbial population comprising over 10
14
 resident microbes, 
creating a symbiotic relationship that confers benefits to both microorganisms and host 
(3). Indeed, the human colon harbors a highly complex microbial ecosystem of about 
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200 grams of living cells, at concentrations of 10
12
 microbes per gram gut content, the 
highest recorded for any microbial habitat (35). It has been estimated that at least 1,000 
different bacteria species cohabit the human gut, although some studies suggest this 
number may be as large as 35,000 (35). 
 The interactions of microbes with the host have evolved into a complex balance of 
host genes, gut environment, and microbes defined as the microbiome (4, 36). These 
microbes modulate the normal function and development of the GI tract and the overall 
health of humans (37). However, the gut environment can be shared by multiple 
pathogens that utilize the mucosa as invasion and infection sites and spread disease. It is 
the role of the immune system to concurrently control the responses to commensal and 
pathogenic organisms (37).  
 The importance of the microbiome and human disease is evident from the recent 
National Institutes of Health (NIH) initiative on the “Human Microbiome Project.” This 
$140 million project is to focus and compare the human microbiome between 
individuals, and to assess how changes in the microbiome correlate with human disease, 
using metagenomic and genomic DNA sequencing techniques (38). A part of these 
studies will aim at understanding the biological and/or chemical factors produced by the 
gut microbiome that influence the pathogenicity of common bacterial and fungal 
pathogens, but the sheer complexity of the gut in terms of the abundance of eukaryotic 
and prokaryotic cell signals that can influence the disease-causing ability of a pathogen 
will make such studies particularly challenging. 
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2.1.1. Gut infection model 
 Food and water are the most common carriers of pathogens into the GI tract (7). 
Each kind of pathogen favors specific sites in the gut for colonization and infection (e.g., 
S. typhimurium infects the small intestine, whereas EHEC infects only the colon in the 
large intestine, and P. aeruginosa infects both the small and large intestine) (39). 
Infection in the gut is hypothesized to occur through three distinct steps (11) as shown in 
Fig. 2.1. First, the pathogen recognizes the gut environment by chemo-sensing specific 
favorable commensal or host-derived chemical signals and moves toward its target site. 
The process of sensing a chemical signal and movement toward a favorable or away 
from a hostile environment known as chemotaxis helps the pathogen “identify” the 
appropriate site for infection (40). Second, using different adherence factors, pathogens 
colonize specific sites in the gut. They can attach directly to the mucosal layer covering 
the epithelium or to the commensal microbes that have already colonized the site (11). 
Some pathogenic (e.g., Uropathogenic E. coli or UPEC) proliferate on the epithelial 
surface and form biofilms before initiating infection (41) Third, initiation of infection 
by either translocation of the pathogen into the epithelial cells (invasive type of 
infection), or transport of toxins from the cytoplasm of the pathogen into the host 
epithelial cell followed by cell death (11). 
 
2.2 Escherichia coli infections  
 E. coli is a Gram-negative bacterium and a predominant species among facultative 
anaerobic bacteria of the gastrointestinal tract (11). Non-pathogenic E. coli and its 
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human host have coexisted in good health and with mutual benefit for thousands of years 
(34). These commensal E. coli strains rarely cause disease except when the host is 
immuno-compromised or when the normal gastrointestinal epithelial cell barrier is 
disrupted (42). The niche of commensal E. coli is the mucous layer of the mammalian 
colon (42). However, there are several highly adapted E. coli strains that have acquired 
specific virulence attributes, which confers an increased ability to adapt to new niches in 
the gut that allows them to cause a broad spectrum of disease (11).  Three general 
clinical syndromes can result from pathogenic E. coli infections: enteric/diarrheal 
disease, urinary tract infections (UTIs) and sepsis/meningitis (11). The pathogenic E. 
coli that cause enteric disease can be classified into six categories: enteropathogenic E. 
coli (EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent 
E. coli (DAEC) (43).  E. coli virulence factors can be encoded by several mobile genetic 
elements, including transposons (e.g., heat stable enterotoxin (ST) of ETEC), plasmids 
(for e.g. heat-labile enterotoxin (LT) of ETEC and invasion factors of EIEC), 
bacteriophage (e.g., Shiga toxin of EHEC) and pathogenicity islands (PAIs) (e.g. the 
locus of enterocyte effacement (LEE) of EPEC/EHEC) (11). 
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Fig.  2.1. Pathogen infection model. (1) Recognition and migration of pathogens to the 
epithelial cell surface (chemotaxis). (2) Proliferation, attachment, and colonization of 
pathogens on the commensal microbial or mucosal layer covering the epithelium. (3) 
Initiation of infection by translocation of the pathogen (invasive) or its toxins (non-
invasive) into the epithelium.   
 
 
2.2.1 Escherichia coli chemotaxis  
 Chemotaxis, or the movement toward or away from chemicals, is a universal 
attribute of motile cells and organisms (44).  E. coli cells swim toward amino acids 
(serine and aspartic acid), sugars (maltose, ribose, galactose, glucose), dipeptides, 
pyrimidines and electron acceptors (oxygen, nitrate, fumarate) (45-47). Cells also swim 
away from potentially harmful chemicals, such as alcohols and fatty acids, but repellent 
responses have not been as extensively studied (48). In the absence of any stimulating 
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chemical gradient, E. coli swims in a random walk pattern produced by alternating 
episodes of counter-clockwise (CCW) and clockwise (CW) flagellar rotation (49).  In an 
attractant or repellent gradient, the cells monitor chemoeffector concentration changes as 
they move and use that information to control the probability of the next tumbling event 
(50).  These flagellar responses extend runs that take the cells in favorable directions 
(toward attractants and away from repellents), resulting in net movement toward 
preferred environments.  E. coli senses chemoeffector gradients in a temporal fashion by 
comparing the current concentrations to those encountered over the past few seconds of 
travel.  Out of the five chemoreceptors in E. coli, four (Tsr, Tar, Tap, and Trg) are 
transmembrane receptors. These methyl-accepting chemotaxis proteins (MCPs) or have 
periplasmic ligand binding sites and conserved cytoplasmic signaling domains (50) (Fig. 
2.2) and record the cell's recent chemical past (ligand concentration) in the form of 
reversible methylation of specific glutamic acid residues in the cytoplasmic signaling 
domain of the chemoreceptors (50).  Whenever the ligand bound to the periplasmic 
domain of the MCP‟s dissociates from the receptor, the flagellar motor response stops 
until a new ligand binds to the MCP (50). A fifth MCP-like protein, Aer, mediates 
aerotactic responses by monitoring redox changes in the electron transport chain (50).  
Aer undergoes sensory adaptation through a poorly understood, methylation-independent 
mechanism. The five MCP-family receptors in E. coli utilize a common set of 
cytoplasmic signaling proteins to control flagellar rotation and sensory adaptation (Fig. 
2.2) (50).  Receptor CheW and sensor kinase CheA generate receptor signals in the form 
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of phosphoryl groups to CheY and CheZ which control motor responses in response to 
chemical stimuli; CheR and CheB regulate MCP methylation state (50). 
 
2.2.2 Methods for studying bacterial chemotaxis 
 There are several established qualitative and quantitative techniques for assaying 
bacterial chemotaxis as reviewed by Englert et al. (29). The most commonly used 
techniques are highlighted below. 
 
2.2.2.1 Swim and swarm plate assays  
 Chemotaxis of bacteria toward a chemoeffector that can be metabolized can be 
measured using agar plate assays (29). For swim plate assays, motility medium 
containing low agar concentrations (0.25 to 0.4%) are used (29). The bacteria move in 
the aqueous channels inside the agar, and these channels are large enough for them swim 
through. As the colony grows, it metabolizes any attractants it can which causes the 
formation of a spatial concentration gradient in the agar. As a result, the cells migrate 
outward towards higher concentrations (29). By measuring the size of the sharp ring 
formed by cells at the edge of the steepest gradient, the strength of attraction can be 
measured (29).  You list disadvantages for swarm plates below so only logical that you 
do the same for swim plates here 
 A variation on the swim plate method is the swarm assay. Motility medium 
containing higher concentrations of agar (0.5% to 0.7%) are used, and the cells swim 
through the aqueous layer that forms on the agar surface (51). Swarming cells typically 
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produce more, longer flagella (51)Both swimming and swarming assays cannot be used 
for measuring repellent taxis, and chemotaxis toward chemoeffectors that cannot be 
metabolized by the cells (29). 
 
 
 
Fig. 2.2. E. coli chemotaxis signaling circuit.  Five E. coli chemoreceptors Tsr, Tar, 
Tap, Trg, and Aer are shown along with their chemoeffector ligands serine, maltose/ 
aspartate, dipeptides/pyrimidines, galactose/ribose, and oxygen respectively. All five 
receptors employ a common set of cytoplasmic signaling proteins, CheW and CheA, 
which interact with cytoplasmic domain of chemoreceptor to form stable ternary 
complexes that generate stimulus signals in the form of phosphoryl groups. CheY and 
phospho-CheY signal the CCW and CW flagellar rotation, CheZ controls the 
phosphorylation or dephosphorylation of cheY, CheR (methyltransferase) and CheB 
(methylesterase) regulate the MCP methylation state.   
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2.2.2.2 Capillary assays  
 This assay was developed by Adler et al. (45) and is widely used for investigating 
chemotaxis. Chambers on the order of 1 cm
2
 made from plastic o-rings with a 60
o
 cut 
and 1 mm in height are loaded with a suspension of highly motile bacteria in chemotaxis 
buffer to create a pond (Fig. 2.3). A 1 mm capillary is sealed at one end and filled with 
several mm of an attractant at the desired concentration at the other. The capillary is then 
inserted into the pond and incubated at the desired temperature for 30 to 45 minutes. The 
chemoeffector in the capillary will diffuse out into the well creating a gradient that the 
can be sensed by the bacteria around the opening of the capillary. The bacteria will then 
migrate into the capillary if the chemoeffector is an attractant. The capillary is then 
removed, and the contents placed into dilution buffer. Dilutions are plated on nutrient 
agar and colonies are counted the next day. The colony counts allow the number of cells 
entering the capillary to be calculated. These numbers can then be used to compare the 
chemotactic response and strength of response to various compounds. Although the 
capillary assay can be used for measuring repellant taxis, the results are not nearly as 
sensitive as those for attractants. Therefore, it is not ideal for use with repellents.  
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Fig. 2.3. Experimental setup for the capillary assay.   
 
2.2.2.3 Microfluidic assays 
 Capillary assays are not ideal for quantifying subtle differences in migration rates or 
for investigating responses to complex gradients consisting of multiple chemoeffectors 
(29). These issues can be addressed by using microfluidics-based chemotaxis models 
(29). Microfluidic methods have tremendous potential for chemotaxis studies because 
they can be used to measure chemotaxis quantitatively (29, 52, 53). In addition, they 
work equally well for attractants and repellents, and they can generate highly stable 
gradients over any user-defined concentration range (29). Microfluidics assays are 
becoming increasingly popular in biological studies because of features such as small 
volume and large surface-to-volume ratio, laminar flow, high throughput, and compact 
system size for fast and accurate analysis of samples (54). Mao et al. (55) were the first 
to investigate bacterial taxis in a microfluidic flow cell, in which a concentration 
gradient was formed by diffusion of two parallel streams. Englert et al. (29, 52, 53, 56) 
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have developed a qualitative (microPlug assay) and a flow-based quantitative 
(microFlow assay) for studying chemotaxis. 
 
2.2.3 Escherichia coli biofilms  
 Biofilms are highly-structured, matrix-enclosed bacterial communities (57). Bacterial 
biofilms are commonly are commonly found in the site of infection and are a common 
cause of persistent infections (57). Some of the common infections such as those related 
to dental caries, periodontitis, cystic fibrosis pneumonia, urinary catheter cystitis, contact 
lens, sutures, central venous catheters, and orthopedic devices are caused by single or 
multispecies biofilms (57). Biofilms can be up to 1,000 times more resistant to 
antibiotics than the planktonic cells (58).  Bacteria in biofilms infect 4.3% of orthopedic 
and 7.4% of cardiovascular implants, and the treatment costs amount to more than $3 
billion in the USA alone (58).  The biofilm matrix is comprised of bacterial cells, 
secreted cell products, proteins, polysaccharides, DNA, and water (59, 60). Biofilm 
matrix formation depends on both genetic and environmental factors (59). 
 E. coli is a predominant species among facultative anaerobic bacteria of the 
gastrointestinal tract, where it thrives in an environment as multispecies biofilm (1, 61). 
E. coli biofilm formation can be affected by different molecules in different ways.  AHL 
signals reduce biofilm formation (21), whereas AI-2 increases biofilm formation in E. 
coli (62).  The internal messenger cyclic diguanylic acid (c-di-GMP) increases biofilm 
formation in E. coli (63).  The eucaryotic signal furanones produced by alga Delisea 
pulchra (64, 65) decreases biofilm formation in E. coli by inhibiting AI-2 signaling (66). 
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Human stress hormones epinephrine and norepinephrine increase biofilm formation in E. 
coli O157:H7 (22) whereas bacterial signals such as indole, 7-hydroxyindole, and 5-
hydroxyindole decrease biofilm formation in both pathogenic and non-pathogenic E. coli 
(21, 22, 67).  Isatin increases biofilm formation in pathogenic E. coli and does not affect 
the biofilm formation in non-pathogenic E. coli K-12 strain (23). 
 
2.3. Pseudomonas aeruginosa  
 P. aeruginosa is a Gram-negative bacterium frequently found in soil, aqueous 
habitats, plants, animals, and humans (68-70). P. aeruginosa contains two pathogenicity 
islands (PAPI-1 and PAPI-2) which harbor a shared subset of virulence genes to elicit 
infection in both plants and animal hosts (71, 72). P. aeruginosa is an opportunistic 
pathogen for humans and is present at clinically-undetectable levels in the normal gut 
(10). However, in critically-ill and immune-compromised patients, Pseudomonas sp. 
levels have been shown to increase by as much as several hundred fold (16) leading to 
the expression of virulence determinants (e.g., PA-I lectin/adhesin) (10) that lead to 
infection. P. aeruginosa translocates from the GI tract into the systemic circulation 
following shock or injury (17), and the resultant sepsis rapidly leads to mortality (18). In 
fact, the mere presence of P. aeruginosa in the gastrointestinal (GI) tract of critically-ill 
surgical patients has been associated with nearly 70% mortality (10). P. aeruginosa 
produces many secreted virulence determinants through the interrelated Las and Rhl 
quorum-sensing (QS) systems (73). In addition, the secreted Pseudomonas quinolone 
signal (PQS, 2-heptyl-3-hydroxy-4-quinolone) is also involved in the expression of 
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several virulence determinants (74).  The regulation of PQS is not independent, but 
integrated with the las and rhl QS (75), as the regulator for PQS production (pqsR, also 
known as mvfR) is positively regulated by lasR and negatively regulated by rhlR (75).  
 
2.3.1 Virulence factors of Pseudomonas aeruginosa  
 P. aeruginosa is notorious for its multiple virulence factors such as adhesions for 
biofilm formation, cyanides, elastases, hemagglutinin, motility, phenazines, pyocyanin, 
rhamnolipids, type III secretion, and siderophores  (70, 76-80).  Many of these virulence 
factors are regulated through QS pathways (81).  These virulence factors have different 
effects on the physiology of the host cells; for instance, pyocyanin inhibits respiration 
(82), elastase disrupts blood vessels and degrades the extracellular matrices of epithelial 
cells (83), and rhamnolipids disrupts the cells and promote the invasion of P. aeruginosa 
(84).  The tissue damages caused by the toxins of P. aeruginosa deteriorate the human 
immune system (85).  
 
2.4 Bacterial and host signaling molecules 
 
2.4.1 Autoinducer-2 (AI-2) 
 AI-2 is produced by a wide range of Gram-negative and Gram-positive bacterium 
such as E. coli, S. typhimurium, V. harveyi, V. cholerae, P. gingivalis, Actinobacillus 
actinomycetemcomitans, and Streptococcus mutans (19). Inside cells, AI-2 exists in 
multiple forms that are in equilibrium with each other (86) and is derived from the 
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spontaneous cyclization of the metabolite 4,5-dihydroxy-2,3-pentanedione (DPD). DPD 
is made from S-ribosylhomocysteine by LuxS (87). The form that is active in V. harveyi 
is (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran borate (S-THMF borate) (88). 
This form of AI-2 binds to the periplasmic protein LuxP. In E. coli and S. typhimurium, 
a boron-free isomer of AI-2 [(2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetra-hydrofuran (R-
THMF)] binds to the periplasmic LsrB protein (89). LsrB is the recognition component 
of an ABC transporter for AI-2, and lsrB is in the lsrACDBFGE operon. LsrACD are the 
membrane-bound components of the ABC transporter for AI-2. Following uptake, AI-2 
is phosphorylated in the cytoplasm by the LsrK kinase and then further broken down by 
the products of the lsrFG genes (90).  this operon is under the control of LsrR, a 
repressor that is inactivated upon binding of phosphorylated AI-2. In E. coli, the 
membrane-bound YdgG (TqsA) protein has been implicated in AI-2 export from the 
cytoplasm (91). AI-2 is a potent chemoattractant for E. coli (27, 92). AI-2 also increases 
biofilm formation in E. coli (62).   
 
2.4.2 Indole 
 A variety of bacteria such as E. coli (93), Vibrio vulnificus (94), Haemophilus 
influenzae (95), Pasteurella multocida (96), Klebsiella oxytoca (97), Proteus vulgaris 
(98), and  Bacteroides thetaiotaomicron (99) produce indole from L-tryptophan.  Nearly 
80 other species have been shown to possess the tryptophan indole-lyase or 
tryptophanase (encoded by tnaA) that mediates the breakdown of tryptophan to indole, 
pyruvate, and ammonia. Indole is an extracellular signaling molecule produced during 
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the late exponential and stationary phase (100) that represses biofilm formation, motility, 
acid resistance (21, 22, 101, 102), and attachment of EHEC to epithelial cells (22).  
Indole works through QS (67) primarily at temperatures less than 37°C in E. coli (102).  
Indole increases the expression of multidrug exporter genes in E. coli (103) and in S. 
enterica (104).  However, indole induces biofilm formation of P. fluorescens and P. 
aeruginosa (21).  
 
2.4.3. Norepinephrine (NE)  
 NE is a catecholamine neurotransmitter (stress hormone) that is normally produced 
in the GI tract through the enteric nervous system (105, 106) and is important in GI-tract 
infections. The concentration of NE increases during early sepsis (107), and NE has been 
shown to stimulate the growth of several Gram-negative and -positive bacteria that are 
present in the intestinal lumen (108), including P. aeruginosa (109). Alverdy and co-
workers (10) have correlated the increased NE in the luminal contents of mice after a 
30% hepatectomy to increased expression of the P. aeruginosa virulence determinant 
PA-I lectin and gut-derived sepsis. The NE released in the GI tract during stress has also 
been reported to influence the virulence and infection of other GI tract pathogens. Bansal 
et al. (22) and others (110, 111) have shown that NE increases EHEC O157:H7 
attachment and colonization to epithelial cells and colonic mucosa, respectively. NE also 
enhances the growth, motility, and invasiveness of Campylobacter jejunii (112), the 
expression of the K99 pilus adhesin virulence-related factor in ETEC (113), EHEC 
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O157:H7 virulence gene expression (22, 114), and EHEC O157:H7 chemotaxis, 
motility, and biofilm formation (22). 
 
2.5. Microfluidics and its application in microbiology 
 Microfluidics deals with the precise control and manipulation of fluids contained in 
small (~10–100 μm) channels in which fluid flow is dominated by surface tension and 
laminar effects (54). Microfluidic based devices require smaller reagent volumes, shorter 
reaction times, and offer the promise of high-throughput operations (54).  The current 
techniques used for fabricating microfluidic devices include methods such as 
micromachining, photolithography, soft lithography, embossing, in situ construction, 
injection molding, and laser ablation (115). Each of these techniques has advantages and 
disadvantages, and the most suitable method of device fabrication often depends on the 
specific application of the device (115). Soft lithography, which refers to the molding of 
a two-part polymer (elastomer and curing agent), called polydimethylsiloxane (PDMS), 
using photoresist masters, is faster, less expensive and a more suitable fabrication 
technique than glass or silicon micromachining which is used for most biological 
applications (116). It has features that are unique and complement conventional 
techniques of microfabrication: (a) It can be performed conveniently, rapidly, and 
inexpensively, (b) it is inert to wide range of chemicals that is found in biological 
systems, (c) it provides the ability to control the properties of surfaces at the molecular 
level, and  (d) PDMS is permeable to oxygen and other gases (116).  
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 Recently soft lithography based microfluidics devices have been used for many 
applications in microbiology (117). These studies can be categorized into biofilm 
research, pathogen detection, and nucleic acid analysis. Microfluidic based flow cell 
devices can be used to precisely control a biofilm environment unlike macro flow cells 
and has been used in several different prototypes cells (30-33). For example, Lee et al. 
(32) have used micro flow cells to study S. epidermidis biofilms, Cho et al. (33) to study 
the self-organization of E. coli colonies into biofilms, and Kim et al. (30) to study the 
effect of a gradient of antibiotics on P. aeruginosa biofilms.  Microfluidic biochips have 
recently been used to monitor the response of biofilms to increased shear stress and 
Candida albicans concentrations (118).  Applications related to pathogens include 
identification of respiratory pathogen Bordetella pertussis (119), a microfluidic system 
for saliva-based detection of infectious diseases (120), pathogenic bacteria detection in 
food  (121), and rapid diagnosis of dengue virus infection (122). Work is also 
progressing on the detection of nucleic acids (DNA and RNA) using microfluidics and 
includes digital PCR multigene analysis of individual environmental bacteria (123) and 
PCR microfluidic devices for DNA amplification (124). 
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CHAPTER III 
THE NEUROENDOCRINE HORMONE NOREPINEPHRINE INCREASES 
PSEUDOMONAS AERUGINOSA PA14 VIRULENCE THROUGH THE LAS 
QUORUM SENSING PATHWAY  
3.1 Overview 
 It has been proposed that the GI tract environment containing high levels of 
neuroendocrine hormones is important for gut-derived P. aeruginosa infections. In this 
study, we report that the hormone norepinephrine increases P. aeruginosa PA14 growth, 
virulence factor production, invasion of HCT-8 epithelial cells, and swimming motility 
in a concentration-dependent manner. Transcriptome analysis of P. aeruginosa exposed 
to 500 µM, but not 50 µM, norepinephrine for 7 h showed that genes involved in the 
regulation of the virulence determinants pyocyanin, elastase, and the Pseudomonas 
quinolone signal (PQS, 2-heptyl-3-hydroxy-4-quinolone) were up-regulated. The 
production of rhamnolipids, which are also important in P. aeruginosa infections, was 
not significantly altered in suspension cultures upon exposure to 500 µM norepinephrine, 
but decreased on semi-solid surfaces. Swarming motility, a phenotype that is directly 
influenced by rhamnolipids, was also decreased upon 500 µM norepinephrine exposure. 
The increase in the transcriptional activation of lasR, but not that of rhlR, and the 
increase in the levels of PQS suggest that the effects of norepinephrine are mediated 
________ 
*Reprinted in part with permission from “The neuroendocrine hormone norepinephrine 
increases Pseudomonas aeruginosa PA14 virulence through the las quorum-sensing 
pathway.” by Manjunath Hegde, Thomas K. Wood, & Arul Jayaraman, 2009, Applied 
Microbiology and Biotechnology, 84(4):763-776. Copyright by Springer-Verlag 
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primarily through the las quorum sensing pathway. Together, our data strongly suggests 
that norepinephrine can play an important role in gut-derived infections by increasing 
the pathogenicity of P. aeruginosa PA14. 
 
3.2 Introduction 
 Pseudomonas aeruginosa is one of the most common opportunistic pathogens that 
are present at clinically-undetectable levels in the normal GI tract (10). However, in 
critically-ill and immuno-compromised patients, Pseudomonas sp. levels have been 
shown to increase by as much as 100-fold (16) leading to the expression of virulence 
determinants (e.g., PA-I lectin/adhesin) (10). P. aeruginosa has been shown to 
translocate from the GI tract into the systemic circulation following shock or injury (17), 
and the resultant sepsis rapidly leads to mortality (18). In fact, the mere presence of P. 
aeruginosa in the gastrointestinal (GI) tract of critically-ill surgical patients has been 
associated with nearly 70% mortality (10).  Although the exact mechanisms underlying 
the increase in P. aeruginosa levels and their translocation during stress are largely 
unknown, it is becoming evident that the interaction of neuroendocrine hormones with 
bacteria, termed as “microbial endocrinology” (106), is important in the expression of 
virulence determinants during infection (10). 
 Norepinephrine (NE), a catecholamine neurotransmitter (stress hormone) that is 
normally produced in the GI tract through the enteric nervous system (105, 106), is one 
such molecule that is important in GI tract infections. The concentration of NE increases 
during early sepsis (107), and NE has been shown to stimulate the growth of several 
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Gram-negative and -positive bacteria that are present in the intestinal lumen (108), 
including P. aeruginosa (109). Alverdy and co-workers (10) have correlated the 
increased NE in the luminal contents of mice after a 30% hepatectomy to increased 
expression of the P. aeruginosa virulence determinant PA-I lectin and gut-derived sepsis. 
The NE released in the GI tract during stress has also been reported to influence the 
virulence and infection of other GI tract pathogens. We (22) and others (110, 111) have 
shown that NE increases Escherichia coli O157:H7 attachment and colonization to 
epithelial cells and colonic mucosa, respectively. NE has also been demonstrated to 
enhance growth, motility, and invasiveness of Campylobacter jejunii (112), the 
expression of the K99 pilus adhesin virulence-related factor in enterotoxigenic E. coli 
(113), E. coli O157:H7 virulence gene expression (22, 114), and E. coli O157:H7 
chemotaxis, motility, and biofilm formation (22). Together, these studies indicate that 
NE plays an important role in the pathogenicity of different bacteria. Although these 
studies have shown that NE increases virulence and pathogenicity, the mechanisms 
through which NE impacts virulence of different bacteria are not fully understood. 
 P. aeruginosa controls the production of many secreted virulence determinants, 
including elastase, rhamnolipids, pyocyanin, exotoxin A, and catalase (73), through the 
interrelated las and rhl quorum sensing (QS) systems (73). In addition, the secreted 
Pseudomonas quinolone signal (PQS, 2-heptyl-3-hydroxy-4-quinolone) is also involved 
in the expression of the virulence determinants rhamnolipids, pyocyanin, and elastase 
(74).  The regulation of PQS is not independent, but integrated with the las and rhl QS 
(75), as the regulator for PQS production (pqsR, also known as mvfR) is positively 
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regulated by lasR and negatively regulated by rhlR (75).  
 The goal of this work was to investigate the effect of 50 µM and 500 µM NE on P. 
aeruginosa virulence and gene expression. The lower concentration (50 µM) was used 
as representative of NE levels present in the GI tract during homeostasis, and has been 
used in recent studies (125) to investigate the effect of hormones on GI tract pathogens. 
The higher concentration (500 µM) was used as representative of supra-physiological 
levels of NE likely to be encountered in the GI tract during catabolic stress (105, 126).  
We investigated the effect of NE on the P. aeruginosa transcriptome, as well as on the 
production of different virulence factors, motility, epithelial cell attachment and 
invasiveness, barley seed infection, and activation of different QS systems. To our 
knowledge, this is the first report investigating the molecular basis of alterations in P. 
aeruginosa physiology by NE. 
 
3.3 Results 
 
3.3.1 Effect of NE on P. aeruginosa PA14 growth 
 The effect of NE on PA14 growth was initially determined in order to design 
subsequent experiments for investigating the effect of NE on the expression of genes 
involved in PA14 virulence determinants. Cultures of PA14 were treated with 50 µM 
and 500 µM NE in serum-RPMI medium, and the turbidity at 600 nm monitored. The 
addition of 50 µM and 500 µM NE increased the specific growth rate of PA14 by ~ 9%  
and 50%  respectively (0.35 ± 0.04 h
-1
 and 0.49 ± 0.03 h
-1
 with 50 µM, and 500 µM NE 
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respectively, compared to 0.32 ± 0.06 h
-1 
for the untreated control).  The maximum 
turbidity at 600 nm reached in the presence of 50 µM and 500 µM NE was 1.75 ± 0.02-
fold and 2.43 ± 0.07-fold greater than untreated controls (Fig. 3.1). 
 
 
 
Fig. 3.1. Effect of NE on growth. P. aeruginosa PA14 was grown in RPMI medium at 
37
o
C for 24 h in the presence of 50 µM and 500 µM NE. The turbidity at 600 nm was 
measured at different time points. Data shown are mean turbidity ± one standard 
deviation and are from three independent cultures. 
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3.3.2 Differential gene expression in planktonic cells upon exposure to NE 
 Whole transcriptome analysis was used to investigate the molecular basis underlying 
the effect of NE on PA14 gene expression, specifically its effect on the expression of 
genes involved in the production and regulation of virulence factors. Exposure to 50 µM 
NE for 7 h (corresponding to late-exponential phase of growth in Fig. 3.1) significantly 
altered the expression of 184 genes as compared to the untreated control. Of these, 128 
genes were induced 4- to 209-fold, while 56 genes were repressed 4- to 42-fold 
(Appendix Table I). The genes that were increased in expression upon exposure to 50 
µM NE included those of nitrate metabolism (narGHIJK1K2; induced 13- to 32.0-fold) 
that are involved in nitrate assimilation and respiration, and genes related to 
molybdenum cofactor synthesis (moeA1B1CDE; induced 5- to 209-fold) that are 
involved in nitrogen metabolism (127). Expression of the heme acquisition protein 
HasAp decreased by 42-fold, while genes involved in pyoverdine siderophore 
biosynthesis and metabolism (pvdADEFGJLNO) were repressed 5- to 15-fold 
respectively in NE exposed cultures. In addition, a few genes involved in virulence such 
as toxA (exotoxinA), aprD (alkaline protease), sodM (superoxide dismutase) were also 
repressed by 8-fold, 4-fold, and 12-fold respectively. However, genes involved in the 
production of other virulence determinants (e.g., elastase, alkaline protease, PQS, and 
rhamnolipids) were not significantly altered upon exposure to 50 µM NE. 
 Exposure of PA14 to a higher concentration of NE for 7 h significantly induced the 
expression of 287 genes and repressed the expression of 50 genes (Appendix Table II). 
The data showed that 34 genes were commonly expressed between PA14 exposed to 50 
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µM and 500 µM NE (Appendix Table III). The commonly-regulated genes primarily 
included those related to nitrogen metabolism and respiration. In addition, the expression 
of several QS-controlled genes associated with virulence was significantly altered in 
PA14 exposed to 500 µM NE (Table 3.1). These included the elastase synthesis genes 
lasA and lasB, which were induced 6.5 and 2-fold respectively, phospholipase gene plcB 
which was induced 4.0-fold, rhamnolipids synthesis related gene (rhlG) which was 
repressed 6.5-fold in the NE treated cells, and phenazine biosynthesis (pyocyanin) genes 
(phzCDEF) which were induced 2.0 to 3.3-fold. Other significantly induced virulence 
factor production and infection genes included those involved in flagellar synthesis (flgD 
and flgL; 2.3-fold and 2.1-fold), type IV fimbriae (pilC and pilD; 2.8-fold and 3-fold), 
PQS synthesis (pqsABE and mvfR; induced 1.9 to 4-fold), exoenzyme S regulation and 
production (exsABC; 2- to 4-fold), and exoenzyme T (exoT, 2-fold). Genes whose 
expression upon exposure to 500 µM NE included those involved in alkaline protease 
secretion (aprA and aprE, 2.1-fold and 2.6-fold) and the Fe (III)-pyochelin outer 
membrane receptor precursor gene fptA (2.5-fold). The fold change values obtained from 
qRT-PCR (Table 3.2) are consistent with those from whole microarray analysis. 
 
 
 
 
 
  
34 
 
                                                         3
4
 
Table 3.1. Partial list of differentially-expressed genes in suspension cells of PA14 grown in serum-RPMI medium at 37 
o
C for 
7 h with 50 µM and 500 µM of NE. Complete data for the 50 µM and 500 µM DNA microarrays are available using GEO 
series accession number GSE 13326. 
1
Most significant changes (greater than 4-fold for 50 µM NE array and 2-fold for 500 µM 
NE array) are shown in bold. 
 
 Fold change
1
  
Locus tag Gene 
name 
NE vs. 
control 
(50 µM) 
NE vs. 
control 
(500 µM) 
Description 
Quorum-sensing controlled genes 
PA0026 plcB -2.3 4.0 phospholipase C 
PA0044 exoT -1.4 2.1 Exoenzyme T 
PA0996 pqsA 1.0 1.9 Probable coenzyme A ligase 
PA0997 pqsB 1.1 2.6 Beta-keto-acyl carrier protein synthase 
PA0998 pqsC 1.1 1.1 Beta-keto-acyl carrier protein synthase 
PA0999 pqsD 1.2 1.7 3-oxoacyl-[acyl-carrier-protein] synthase III 
PA1000 pqsE 1.1 4.3 Quinolone signal response protein 
PA1003 mvfR -1.4 3 Transcriptional regulator MvfR 
PA1130 rhlC -1.3 2.8 Rhamnosyltransferase 2 
PA1148 toxA -8.0 1.2 Exotoxin A precursor 
PA1246 aprD -4.0 1.2 Alkaline protease secretion protein AprD 
PA1247 aprE -2.1 -2.6 Alkaline protease secretion protein AprE 
PA1249 aprA -1.4 -2.1 Alkaline metalloproteinase precursor 
PA1710 exsC -1.3 2.1 Exoenzyme S synthesis protein C precursor. 
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Table 3.1. Continued. 
Locus tag Gene 
name 
NE vs. 
control 
(50 µM) 
NE vs. 
control 
(500 µM) 
Description 
PA1712 exsB -1.1 3.7 Exoenzyme S synthesis protein B 
PA1712 exsA -1.2 2.1 transcriptional regulator ExsA 
PA1871 lasA 1.2 6.5 LasA protease precursor 
PA1898 qscR 2.0 2.5 Quorum-sensing control repressor 
PA1901 phzC2 1.1 2.5 Phenazine biosynthesis protein PhzC 
PA1902 phzD2 1.1 2.0 Phenazine biosynthesis protein PhzD 
PA1903 phzE2 1.0 2.3 Phenazine biosynthesis protein PhzE 
PA1904 phzF2 -1.1 3.3 Probable phenazine biosynthesis protein 
PA3095 xcpZ 1.0 3.7 general secretion pathway protein M 
PA3097 xcpX -1.1 2.6 general secretion pathway protein K 
PA3099 xcpV 1.0 2.8 general secretion pathway protein I 
PA3100 xcpU -1.1 2.8 General secretion pathway outer membrane protein H precursor 
PA3101 xcpT -1.1 2.5 general secretion pathway protein G 
PA3102 xcpS 1.1 2.8 general secretion pathway protein F 
PA3103 xcpR 1.1 2.0 general secretion pathway protein E 
PA3477 rhlR -1.1 1.7 transcriptional regulator RhlR 
PA3479 rhlA -1.2 1.7 Rhamnosyltransferase chain A 
PA3724 lasB 1.2 2.0 Elastase LasB 
PA4209 phzM -1.9 1.3 Probable phenazine-specific methyltransferase 
PA4210 phzA1 -1.5 -1.2 Probable phenazine biosynthesis protein 
PA4217 phzS -2.5 1.1 Flavin-containing monooxygenase 
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Table 3.1. Continued. 
Locus tag Gene 
name 
NE vs. 
control 
(50 µM) 
NE vs. 
control 
(500 µM) 
Description 
Pyoverdine 
 
PA2254 pvcA 1.0 1.2 Pyoverdine biosynthesis protein PvcA 
PA2255 pvcB -1.2 1.4 Pyoverdine biosynthesis protein PvcB 
PA2256 pvcC 1.3 1.6 Pyoverdine biosynthesis protein PvcC 
PA2396 pvdF -8.6 -1.2 Pyoverdine synthetase F 
PA2397 pvdE -12.1 -1.2 Pyoverdine biosynthesis protein pvdE 
PA2398 fpvA -9.2 1.5 Ferripyoverdine receptor 
PA2399 pvdD -8.6 2.3 Pyoverdine synthetase D 
PA2400 pvdJ -7.5 1.3 PvdJ 
PA2426 pvdS -7.5 -2.1 Sigma factor PvdS 
PA4168 fpvB -12.1 2 Second ferric pyoverdine receptor FpvB 
 
Pyochelin 
 
PA4221 fptA -1.9 2.5 Fe(III)-pyochelin outer membrane receptor precursor 
PA4224 pchG -1.2 -1.7 Pyochelin biosynthetic protein PchG 
PA4225 pchF -1.3 -1.6 Pyochelin synthetase 
PA4226 pchE -1.3 -1.5 Dihydroaeruginoic acid synthetase 
PA4227 pchR -2.5 -1.6 Transcriptional regulator PchR 
PA4228 pchD -1.1 -1.9 Pyochelin biosynthesis protein PchD 
PA4229 pchC -1.2 -1.6 Pyochelin biosynthetic protein PchC 
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Table 3.1. Continued.                 
Locus tag Gene 
name 
NE vs. 
control 
(50 µM) 
NE vs. 
control 
(500 µM) 
Description 
PA4230 pchB 1.1 -1.5 Salicylate biosynthesis protein PchB 
PA4231 pchA 1.0 -1.4 Salicylate biosynthesis isochorismate synthase 
 
Motility 
 
PA3115 fimV 1.1 2.1 Motility protein FimV 
PA4526 pilB -1.3 1.7 Type 4 fimbrial biogenesis protein PilB 
PA4527 pilC -2.3 2.8 Still frameshift fimbrial biogenesis protein PilC 
PA4528 pilD -1.1 3 Type 4 prepilin peptidase PilD 
PA1079 flgD -1.1 2.3 Flagellar basal-body rod protein FlgD 
PA1080 flgE -1.1 1.4 Flagellar hook protein FlgE 
PA1087 flgL -1.1 2.1 Flagellar hook-associated protein type 3 FlgL 
PA1099 fleR -1.1 4.3 Two-component response regulator 
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Table 3.2. Gene name and its corresponding primer sequence used for qRT-PCR; relative change in expression of the genes 
determined by microarray (50 µM NE and 500 µM NE) and qRT-PCR at 7 h. Significant changes in gene expression (greater 
than 4-fold for 50 µM NE array and 2-fold for 500 µM NE array) are shown with an asterisk. 
 
PA# Gene Forward primer 
(5’-3’) 
Reverse primer 
(5’-3’) 
Fold change (50 µM 
NE vs. no  NE) 7 h 
Fold change (500 µM NE 
vs. no NE ) 7 h 
Microarray qRT-
PCR 
Microarray qRT-
PCR 
PA0026 plcB ACTACACCTCGTACTGGCACTT TTCAGCTCGCGGTTGTAGAGAT -2.3 -3.4 4.0* 7.1* 
PA1430 lasR TAAGGACAGCCAGGACTACGAGAA TGGTAGATGGACGGTTCCCAGAAA 1.2 1.3 1.0 1.5 
PA1871 lasA ACCCGAAAGTGTTGTTGACCCT TTCCTCGAAACCGTAGTAGCGT 1.2 -1.4 6.5 * 4.7 * 
PA2426 pvdS ATGTGGTCCAGGATGCGTTCTT TATTTCTGTTCGAGCGCCTGCT -7.5* -9.8* -2.1* -3.4* 
PA3477 rhlR AATTTGCTCAGCGTGCTTTCCGTG TGGGTCAGCAACTCGATCATGCAA -1.1 -1.5 1.7 1.3 
PA4527 pilC TTTCCATGCGCACCACCAATGT ATCGGCTCCATCAACGTTGTCA -2.3 -2.8 2.8 * 1.7 
PA0393 proC CAGGCCGGGCAGTTGCTGTC GGTCAGGCGCGAGGCTGTCT - - - - 
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3.3.3. Effect of NE on production of P. aeruginosa PA14 virulence factors  
 The levels of five virulence factors - pyocyanin, elastase, rhamnolipid, PQS, and 
pyoverdine - were determined in PA14 cultures exposed to 50 µM and 500 µM of NE. 
The production of pyocyanin increased 2.1 ± 0.2-fold and 3.9 ± 0.2-fold after 16 h and 
24 h of exposure to 50 µM NE (Fig. 3.2A), but did not change significantly at earlier 
time points. Similarly, exposure to 500 µM NE increased pyocyanin 3.2 ± 0.9-fold, 4.9 ± 
0.5-fold, and 6.4 ± 0.4-fold at 12 h, 16 h, and 24 h, respectively (Fig. 3.2A). NE 
exposure increased elastase production by 3.4 ± 0.3-fold at 16 h and by 6.2 ± 1.4 fold at 
24 h upon exposure to 500 µM NE; however, elastase levels did not increase with 50 µM 
NE (Fig. 3.2B).  The levels of PQS increased by 9.7 ± 0.5-fold after 24 h exposure to 
500 µM NE but not with 50 µM NE (Fig. 3.2C). Rhamnolipid levels were only 
marginally increased upon exposure to both 50 µM and 500 µM NE (1.7 ± 0.1/1.8 ± 0.1-
fold at 16 h and 1.2 ± 0.4/1.3 ± 0.4-fold at 24 h) (Fig. 3.2D). The levels of pyoverdine 
were not altered with either concentration of NE for up to 24 h (not shown).  
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Fig. 3.2. Virulence factor production in the presence of NE. Changes in the levels of 
(A) pyocyanin, (B) elastase, (C) PQS, and (D) rhamnolipid in P. aeruginosa PA14 in the 
presence of 50 µM and 500 µM NE. Virulence factors were measured in triplicate after 
8, 12, 16, and 24 hours of exposure to NE and normalized to the cell density of the 
culture. Data shown are from three independent experiments. Error bars indicate mean 
fold change ± one standard deviation. *: statistical significance at p < 0.05 for NE treated 
cultures relative to untreated control.  
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 We investigated the effect of increased virulence factor levels on attachment and 
invasion of the HCT-8 human enterocyte cell line. The extent of PA14 adhesion to HCT-
8 cells in the presence of 50 µM and 500 µM NE increased by 1.6 ± 0.3-fold and 2.9 ± 
0.4-fold, respectively (Fig. 3.3A). Similarly, invasion of HCT-8 cells was also increased 
by 1.5 ± 0.2-fold and 4.2 ± 0.5-fold upon exposure to 50 µM and 500 µM NE. Together 
with the increase in PA14 virulence factor levels, our data strongly indicate increased 
PA14 virulence and infectivity upon exposure to NE (especially at 500 µM NE). 
 Since PA14 can infect both plant and animal hosts (71), we also investigated the 
effect of increased virulence factor levels on infection using a barley seed infection 
model (128). Germination of barley seeds in the presence of PA14 was reduced to 51 ± 4% 
(p < 0.005) of the untreated control which is in good agreement with our prior work 
(128). The addition of 50 µM and 500 µM NE further reduced germination further to 20 
± 7% and 9 ± 4% of the control (p < 0.01) (Fig. 3.3B); hence, 50 µM and 500 µM NE 
increased P. aeruginosa virulence by 2.6 ± 0.9-fold and 6 ± 3fold, respectively. Nearly 
100% germination of barley seeds was observed in negative controls and seeds treated 
only with 50 µM or 500 µM NE (Fig. 3.3B). These results further confirm that exposure 
to NE increased PA14 virulence. 
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Fig. 3.3. Epithelial cell attachment and invasion and barley seed infection in the 
presence of NE. Relative changes in P. aeruginosa PA14 (A) attachment and invasion 
to HCT-8 cells, and (B) barley seed germination, after exposure to 50 μM or 500 μM 
NE. For the attachment and invasion assays, cell counts (mean ± one standard deviation) 
are from duplicate LB agar plates and generated from nine HCT-8 cell culture wells and 
3 independent experiments. „*‟ indicate statistical significance determined using the 
Student t-test at p < 0.05. For the barley seed germination assay, the percentage of barley 
seeds germinated was calculated. Data are the average of three independent experiments, 
and one standard deviation is shown. „*‟ indicate statistical significance determined 
using the Student t-test at p< 0.001. 
 
3.3.4 Effect of NE on P. aeruginosa PA14 swimming and swarming motility  
 Since motility is directly related to infection (129), we investigated the effect of NE 
PA14 swimming and swarming motility. The swimming motility of PA14 in serum-free 
RPMI with 0.5% agar supplemented with 10 µM FeCl3 (i.e., the same base medium used 
for microarray and virulence factor experiments) increased in the presence of NE in a 
concentration dependent manner (Fig. 3.4). Swimming motility was increased by 30% 
and 60% upon exposure to 50 µM and 500 µM NE. Interestingly, an extracellular 
product zone was detected in control and 50 µM NE plates outside the swimming 
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motility halo, but was absent in the 500 µM plates. The constituent of this clear zone was 
abiotic as it did not grow on plates, and was identified as rhamnolipid using methylene 
blue staining (130). The diameter of this secreted rhamnolipid zone was only slightly 
less than control with 50 µM NE but was virtually abolished at 500 µM (Fig. 3.4), 
suggesting that NE suppressed PA14 rhamnolipid production when growing on agar 
surfaces.  
 Since rhamnolipids contribute to P. aeruginosa swarming (130), we also investigated 
the effect of NE on PA14 swarming motility. Figs. 3.5A-C show that exposure to 500 
µM NE completely inhibited PA14 swarming motility; however, no effect was observed 
with 50 µM NE. Since an increase in intracellular iron levels has been shown to decrease 
rhamnolipid production (131), we investigated whether the NE-mediated decrease in 
swarming motility is due to an increase in intracellular iron levels. Fig. 3.5D shows that 
increasing iron concentration in the swarming agar from 10 µM to 100 µM completely 
inhibited swarming motility similar to that observed with 500 µM NE.  
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Fig. 3.4. Changes in swimming motility upon exposure to NE. Changes in P. 
aeruginosa PA14 swimming motility upon exposure to NE. PA14 was spotted onto 
RPMI 0.3% motility agar medium supplemented with 10 µM FeCl3 containing 50 µM or 
500 µM of NE. The swimming halo diameter and the clear rhamnolipid zone diameter 
were measured after 24 h at 37
o
C. Error bars indicate mean halo diameter or rhamnolipid 
zone diameter ± one standard deviation. Data shown are from three independent 
cultures. *: statistical significance at p < 0.05 for NE treated cultures relative to control. 
**: diameter of the rhamnolipid zone with 500 µM outside the motility halo was 
negligible and could not be accurately measured. 
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Fig. 3.5. Changes in swarming motility upon exposure to NE or excess iron.  P. 
aeruginosa PA14 was spotted onto 0.5% BM2 motility agar containing 10 µM 
FeSO4.7H2O  and (A) 0 µM, (B) 50 µM, or (C) 500 µM NE. (D) 100 µM  of 
FeSO4.7H2O . Representative images from three independent experiments are shown 
 
3.3.5 NE enhances activity of las, but not rhl, quorum sensing  
 We hypothesized that the effects of NE at a concentration of 500 µM are mediated 
primarily through the las, but not the rhl, quorum sensing (QS) system. Therefore, we 
determined the transcriptional activation of lasR and rhlR (i.e., the response regulators of 
the las and rhl QS systems) with NE using a promoter::lacZ reporter fusion (132) during 
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the mid to late-exponential growth phase (i.e., after 4, 5.5, 6.5, and 7.5 hours of growth 
in the presence of NE). PA14 with the plasR::lacZ reporter plasmid showed a 3.2 ± 0.8-
fold increase in β-galactosidase activity in the presence of 500 µM NE after 7.5 hours 
(Fig. 3.6), but did not demonstrate an increase in the presence of 50 µM NE. Although 
detectable β-galactosidase was observed at earlier time points (4 h, 5.5 h, and 6.5 h), the 
changes in activity observed with NE were not statistically significant from the control. 
On the other hand, PA14 with the prhlR::lacZ reporter did not show any change in β-
galactosidase activity in the presence of NE (50 µM and 500 µM) compared to the 
untreated control at any of the time points. These results suggested that NE increases the 
activity of las, but not the rhl, QS pathway. 
 
3.4 Discussion 
 It has been proposed that P. aeruginosa in the GI tract lumen can respond to specific 
environmental cues (e.g., high concentration of hormones) to express different virulence 
determinants and initiate infection (133). This hypothesis is supported by the fact that 
neuroendocrine hormones play an important role in gut-derived sepsis (134), and have 
been reported to spill over into circulation (105) and the lumen (135). In addition, 
intestinal levels of tyrosine hydroxylase, the rate-limiting enzyme in NE biosynthesis, 
has been shown to be increase 2 h after the onset of sepsis, and has been speculated to 
contribute to the increase in gut-derived NE during sepsis (136). Although plasma levels 
of circulating catecholamines have been found to be in the nanomolar range during 
sepsis (105), It should be noted that such plasma levels reflect spillover from tissue sites 
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located throughout the body, and do not accurately reflect the local concentration at any 
particular tissue site. For example, Kopin et al., (137) have estimated that concentration 
of NE at the receptor site during non-septic conditions was at least three-fold higher than 
that detected in the plasma. In fact, the plasma concentrations of hormones may 
underestimate the local concentration of NE in the GI tract by orders of magnitude (138) 
as the mesenteric organs contribute to approximately half of the NE produced in the 
body (126). Therefore, although the concentrations of NE (50 µM and 500 µM) used in 
this study do not reflect reported actual plasma concentrations, they are representative of 
the concentration range reported in the GI tract during normal and catabolic stress (133, 
139) and are consistent with concentrations used in previous studies (112, 125, 140-142). 
 The increase in PA14 WT growth rate with 50 µM and 500 µM NE is consistent with 
in vitro studies showing that NE stimulates the growth of several bacterial pathogens, 
including E. coli and P. aeruginosa (109, 143), in serum-based (i.e., transferrin-
containing) nutritionally-minimal growth media. It has been proposed that NE enhances 
pathogen growth by providing access to iron needed for growth (144) through 
production of siderophores (145). Although pyocyanin synthesis genes are up-regulated 
on exposure to 500 µM NE, interestingly, genes involved in the production of other 
major P. aeruginosa siderophores such as pyoverdine and pyochelin (146) were down-
regulated upon NE exposure. Since several of these genes are regulated by the 
transcription factor Fur and repressed under conditions of iron abundance (147), our data 
suggest that PA14 preferentially utilizes pyocyanin for iron acquisition from a minimal 
nutrient environment (145) such as that seen in the GI tract, and the increase in iron 
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levels leads to down-regulation of other siderophore genes. 
 
Fig. 3.6. Effect of NE on quorum sensing pathways. Changes in lasR and rhlR 
expression were measured using the β-galactosidase activity assay. PA14 cultures 
containing plasmids with lasR::lacZ and rhlR::lacZ transcriptional fusions respectively 
were grown with 50 µM and 500 μM NE. The β-galactosidase activity in one mL culture 
aliquots was determined and normalized to the cell density. The β-galactosidase activity 
of PA14 cultures observed in plasmids with only lacZ (i.e., no lasR or rhlR fusion) was 
negligible. Data shown are from three independent experiments and represent mean β-
galactosidase activity ± one standard deviation. „*‟ indicate statistical significance 
determined using the Student t-test at p < 0.05 
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 The increase in the production of the P. aeruginosa virulence factors such as 
pyocyanin and elastase suggests that the pathogen may opportunistically utilize host 
hormones to facilitate infection. Our data suggest pyocyanin may play a dual role in P. 
aeruginosa infections. Apart from stimulating PA14 growth through rapid acquisition of 
iron in minimal environments, pyocyanin is also likely involved in virulence as our data 
show pyocyanin levels increasing even after 24 h of exposure to NE (i.e., when the 
pathogen is no longer growing). The growth-independent production of pyocyanin likely 
increases the susceptibility of host cells to infection as pyocyanin has also been shown to 
cause oxidative stress in epithelial cells (148) and apoptosis in neutrophils (149). 
Similarly, the increase in the levels of elastase, which is involved in degradation of 
elastin and collagen in host tissues during infection (150), and PQS, which inhibits 
human T cell proliferation and acts as an immune modulator (151, 152), also reinforce 
the idea that the NE-mediated increase in virulence factor levels could contribute to P. 
aeruginosa infections. The concordance between virulence factor production and 
attachment/invasion of epithelial cells supports the idea that PA14 could utilize NE 
during colonization and infection of the GI tract. The increase in infection with the 
barley seed germination assay, a valid model for P. aeruginosa PA14 virulence as this 
strain contains a common set of virulence genes to elicit soft rot disease in lettuce and 
Arabidopsis plants, as well as in mice (72), further strengthens the hypothesis that high 
concentrations of NE increases PA14 virulence.   
 Since NE is produced in situ in the GI tract (105, 106, 141), it is likely that 
pathogens in the GI tract encounter either low luminal concentrations of NE under 
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normal conditions, or short-lived bursts of higher NE concentrations during acute stress. 
The observation that sustained exposure (> 8 h) to 500 µM, but not 50 µM, of NE is 
needed to cause an increase in pyocyanin, elastase, and PQS levels is significant in the 
context of gut-derived P. aeruginosa infections as it suggests that acute exposure to 
hormones is not likely to lead to P. aeruginosa infection.  
 The fact that NE significantly increased the levels of only pyocyanin (6.4-fold), 
elastase (6.2-fold), and PQS (9.7-fold), but not rhamnolipids (30%) and pyoverdine 
(unchanged), in suspension cultures at 24 h, argues that the increase in virulence factor 
levels is due to a NE-specific effect and not merely due to the increased cell density 
upon NE exposure. Four lines of evidence suggest that the las QS pathway is involved in 
mediating the effects of NE in PA14. First, the increase in expression of lasA and lasB, 
the up-regulation of lasR promoter activity, and increased production of elastase, 
strongly suggest the involvement of the las QS system. Second, the increase in the 
expression of other las QS-controlled P. aeruginosa virulence factor genes 
(phospholipase C) and in the expression of type II secretion genes (xcpRSTUVXZ) (153) 
that is involved in secreting elastase and phospholipase and is itself controlled by las QS 
(153), is also indicative of the las QS being activated upon exposure to NE. Third, the 2-
fold increase in the expression of the global response regulator gacA, which positively 
regulates lasR and the production of extracellular virulence factors such as pyocyanin, 
cyanide, and exoenzyme lipase (154), in the presence of 500 µM NE suggests that NE 
may be acting through gacA to increase the las QS activity. Fourth, the increase in the 
levels of PQS also suggests increased las QS activity, as the expression of mvfR (up-
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regulated 3-fold in our study), the regulator of PQS production, has been shown to be 
up-regulated by lasR but down-regulated by rhlR (75). The activation of P. aeruginosa 
QS by host hormones is also consistent with other studies showing that eukaryotic 
hormones such as epinephrine can influence E. coli O157:H7 quorum sensing (155).  
 It was surprising to note that while rhamnolipid levels were slightly increased or 
unchanged (16 h and 24 h data points, respectively in Fig. 3.2D) upon exposure to 500 
µM NE in suspension cultures, they were significantly decreased on motility agar plates 
after 24 h. It is possible that the effect of NE on rhamnolipid production depends on the 
culture format in which PA14 is grown (i.e., in suspension or on semi-solid surfaces). 
Overhage et al. (156) recently reported that ~ 7.5% of the P. aeruginosa PAO1 genome, 
including genes involved in the type III secretion system, extracellular proteases, and 
siderophore synthesis, are differentially expressed under swarming conditions compared 
to suspension cells or biofilms. Since colonization on a semi-solid surface closely 
mimics the in vivo scenario where a mucus layer covers epithelial cells, it is possible that 
the NE-mediated decrease in rhamnolipid production is significant in the context of 
PA14 virulence in vivo. Since colonization of epithelial cells is necessary for the 
infection process, the decrease in swarming motility observed with 500 µM NE could 
contribute, in part, to increased colonization and subsequent invasion. Further work is 
required to completely understand differences between P. aeruginosa pathogenesis in 
surface-associated and planktonic cultures. 
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3.5 Summary 
 We have shown that NE at a concentration of 500 µM, but not 50 µM, increases P. 
aeruginosa PA14 growth, motility, attachment, and virulence, all of which are integral to 
infection. Our data also show that the actions of NE are mediated primarily through the 
las, and not the rhl QS system. We propose that P. aeruginosa can utilize NE for 
colonization of the GI tract to initiate infection that eventually leads to gut-derived sepsis. 
 
3.6 Materials and methods 
 
3.6.1 Bacterial strains, mammalian cell line and materials 
 P. aeruginosa PA14 wild type (157) was used for all the experiments. E. coli DH5α 
transformed with plasmids pLP170, pPCS1001, and pPCS1002 containing the lacZ, 
plasR::lacZ, and prhlR::lacZ transcriptional fusions respectively, was kindly provided 
by Dr. Barbara Iglewski (132). PA14 was grown at 37
o
C in RPMI 1640 medium (MP 
Biomedicals, Solon, Ohio) supplemented with 10% heat-inactivated horse serum 
(Hyclone, Logan, Utah) in all experiments unless indicated otherwise. L-(-)-
Norepinephrine-(+)-bitartrate (NE) was obtained from EMD Biosciences, La Jolla, CA. 
The human ileo-cecal colorectal adenocarcinoma line, HCT-8 (ATCC, Mansasses, VA), 
derived from enterocytes at the junction of the large and small bowel, was grown at 37
o
C 
in a 5% CO2 humidified environment using  RPMI 1640 medium supplemented with 10% 
horse serum (HS) as the growth medium. Elastin-Congo Red obtained from MP 
Biomedicals was used for the elastase assay. Carbenicellin and gentamicin was obtained 
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from Fisher Scientific (Fair Lawn, NJ) and MP Biomedicals, respectively. 
 
3.6.2 Growth rate measurement 
 For growth rate measurements, a single colony of PA14 was grown overnight in 
Luria-Bertani (LB) broth, and re-inoculated in serum-RPMI medium in the presence of 
50 µM and 500 µM NE to an initial turbidity of ~ 0.05 at 600 nm.  The turbidity of the 
cultures at 600 nm was monitored every hour and the growth rate of the exponentially 
growing cultures was calculated. Growth curves were obtained in triplicate using three 
independent cultures, and the statistical significance of specific growth rate was 
determined using the unpaired Student‟s t-test. 
 
3.6.3 Total RNA isolation and microarray analysis 
      PA14 was grown overnight in LB to turbidity at 600 nm of ~5.0 and diluted in 100 
mL of serum-RPMI medium to an initial turbidity at 600 nm of 0.05.  Different 
concentrations of NE (50 µM or 500 µM) were added and the cultures grown for 7 hours 
until late exponential phase (turbidity at 600 nm of ~0.5, 1.1 and 1.5 with 0 µM, 50 µM 
and 500 µM NE, respectively). Cell pellets were prepared and RNA was isolated as 
described previously (158). 
  The P. aeruginosa Genome Array (Affymetrix, P/N 510596) containing 5,500 of the 
5,570 open reading frames of P. aeruginosa PA01, was used to analyze changes in the 
PA14 transcriptome. cDNA synthesis, fragmentation and hybridizations were as 
described previously (159). Hybridization was performed for 16 h at 50°C, and the total 
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cell intensity was scaled to an average value of 500. The probe array images were 
inspected for any image artifact. Background values, noise values and scaling factors of 
all the arrays were examined and were comparable. The intensities of polyadenosine 
RNA control were used to monitor the labeling process. For each binary microarray 
comparison of differential genes expression, if the gene with the larger transcription rate 
did not have a consistent transcription rate based on the 13 probe pairs (p-value less than 
0.05), these genes were discarded. A gene was considered differentially expressed when 
the p-value for comparing two chips was lower than 0.05 (to assure that the change in 
gene expression was statistically significant and that false positives arise less than 5%), 
and the expression ratio (between cells treated with NE and control) was greater than 4.0 
for 50 µM NE array and 2.0 for 500 µM NE array (based on the standard deviation of 
fold-change values) (160). Gene functions were obtained from 
http://www.pseudomonas.com/download.jsp . The expression data have been deposited 
in the NCBI Gene Expression Omnibus (161) and are accessible through Accession No. 
GSE# 13326.  
 
3.6.4 Quantitative Reverse-Transcription Polymerase Chain Reaction (RT-PCR) 
 Quantitative RT-PCR was performed using a Bio-Rad iCycler (Bio-Rad, CA) real-
time PCR unit. Approximately 20 ng of total RNA from control or NE-treated PA14 was 
used for each reverse transcription reaction.  Gene sequences were downloaded from 
http://www.pseudomonas.com/search.jsp and gene-specific primers were used for plcB, 
lasR, lasA, pvdS, rhlR, pilC, and proC (housekeeping control) (Table 3.2). Threshold 
55 
 
 
55 
cycle numbers were calculated using the MyiQ software (Bio-Rad), and PCR products 
were verified using agarose electrophoresis. RT-PCR experiments were performed thrice 
(i.e., three experimental replicates) using the same RNA sample used for the microarray 
analysis. 
 
3.6.5 Virulence factor assays 
 PA14 cells were grown in serum-RPMI with 50 µM or 500 µM NE for 8, 12, 16, and 
24 h. At each time point, pyocyanin was extracted from the cell-free culture supernatant 
into the aqueous phase as described previously (162).  The pyocyanin concentration was 
normalized to the cell density (turbidity at 600 nm). The PA14 phzM mutant was used as 
the negative control.  
 Elastase activity in PA14 cultures exposed to 50 µM or 500 µM NE was determined 
as described previously (163). The elastase activity was normalized with the cell density 
(turbidity at 600 nm) to determine elastase activity per cell. The PA14 lasI mutant was 
used as the negative control for elastase production.  
 PQS was extracted from control and NE-treated PA14 cultures as described 
previously (164), and measured using a thin layer chromatography (TLC) assay (165). 
Synthetic PQS (Syntech Solution, San Diego, CA) was used as a standard, and the PA14 
pqsA mutant was used as the negative control. PQS levels were determined by imaging 
the TLC plate using a VersaDoc 3000 imaging system (BioRad, Hercules, CA, USA).  
 The pyoverdine concentration was determined by measuring the absorbance of the 
culture supernatant at 405 nm and normalizing with the cell density (turbidity at 600 nm) 
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as described previously (166).  The PA14 pvdF mutant was used as the negative control 
for pyoveridin production.  
 The rhamnolipid assay was adapted from Ohman et al. (163). PA14 cells were grown 
in serum-RPMI with and without 50 µM and 500 µM NE. After 8 h, 12 h, 14 h, and 24 h, 
1 mL of the cell suspension was centrifuged at 10,000×g for 2 min, and rhamnolipids 
were extracted into the aqueous phase as described previously (164). The absorbance of 
the aqueous layer was recorded using the orcinol colorimetric assay at 495 nm and 
normalized by the cell density (turbidity at 600 nm). The PA14 rhlR mutant was used as 
the negative control for rhamnolipid production. All virulence factor assays were 
performed in triplicates using three independent cultures. 
 
3.6.6 Swimming and swarming motility 
 The swimming motility assay was adapted from Bearson and Bearson (167). Briefly, 
a single colony of PA14 was grown overnight in LB and sub-cultured at 1:100 in LB 
medium, and grown to a turbidity of ~ 1.0 at 37
o
C. NE (50 µM and 500 µM) were added 
to 0.3% agar (Difco Laboratories, Detroit, MI) in serum-free RPMI medium. Serum was 
not included in the plates because of difficulties in preparing serum-RPMI agar plates.  
Instead, 10 µM FeCl3 (Acros Organics, NJ) was added to the medium as Bearson and 
Bearson (167) have shown that iron is required for observing NE-mediated changes in 
phenotype (e.g., swimming motility) in the absence of serum-derived iron. The size of 
the motility halos were measured after 24 hours. Five motility plates were used for each 
concentration of NE, and the experiment was repeated with three independent cultures 
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(total of 15 plates per NE concentration). The diameter of the transparent zone 
surrounding the motility halo in PA14 control plates was determined by adding 50 µL of 
methylene blue (Fisher Scientific, Fair Lawn, NJ) to the edge of the clear zone and by 
tracing the dye till it covered the border of the entire zone (130). 
 Swarming motility was performed as described previously (156). Briefly, fresh BM2 
swarm agar plates containing 10 µM FeSO4.7H2O and supplemented with 0.1% 
casamino acids (Difco Laboratories, Detroit, MI) and 0.5% bacto-agar (Difco 
Laboratories, Detroit, MI) were used. PA14 were grown overnight in LB, re-inoculated 
at 1:100 in LB medium, and grown to a turbidity of ~ 1.0 at 37
o
C. NE (50 µM and 500 
µM) were added to the BM2 swarm agar plates, and the swarming motility pattern was 
observed after 24 hours. The concentration of iron source in BM2 agar was increased to 
100 µM and 1 mM FeSO4.7H2O and swarming motility pattern of PA14 was observed 
after 24 h. Motility agar plates were freshly prepared and dried for 3 h prior to the 
experiment. Five motility plates per NE concentration were used, and the experiment 
was repeated with three independent cultures (total of 15 plates per NE concentration). 
 
3.6.7 Epithelial cell attachment and invasion assay 
 Adhesion of PA14 on epithelial cells and its invasion into epithelial cells was 
determined as described by Bansal et al. (22) and Fleiszig et al. (168), respectively. Low 
passage HCT-8 cells were seeded into standard 24-well tissue culture plates (Corning 
Inc., Corning, NY) and grown to ~ 80% confluency. HCT-8 cell monolayers were 
washed twice with sterile phosphate buffered saline (PBS) to remove unattached cells, 
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and the growth medium was replaced with antibiotic-free medium containing 10% heat-
inactivated HS. PA14 (turbidity at 600 nm of ~ 0.8) and NE (50 µM or 500 µM) were 
added to wells and incubated for 3 hours. Loosely attached PA14 were removed by 
washing the wells thrice with sterile PBS.  
 For the adhesion assay, HCT-8 cells were lysed in the wells with 0.1% Triton X-100 
and the cell suspension vigorously mixed prior to enumeration of bacteria. For the 
invasion assay, fresh RPMI medium with 200 µg/ml gentamicin (a concentration which 
completely killed PA14 suspension cells) was added to each well after removal of 
loosely attached PA14 cells. After a 2 h incubation to kill attached (extracellular) P. 
aeruginosa, HCT-8 cells were washed once with PBS and lysed with 0.1% Triton X-100. 
Bacterial counts for both the adhesion and invasion assays were enumerated by plating 
the appropriate dilutions of the lysate on LB agar plates. Colonies were counted after 24 
h incubation at 37
o
C. The experiment was repeated thrice with independent HCT-8 
cultures. 
 
3.6.8 Barley seed pathogenicity  
       The barley seed pathogenicity assay (128) was used to assess P. aeruginosa 
virulence. Briefly, an overnight culture of P. aeruginosa PA14 was re-inoculated in LB 
medium at 37°C and grown to turbidity at 600 nm of ~1. The cells were washed once 
with sterilized distilled water and twice with sterile Hoagland solution (169), and then 
re-suspended to turbidity at 600 nm of 1.00 ± 0.03. Fifteen sterilized barley seeds were 
placed in beakers containing 10 mL of Hoagland solution with the appropriate 
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concentration of NE and/or PA14 at 25°C with gentle shaking (200 rpm). After 3 days, 
the number of germinated seeds was counted in each beaker. The experiment was 
performed with two independent cultures in triplicate (total 90 seeds per condition).  
 
3.6.9 β-galactosidase reporter assay 
 PA14 with the reporter plasmids pLP170 (control with promoterless lacZ), 
pPCS1001 (plasR::lacZ) and pPCS1002 (prhlR::lacZ) (132) were introduced into PA14 
by electroporation. PA14 reporter strains were grown overnight in LB supplemented 
with 100 µg/mL carbenicellin, and re-inoculated in two flasks containing 25 mL of 
serum-RPMI medium at 1:100 dilution. NE (50 µM  and 500 µM) was added into the 
flasks and the culture was assayed for β-galactosidase activity at 25 oC at 4 h, 5.5 h, 6.5 
h and 7.5 as previously described (170). The PA14 cells resuspended in ice-cold TEP 
buffer (50 mM Tris-HCl [pH 7.4], 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride) 
were sonicated for 30 s twice with an interval of 15 s to disrupt the cell membrane. 
Significant differences between experimental groups were determined using the 
Student‟s t-test at a level of significance of p < 0.05 or lower.  
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CHAPTER IV 
CHEMOTAXIS TO THE GENERAL QUORUM-SENSING SIGNAL AI-2 
REQUIRES THE TSR CHEMORECEPTOR AND THE PERIPLASMIC LSRB 
AI-2-BINDING PROTEIN 
 
4.1 Overview 
Autoinducer-2 (AI-2) is a quorum-sensing autoinducer made by Gram-positive and 
Gram-negative bacteria. In Salmonella enterica serovar Typhimurium, AI-2 binds to the 
periplasmic binding protein LsrB as (2R,4S)-methyl-2,3,3,4-tetrahydroxytetrahydrofuran 
(R-THMF). LsrB is the recognition component of an ABC transporter used for AI-2 
uptake.  Several different chemotaxis assays demonstrate that AI-2 is a potent attractant 
for Escherichia coli and S. typhimurium. The Tsr chemoreceptor and LsrB are necessary 
for sensing AI-2, although uptake of AI-2 into the cytoplasm is not. We conclude that 
Thr-61 and Asp-63 of LsrB, when bound to AI-2, interact directly with the periplasmic 
domain of Tsr, making LsrB the first known periplasmic-protein partner for Tsr. 
Chemotaxis toward a bacterial-cell-density signal like AI-2 may be an important 
virulence factor within the gastrointestinal (GI) tract and could help free-swimming, 
planktonic bacteria colonize developing biofilms. 
 
________ 
*Reprinted in part with permission from “Chemotaxis to the quorum-sensing signal AI-2 
requires the Tsr chemoreceptor and the periplasmic LsrB AI-2-binding protein” by 
Manjunath Hegde, Derek L. Englert, Shanna Schrock, Bill Cohn, Christian Vogt, 
Thomas K. Wood, Michael D. Manson, and Arul Jayaraman, 2011, Journal of 
Bacteriology, 193(3):768-773. Copyright by American Society for Microbiology 
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4.2 Introduction 
Many functions in bacteria are regulated by population density, including formation 
of biofilms and production of virulence factors (171). Assessment of population density, 
known as quorum sensing, relies on the ability of cells to determine the concentration of 
compounds known as autoinducers (AIs). As the cell density increases, the AI 
accumulates to a concentration that triggers a quorum-sensing response. Autoinducers 
typically activate the expression of certain genes and repress the expression of others. 
The genes whose expression is induced typically include those responsible for 
production of the autoinducer, resulting in a positive feedback loop. In several well-
studied systems, the cell densities required to accumulate enough AI for good induction 
are 10
8
 per ml or higher. 
AIs are of two basic types: species-specific and general (86). Species-specific 
AI-1s are usually acyl homoserine lactones in Gram-negative bacteria and modified 
peptides in Gram-positive bacteria. Induction of bacterial luciferase in the 
bioluminescent marine species Vibrio fischeri, the sole colonizer of the light organ of the 
Hawaiian bobtail squid, requires an AI-1 specific to that organism (172). The marine 
bacterium Vibrio harveyi, which colonizes the surface of dead organic matter, requires 
both a specific AI-1 and a general autoinducer, called AI-2 (173), for full induction of 
bioluminescence. AI-2 is derived from the spontaneous cyclization of the metabolite 4,5-
dihydroxy-2,3-pentanedione (DPD). DPD is made from S-ribosylhomocysteine by the 
enzyme LuxS (87). S-ribosylhomocysteine is an intermediate in the breakdown of S-
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adenosylhomocysteine, the product remaining after methyl-group donation by S-
adenosylmethionine.  
AI-2 is produced by a wide range of Gram-negative and Gram-positive bacteria 
and exists in multiple forms that are in equilibrium with each other (86). The form that is 
active in V. harveyi is (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran borate (S-
THMF borate) (88). This form of AI-2 binds to the periplasmic protein LuxP. In S. 
typhimurium, a boron-free isomer of AI-2 [(2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetra-
hydrofuran (R-THMF)] (Fig. 4.1A) binds to the periplasmic LsrB protein (89). LsrB is 
the recognition component of an ABC transporter for AI-2, and the lsrB gene is in the 
lsrACDBFGE operon. LsrACD are the membrane-bound components of the ABC 
transporter for AI-2. Following uptake, AI-2 is phosphorylated in the cytoplasm by the 
LsrK kinase and then further broken down by the products of the lsrFG genes (90). This 
operon is under the control of LsrR, a repressor that is inactivated upon binding of 
phosphorylated AI-2. Thus, AI-2 induces its own uptake and destruction, and auto-
stimulation by self-produced AI-2 is transient (90). The production and possible fates of 
AI-2 in S. typhimurium are shown in Fig. 4.1B. E. coli also contains an Lsr uptake 
system similar to that of S. typhimurium. In E. coli, the membrane-bound YdgG (TqsA) 
protein has been implicated in AI-2 export from the cytoplasm (91). 
Prior work has shown that AI-2 is a chemoattractant for E. coli (174, 175). 
However, the receptor(s) involved in AI-2 sensing has/have not been identified. In this 
study, we investigated the molecular mechanism underlying AI-2 chemotaxis in E. coli 
and show that the same system probably operates in S. typhimurium. 
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Fig. 4.1. Structure of AI-2 and post-production processing (A) Structure of AI-2. 
Although AI-2 exists in multiple forms that are in equilibrium with each other, only the 
R-THMF form of AI-2 that was found bound to LsrB in S. typhimurium (89) is shown. 
(B) Production, transport, sensing, and metabolism of AI-2. AI-2 is produced inside the 
cells in several steps during the degradation of S-adenosylhomocysteine (SAH). The last 
step in AI-2 (solid red pentagon) production is catalyzed by LuxS. AI-2 is secreted, most 
likely by TqsA (91), to the periplasm. It presumably passes freely in and out of the 
periplasmic space through porins in the outer membrane and equilibrates with the 
external environment. When AI-2 accumulates to a high enough level, it binds to the 
LsrB protein in the periplasm. LsrB-AI-2 may interact directly with the ligand-binding 
domain of the Tsr chemoreceptor to evoke an attractant response by inhibiting (red X) 
the activity of the CheA kinase and thus lowering the cytoplasmic concentration of the 
tumble regulator, phospho-CheY. LsrB associated with AI-2 can also bind to LsrACD, 
an ABC transporter that imports AI-2 into the cytoplasm, where it is phosphorylated by 
the LsrK kinase (89). Phospho-AI-2 binds to the LsrR repressor to induce transcription 
of the lsrACDBFGE operon. LsrF and LsrG together break down phospho-AI-2 into an 
unknown product (open red pentagon).  
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4.3 Results  
 
4.3.1 Escherichia coli chemotaxis toward AI-2 is mediated through Tsr and LsrB  
The microPlug (μPlug) assay (176), a modified plug-in-pond assay, provides a 
qualitative but highly visual representation of chemotaxis (Fig. 4.2). The responses of E. 
coli strain CV1 and its isogenic tsr and lsrB mutant derivatives are shown in Fig. 4.3. In 
the absence of AI-2 in the plug, CV1 cells distributed themselves randomly (Fig. 4.3A). 
However, when CV1 cells were exposed to plugs containing 200 M L-serine or 200 
M AI-2, they exhibited strong attractant responses, shown by the accumulation of 
bacteria at the agarose plug-liquid interface (Fig. 4.3B and C). Strain CV5 (CV1 tsr), 
which lacks the L-serine receptor Tsr, did not respond to L-serine (Fig. 4.3D) and gave a 
severely attenuated response to AI-2 (Fig. 4.3E). Strain CV12 (CV1 tar-tap trg), 
which has Tsr as its only functional receptor (other than Aer), responded to both L-serine 
and AI-2 (data not shown), although the accumulation was somewhat decreased relative 
to that of strain CV1. Thus, Tsr is both necessary and sufficient for good AI-2 
chemotaxis in E. coli K-12, although there may be a small residual response in cells 
lacking Tsr. 
 Because AI-2 is known to bind to the periplasmic protein LsrB, we also looked at the 
responses of MJ101 (CV1 lsrBΩKanr) cells. These cells responded like strain CV1 to L-
serine (Fig. 4.3F) but showed no accumulation around plugs containing 200 M AI-2 
(Fig. 4.3G). In contrast, MJ102 (CV1 lsrCΩKanr) cells, which should still produce LsrB 
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but not be able to take up AI-2 into the cytoplasm, accumulated around plugs containing 
200 M L-serine (data not shown) and 200 M AI-2 (Fig. 4.3H). The accumulation to 
AI-2 was somewhat weaker than that of strain CV1, perhaps because of a polar effect of 
the lsrCΩKanr insertion on the downstream lsrB gene in the lsrACDBFGE operon (177). 
MJ101 cells containing plasmid pCA24N-PT5-lac::lsrB, which encodes wild-type E. coli 
LsrB, accumulated around AI-2-containing plugs about as well as MJ102 cells (data not 
shown) when 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce 
LsrB synthesis. 
 
Fig. 4.2. Schematic of the modified Plug assay. Both top and side views of the 
chamber are shown. GFP-labeled bacteria suspended in CB were introduced at the inlet, 
and the outlet allowed escape of air. The agarose plug contained CB plus L-serine or AI-
2 at the desired concentration. The plug was visualized by addition of 5% bromophenol 
blue to provide optical contrast. Gradients in the bacterial suspension form by diffusion 
of attractant out of the plug. Gradients develop rapidly and are relatively steep. The 
cartoon shows the distribution of GFP-labeled cells when they are first introduced (t = 0 
min) and at the end of the experiment (t = 30 min). 
Top view Side view 
Inlet Plug Outlet 
Inlet 
Plug 
Outlet 
t = 0 min 
t = 30 min 
Figure S2 
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Fig. 4.3. Chemotactic responses to L-serine and AI-2 in the µPlug assays. Panels A-H show the results of  (A) 
Distribution of wild-type (CV1) cells in the absence of any attractant in the plug. (B) Distribution of wild-type (CV1) cells 
with 200 M L-serine in the plug. (C) wild-type (CV1) cells with 200 M AI-2 in the plug. (D) tsr (CV5) cells with 200 M 
L-serine in the plug. (E) tsr (CV5) cells with 200 M AI-2 in the plug. (F) lsrBΩKanr (MJ101) cells with 200 M L-serine in 
the plug. (G) lsrBΩKanr (MJ101) cells with 200 M AI-2 in the plug. (H) Distribution of lsrCΩKanr (MJ102) cells with 200 
M AI-2 in the plug.  
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 To quantify the response to AI-2 and to compare it to the response to L-serine, we 
performed capillary assays (178). As expected from the Plug assay results, CV1 and 
CV12 cells accumulated in capillaries containing either L-serine or AI-2 (Fig. 4.4A), 
with the CV1 strain giving a stronger response, whereas CV5 (tsr) cells did not 
accumulate in capillaries containing either compound. MJ101 cells (lsrBΩKanr) 
responded to L-serine but not to AI-2, whereas MJ102 cells (lsrCΩKanr) responded to 
both (Fig. 4.4B). Thus, the conclusions from the Plug assay were confirmed. 
By plotting the data from the capillary assay on a log/log plot, we could extrapolate 
back to a threshold concentration for both compounds in each strain (179). With L-
serine, the extrapolated detection thresholds for strains CV1, CV12, and MJ101 are all in 
the range of 2-4 X 10
-12
 M (Fig. 4.4C). The result is quite different with AI-2, because 
strains CV1 and CV12 have extrapolated detection thresholds of ~5 X 10
-12
 and 2 X 10
-
11 
M (Fig. 4.4D), respectively, but the extrapolated detection threshold for the LsrC
-
 
strain MJ102 is at least 100-fold lower at ~2 X 10
-14
 M (Fig. 4.4D). This is the result 
expected if the periplasmic AI-2 concentration in MJ102 cells is higher than in CV1 
cells, because in the latter strain AI-2 is being cleared from the periplasm by transport 
into the cell. The same phenomenon has been seen with cells containing maltose-binding 
protein in the absence of a functional maltose transport system (180). 
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Fig. 4.4. Responses of cells to L-serine and AI-2 in the capillary assay. Background 
accumulations in buffer-only capillaries were in the range of 500-1000 cells. (A) 
Normalized (buffer-only control subtracted) values of CV1 (wt) cells, CV5 (tsr) cells, 
and CV12 (tar-tap  trg) cells exposed to capillaries containing L-serine (open 
symbols) or AI-2 (closed symbols). (B) Normalized values of CV1 cells, MJ101 
(lsrBΩKanr) cells, and MJ102 (lsrCΩKanr) cells exposed to capillaries containing L-
serine (open symbols) or AI-2 (closed symbols). (C) The data for the responses of the 
CV1, CV12, and MJ101 cells to L-serine plotted on a log-log scale. The straight lines are 
linear regressions can be extrapolated back to a threshold value. The extrapolated 
threshold concentrations, as predicted by Weber‟s law, are 1.7 x 10-12 for strain CV12 
and 3.5 x 10
-12
 M for strain CV1 and MJ101. The regression lines for CV12 and MJ101 
are identical. (D) The data for the responses of CV1, CV12, and MJ102 cells to AI-2 
plotted on a log-log scale. The linear regressions can be extrapolated back to a threshold 
value. The extrapolated threshold concentrations are 1.6 x 10
-11
 for strain CV1, 4.6 x 10
-
12
 M for strain CV12, and 2.5 x 10
-14
 M for strain MJ102.  
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To test the relative sensitivity of cells to L-serine and AI-2 in an independent assay, 
we employed the Flow device (176, 181). The gradients were created in two ways. In 
the first scenario, a linear gradient was generated across the 1050 m width of the 
microfluidic observation chamber by utilizing two input channels delivering 0 and 200 
M chemoeffector, respectively. In the second scenario, a non-linear gradient was 
generated by using five input channels to deliver 0, 0, 2, 20, and 200 M chemoeffector, 
respectively. The configurations of the device and the resulting gradients are shown in 
Fig. 4.5.  The concentration at the entry point for the cells was 100 M in the linear 
gradient and 2 M in the non-linear gradient, and the cells were pre-equilibrated with 
these concentrations prior to their introduction into the observation chamber. The 
distribution profiles of fluorescently labeled CV1 cells in L-serine and AI-2 are shown in 
Fig. 4.6. For each set of conditions, the chemotaxis migration coefficients (CMC values; 
(181, 182)) were calculated and are shown in Fig. 4.6. CV1 cells responded to non-linear 
and linear gradients of AI-2 (Fig. 4.6D and F) with similar CMC values (0.24 and 0.25), 
but they responded significantly only to the non-linear gradient of L-serine, in which the 
gradient is very steep at the point at which the cells enter the chamber (compare Fig. 
4.6C and E). Even in the non-linear gradient, the CMC value for L-serine was only 0.13, 
about 50% that of the CMC value for AI-2. These results are consistent with the idea that 
chemotaxis to AI-2 is more sensitive at higher chemoeffector concentrations than is 
chemotaxis to L-serine.  
We also tested the MJ102/pCA24N-PT5-lac::lsrB strain in a non-linear AI-2 gradient 
in the Flow device (data not shown). It gave a CMC value of 0.18, lower than the value 
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for CV1 cells in non-linear AI-2 gradients but higher than that for CV1 cells in non-
linear gradients of L-serine. At present, we have no way of measuring periplasmic levels 
of LsrB, but the somewhat attenuated response of MJ102/pCA24N-PT5-lac::lsrB cells 
relative to wild-type cells could reflect a decreased level of LsrB in the complemented 
strain. 
 
4.3.2 Tsr and LsrB are required for AI-2 chemotaxis in S. typhimurium 
We asked whether the pathogenic strain 14028 of S. typhimurium was also attracted 
to AI-2. The parental strain swam toward plugs containing 200 µM L-serine or AI-2 
(Fig. 4.7A and B), whereas a tsr derivative of strain 14028 responded neither to L-
serine nor AI-2 (Fig. 4.7C and D), indicating that Tsr is required for AI-2 chemotaxis in 
S. typhimurium. S. typhimurium strain MET259 (14028 lsrB::mudJ) (183), which lacks 
LsrB, also did not respond to AI-2 in the Plug assay (Fig. Fig. 4.7E), whereas S. 
typhimurium strain MET235 (183) (14028 lsrC::mudJ) cells lacking LsrC did (Fig. 
4.7F). Again, the response of strain MET235 to AI-2 might be attenuated by polarity of 
the lsrC::mudJ insert on lsrB expression. We conclude that AI-2 chemotaxis in S. 
typhimurium is also mediated through Tsr and LsrB. Accumulations around the plug 
were consistently lower with S. typhimurium than with E. coli, perhaps because the 
higher swimming speed of S. typhimurium minimized accumulation. 
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Fig. 4.5. The µFlow device (A) Schematic representation of the µFlow chemotaxis 
device. The device consists of a gradient-mixing module with five inlets and a 
chemotaxis observation chamber (20 x 1050 x 11500 µm). The bacterial inlet is 50 μm. 
For visualization, a gradient made from dyes of five different colors is shown. Inset 
shows a representative snapshot of cells moving up a concentration gradient. (B) 
Formation of concentration gradients in the μFlow device. Linear (black line; generated 
using two inputs) and non-linear (red line; generated using five inputs) concentration 
gradients of 0 – 100 ng/mL of fluorescein isothiocyanate (FITC) were established in the 
chemotaxis observation chamber. Fluorescence images were acquired after 30 min, and 
the fluorescence intensity was determined at 16 m intervals using Matlab.  
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Fig. 4.6. Assays of chemotactic behavior in the Flow device. (A) Typical distribution 
of RFP-labeled dead cells, shown in red. The distribution of cells from one run is shown; 
it is typical for that found for RFP-labeled dead cells in all runs. The area occupied by 
dead cells is delineated by the gray bar enclosed in dashed lines. (B) Typical distribution 
of CV1 (wt) GFP-labeled cells in the absence of a chemoeffector gradient. The 
distribution of cells moving in the up-gradient direction beyond the “dead” zone is 
highlighted in green, and the distribution of cells moving in the down-gradient direction 
is highlighted in yellow. GFP-labeled cells remaining in the region occupied by dead 
cells (highlighted in red) were not included in the calculation of CMC values.  (C) 
Typical distribution of CV1 cells in a 0-200 M non-linear gradient of L-serine. (D) 
Typical distribution of CV1 cells in a 0-200 M non-linear gradient of AI-2. (E) Typical 
distribution of CV1 cells in a 0-200 M linear gradient of L-serine. (F) Typical 
distribution of CV1 cells in a 0-200 M linear gradient of AI-2. All assays were run a 
minimum of three times.  CMC values are indicated on the graphs. 
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Figure 4.7. Response of S. typhimurium to L-serine and AI-2 in the Plug assay. 
Cells were resuspended in chemotaxis buffer, added to the Plug device, and incubated 
at room temperature for 30 min. (A) S. typhimurium strain 14028 exposed to 200 μM L-
serine in the plug. (B) 14028 exposed 200 μM AI-2 in the plug. (C) 14028 Δtsr exposed 
to 200 μM L-serine in the plug. (D) 14028 Δtsr exposed to 200 μM AI-2 in the plug (E) 
S. typhimurium strain MET259 (lsrB::mudJ) exposed to 200 μM AI-2 in the plug. (F) S. 
typhimurium strain MET235 (lsrC::mudJ) exposed to 200 μM AI-2 in the plug. 
Fluorescence images were taken at t = 30 min.         
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4.3.3 LsrB-AI-2 complex binds the periplasmic domain of Tsr 
Zhang et al. (184) used the known structures of the periplasmic domain of E. coli Tar 
and the maltose binding protein (MBP) along with results of a mutational analysis, to 
develop a computationally derived model for the docking of MBP with Tar. In the 
model, the two domains of MBP contact the two subunits of the periplasmic domain of 
Tar. Since the periplasmic binding domains of Tar and Tsr are similar (Fig. 4.8), and 
structures for the ligand (AI-2)-bound LsrB (185) and the periplasmic domain of Tsr 
(186) are also available, we developed a computer-generated model for the Tsr/LsrB 
interaction using the MBP/Tar simulation as a guide. We developed an energy-
minimized docking structure for AI-2-bound LsrB and Tsr (Fig. 4.9B and D) that was 
based on the docking model for maltose-bound MBP and Tar (Fig. 4.9A and C)  (184). 
AI-2 bound to LsrB was docked with Tsr (187) by bringing the two proteins as close to 
each other as possible using the SPOCK software package. Next, the molecular 
dynamics module of the AMBER software package (188) was used to allow the side 
chains to repack in order to minimize the energy of interaction between the two proteins, 
so that regions in both binding clefts of LsrB that that possibly interact with Tsr could be 
identified. The amino acid regions of LsrB that were identified as possibly interacting 
with Tsr were positions 56-65 in the β2 sheet, and positions 196-211 and 221-236 in the 
α helices 6 and 7, respectively (Fig. 4.10). Thr-61 and Asp-63 in LsrB were found to be 
the closest to Asp 143 and Lysine 145 of the T subunit of Tsr. Thus, LsrB/Tsr docking 
served as the starting point for targeting areas of the LsrB and Tsr proteins for 
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mutational analysis in order to identify regions involved in the interactions of these two 
proteins. 
 
Fig. 4.8. Amino acid sequences in Tsr and LsrB that are candidates for Ala-
scanning mutagenesis based on the computer-generated LsrB/Tsr docking model. 
(A) Tsr regions predicted to be in contact with LsrB; below the Tsr sequences, the 
equivalent sequences in E. coli Tar are shown. Bold-faced, underlined residues in the 
Tar sequence show positions at which residue substitutions gave specific defects in 
maltose chemotaxis. (B) LsrB regions to be in contact with Tsr; they correspond to β 
strand 2 and α helices 6 and 7.   
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Fig. 4.9. Docking models for periplasmic binding proteins and chemoreceptors 
(MCPs). (A)  The energy-minimized MBP/Tar docking model (184). MBP is shown in 
blue, and the two subunits of E. coli Tar are shown in magenta and green. (B) The 
energy-minimized LsrB/Tsr docking model. LsrB is shown in yellow, and the two 
subunits of E. coli Tsr are shown in magenta. (C) Close-up of the MBP/Tar interface in a 
space filling model. Positive surface charge is indicated in blue, negative surface charge 
is indicated in red. The yellow arrowheads point to the closest approach of MBP to Tar. 
(D) Close-up of the LsrB/Tsr interface in a space filling model. The yellow arrowheads 
point to the closest approach of LsrB to Tsr.  
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Fig. 4.10. 3-D geometry of LsrB in complex with AI-2 showing regions interacting 
with β2 and α6-7 regions interacting with periplasmic domain of Tsr (185). 
 
4.3.4 Mutational analysis to identify regions of interactions between LsrB and Tsr 
Based on the docking model, we performed site directed alanine scanning 
mutagenesis by replacing every amino acid in the region 56-65 of LsrB with alanine. We 
also replaced two amino acids that were predicted to be the closest amino acids 
interacting with Tsr - Thr-61 and Asp-63 - to isoleucine and valine, respectively. The 
amino acid substitutions that are most important for AI-2 sensing by Tsr were identified 
using capillary assays. At the highest concentration tested (1 mM), the net accumulation 
of CV1 ΔlsrB cells complemented with plasmid producing LsrB wt (i.e., the native LsrB 
protein) in the capillary varied between 70,000 and 86,000 (Fig. 4.11A and B). The 
chemotaxis response of the alanine substitutions to AI-2 was attenuated compared to the 
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unmodified LsrB protein. Among the ten alanine substitutions tested, T61A and D63A 
were the two substitutions that significantly reduced the response to 1 mM AI-2 by ~2.1 
and 3.3 fold respectively (Fig. 4.11A). When threonine (polar) at position 61 was 
changed to isoleucine (nonpolar), the response to 1 mM AI-2 was ~2 fold less than the 
native LsrB protein (Fig. 4.11B). However, when the polar amino acid Asp (position 63) 
was changed to the non-polar valine, the response to 1 mM AI-2 was reduced further to 
~4.7 fold (Fig. 4.11B). These results along with those obtained from alanine 
substitutions indicated that Thr-61 and Asp-63 are important in the LsrB/Tsr interaction, 
and validates the prediction of the docking model. We further confirmed this by making 
a double substitution of amino acids 61 and 63 (T61A D63A) (Fig. 4.11A) and T61I 
D63V (Fig. 4.11A), which removed AI-2 chemotaxis. The P65A (Fig. 4.11A) 
replacement abolished AI-2 chemotaxis as the accumulation inside the capillary upon 
exposure to 1 mM AI-2 was comparable to the control. Since proline is an important 
residue required for protein folding, it is possible that replacing proline altered the 
overall structure of LsrB and changed its interaction with AI-2 and Tsr.  
Since LsrB is also involved in AI-2 uptake (189), we also performed the AI-2 uptake 
assay (27) to investigate if the amino acid substitutions in LsrB affected the transport of 
AI-2 into the cell. All the single amino acid substitutions between positions 56 and 64 
did not affect AI-2 uptake as the intra-cellular accumulation of AI-2 was with the 
different substitutions was similar to that seen with the native LsrB protein. However, 
the P65A substitution demonstrated ~30 fold less AI-2 uptake than the unmodified LsrB 
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protein, which further confirmed that the proline substitution altered the overall structure 
of LsrB.  
 
Fig. 4.11. Capillary assays with CV1 ΔlsrB complemented with lsrB mutated at 
codons for amino acid positions in the β2 sheet of LsrB. (A) comparison of cells 
accumulated in the capillary with LsrB wt producing CV1 ΔlsrB versus those producing 
LsrB with substitution in each amino acid between positions 56-65 with alanine. (B) 
Comparison of cells accumulated in the capillary with LsrB wt producing CV1 ΔlsrB 
versus those producing mutated LsrB, in which threonine (T) at position 61 is replaced 
by isoleucine (I) and/or aspartic acid (D) at position 63 is replaced by valine (V).   
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4.4 Discussion 
In this chapter, we report that AI-2 is sensed as a chemoattractant by non-pathogenic 
E. coli and pathogenic Salmonella typhimurium through the Tsr chemoreceptor. Tsr 
analogues have been reported in many bacterial species (190), and it seems possible that 
all motile bacteria that produce both Tsr and LsrB exhibit chemotaxis to AI-2.  
Tsr is the only one of the four canonical chemoreceptors of E. coli not known to 
interact with a substrate-binding protein. The reason why LsrB is essential for 
chemotaxis to AI-2 is not known. The role of LsrB in chemotaxis does not seem to be 
essential for transport of AI-2 into the cytoplasm, because strain MJ102, which carries 
the lsrCΩKanr mutation, is defective for AI-2 transport (191) but is still able to carry out 
AI-2 chemotaxis. By analogy with other binding-protein-dependent chemoreceptors 
systems, such as maltose-binding protein (MBP) and Tar (180), it may be that AI-2-
bound LsrB assumes a conformation that enables it to interact with Tsr directly in the 
periplasm. Similar interactions have been postulated for the involvement of galactose-
binding protein (192) and ribose-binding protein (193) with the Trg chemoreceptor in 
taxis to those two sugars, and for dipeptide-binding protein with Tap (194).  
Although we do not know the level of LsrB present in the periplasm of cells grown 
under various conditions, it is likely to be lower than other binding proteins, which 
typically far outnumber their cognate membrane-bound partners in a transport system. 
The KD for AI-2 binding to LsrB has been reported as ~160 µM (195), which is higher 
by a factor of a hundred than the KD values of most sugar-binding proteins for their 
ligands. Thus, the typical binding-protein paradigm of high affinity for ligand but low 
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affinity for the chemoreceptor partner, as seen with maltose, MBP, and Tar (180), could 
be very different for AI-2, LsrB, and Tsr. 
AI-2, unlike other known attractants for E. coli, does not serve as food for bacteria 
(177), but is, rather, an intra-specific and inter-specific signal of cell density. Therefore, 
chemotaxis to AI-2 may not have the rather narrow dose-response range that is 
characteristic of most indirectly binding chemoattractants (196). For nutrients, migration 
to concentrations higher than those needed for the maximum rate of uptake has no 
selective value. Given that AI-2 is produced by many different species of biofilm-
forming bacteria (197), it may be that chemotaxis to AI-2 serves to recruit free-
swimming, planktonic bacteria to biofilms (198). If so, there is no obvious reason why 
the response to AI-2 should saturate; the selective pressure may be to swim as close as 
possible to a source of AI-2. We are currently characterizing the molecular mechanism 
of AI-2 chemotaxis in order to understand how it has evolved to match to the ecological 
context in which AI-2 chemotaxis occurs. 
 
4.5 Summary 
Given that AI-2 has been reported as a universal quorum-sensing molecule and inter-
species signal, chemotaxis to AI-2 by both pathogenic and non-pathogenic bacteria is 
likely to be important in microbial ecology and virulence. Indeed, several bacterial 
species that colonize the oral cavity or the human gastrointestinal (GI) tract are known to 
produce AI-2 or to possess the luxS gene needed for its production. AI-2 chemotaxis 
may ultimately serve as a mutually beneficial, general chemical homing device that 
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allows aggregations of bacteria to recruit new members and that enables free-swimming, 
planktonic bacteria to identify and join such aggregates. 
 
4.6 Materials and methods  
 
4.6.1 Bacterial strains, materials, and growth media 
Strain CV1, which is equivalent to strain RP437 (199), was used as the wild-type E. 
coli strain for chemotaxis, and strain 14028 was used as the wild-type S. enterica serovar 
Typhimurium. All relevant strains and plasmids are listed in Table 4.1. Tryptone broth 
(TB; 10 g/L tryptone and 8 g/L NaCl) was used to grow E. coli, and lysogeny broth (LB; 
10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl) was used to grow S. 
Typhimurium. Chemically synthesized DPD (3.9 mM), dissolved in water, was 
purchased from Omm Scientific (Dallas, TX). L-serine was obtained from Fisher 
Scientific (Fair Lawn, NJ). 
 
4.6.2 Fabrication of the µPlug and µFlow microfluidic devices  
Microfluidic devices were fabricated as previously described (175, 200) in the Materials 
Characterization Facility at Texas A&M University. Briefly, device designs were drawn 
in AutoCAD and used to create a high-resolution (>3000 dpi) photolithography mask 
with a laser printer (Advanced Reproductions, North Andover, MA). Standard 
photolithography techniques, using an SU-8 2050 photoresist (Microchem Corp, MA), 
generated imprints of the microfluidic devices on silicon. 
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 Table 4.1. Bacterial strains and plasmids 
Strain or Plasmid Genotype Resistance
a
 Source 
Escherichia coli    
CV1 Chemotaxis wild type  
(same as RP437) 
Str (203) 
TG1/pDS-Red Express Wild type, dead cell control Amp Stratagene 
CV5 CV1 tsr Str This study
b 
CV12 lsrCΩKanr CV1 tar-tap trg::Tn10 Str Tet This study
c
 
MJ101 CV1 lsrBΩKan
r
 Str Kan This study
d
 
MJ102 CV1 lsrCΩKan
r
 Str Kan This study
e
 
BW25113 lsrBΩKanr  lsrBΩKan
r
 Kan (204) 
BW25113 lsrCΩKanr  lsrCΩKan
r
 Kan (204) 
 
Plasmids 
  
 
 
pCM18 GFP-expressing vector Erm (205) 
pDS-RedExpress RFP-expressing vector Amp Clonetech 
pCA24N-lsrB pCA24N PT5-lac::lsrB; expresses E. 
coli LsrB from placZYA 
Cm (206) 
a
 Str-streptomycin, Tet-tetracycline, Kan-kanamycin, Erm-erythromycin, Amp-ampicillin, Cm-
chloramphenicol 
b
 Made by introducing tsr9101 (207) into CV1 by phage P1 transduction (208) with selection 
for Thr
+
 and screening for Tsr
-
. 
c
 Made in two steps: tar-tap5201 (209) was introduced into CV1 by phage P1 transduction with 
selection for Eda
+
, followed by screening for Tar
-
, then trg::Tn10 was introduced by phage P1 
transduction followed by selection for Tet
r
 on lysis broth (LB; (170)) agar plates contain 10 
g/mL tetracycline, followed by screening for Trg-. 
d
 Made by introducing lsrBΩKanr (204) into CV1 by phage P1 transduction with selection for 
Kan
r
 and confirmation of the  lsrB gene disruption by PCR. 
e
 Made by introducing lsrCΩKanr (204)  into CV1 by phage P1 transduction with selection for 
Kan
r
 and confirmation of the lsrC gene disruption by PCR. 
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wafers. The silicon-wafer templates, called SU-8 masters, were used as negative molds 
to generate the chemotaxis devices in poly(dimethyl)siloxane (PDMS), using standard 
soft-lithography protocols (175). Chamber dimensions were measured using a 
profilometer. Devices were fabricated by bonding the patterned PDMS slab to clean 
glass slides, using oxygen-plasma bonding in a plasma etcher (100 mTorr, 100 W, 40 
sec) to create optically transparent devices. Access ports were punched into the PDMS 
using a blunt 19-gauge needle. 
The μPlug assay (175, 200) is an improved version of the well-established plug-in-
pond assay (201). It consists of a 15 X 15 mm square chamber with a height of ~75 µm. 
Agarose mixed with chemoeffector is introduced through a 1.5 mm diameter hole in the 
middle of the chamber. Two additional holes are punched with a blunt 19-gauge needle 
along the diagonal to introduce cells into the chamber and to provide a vent, 
respectively.  
The μFlow assay (175, 200) measures the chemotaxis response of bacteria, 
fluorescently labeled by GFP expression, when they encounter a stable concentration 
gradient of a chemoeffector established across the width of a microfluidic chamber. The 
µFlow chemotaxis device consists of two modules – a concentration-gradient generator 
and a chemotaxis-observation chamber. The gradient generator comprises a network of 
microfluidic channels that uses diffusive mixing from two or five inputs to generate 
nearly linear or highly non-linear concentration gradients, respectively, across the width 
of the observation chamber. The length of the network is 13,500 µm and 18,570 µm for 
the linear and non-linear gradient generators, respectively. The width of each inlet 
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entering the observation chamber is 500 µm. The observation module is a chamber (20 x 
1050 x 11,500 µm) connected to the gradient-generator module. A secondary inlet (50 
µm) is used to introduce bacteria into the observation module at the mid-point of the 
concentration gradient; these cells were pre-incubated with the mid-point concentration 
of chemoeffector. The bacteria and the concentration gradients are introduced into the 
device through silicon tubing. 
 
4.6.3 Growth of bacteria for the µPlug and µFlow chemotaxis assays  
Bacteria were prepared for chemotaxis assays as described by Mao et al. (202). 
Briefly, overnight cultures of GFP-expressing bacteria, grown overnight at 32
o
C in TB 
containing 150 µg/mL erythromycin or at 37
o
C in LB containing 150 µg/mL 
erythromycin (for E. coli and S. Typhimurium, respectively), were inoculated into 25 
mL of the same medium lacking erythromycin to a turbidity of ~ 0.05 at 600 nm. 
Cultures were grown at 32
o
C or 37
o
C, as appropriate, to late-exponential phase (turbidity 
of 0.5 at 600 nm). A three mL aliquot of cells was centrifuged at 400 x g for 5 min at 
room temperature and very gently resuspended in 2 mL of chemotaxis buffer (CB; 1X 
phosphate-buffered saline, 0.1 mM EDTA, 0.01 mM L-methionine, and 10 mM DL-
lactate).  TG1 cells expressing RFP were killed by exposure to 1 mM kanamycin for 1 h 
(complete killing was verified by lack of growth on LB agar plates) and mixed with 
GFP-expressing motile cells at approximately equal densities. Both assays were 
performed within ~10 min after resuspension of the bacteria in CB.  
4.6.3.1 µPlug assay 
 
      The  agarose  plug was  made  by melting  25 mg low-melting-temperature agarose in
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900 µL of CB and 100 µL of 5% bromophenol blue solution (to provide optical contrast) 
at 70°C. The temperature of the agarose was reduced to 55°C, and chemoeffector was 
added to the final concentration desired and thoroughly mixed. An 8 µL aliquot of the 
agarose mixture was introduced into the µPlug device via the center hole, as shown in 
Supplemental Information Figure SI 2. The device was allowed to sit for 5 min to cool 
to room temperature. The mixture of GFP-expressing (live) and RFP-expressing (dead) 
cells was introduced gently via one of the corner holes until the chamber wasfull, 
taking care to avoid air bubbles. Green and red fluorescent images of the cells around the 
plug were taken immediately after the device was placed on the microscope stage and 
every 5 min thereafter for 30 min during incubation at room temperature (~23
o
C). The 
uniform distribution of red cells was used to ensure that no bulk flow had occurred.  
 
4.6.3.2 µFlow assay 
The assay was performed as described previously (175, 200). A mixture of GFP-
expressing and RFP-expressing cells was resuspended in CB containing the 
chemoeffector at the concentration expected at the mid-point of the observation 
chamber: 2 μM for the non-linear gradient and 100 M for the linear gradient. All 
experiments were conducted at room temperature. The flow rate in the microfluidic 
device was controlled using a PicoPlus programmable pump (Harvard Apparatus, 
Holliston, MA). The assembled device was positioned on the stage of a Leica TCS SP5 
resonant-scanner confocal microscope. Multiple 500 µL gas-tight glass syringes 
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(Hamilton, Reno, NV), containing either CB or CB with chemoeffector, were carefully 
connected to the inlets of the gradient-generator module to avoid introducing air bubbles 
into the device. The bacterial mixture was introduced into the chemotaxis chamber 
through the bacterial inlet port, using a 50 µL gas-tight glass syringe. The syringes 
connected to the gradient generator and the bacterial inlet were operated at the same 
flow rate, using different pumps. The total flow rate in the observation module (from the 
five gradient inlets and one bacterial inlet for the non-linear gradient, or the two gradient 
inlets and one bacterial inlet for the linear gradient) was maintained at 2100 nL/min. 
Green and red fluorescence images were acquired for 20 min. For each experiment, 100 
images for each fluorophore were collected ~7 mm from the inlet at 2.5 sec intervals. 
The 2.5 sec imaging interval was chosen based on our observation that bacteria take an 
average of 2.5-3 sec to traverse a 100 m imaging field-of-view at this flow rate (175). 
Therefore, bacteria were exposed to the gradient for an average of 18-21 sec prior to 
imaging.  
 
4.6.4 Quantification of chemotaxis using image analysis  
The migration and distribution of bacteria in each image was quantified using a 
Matlab (Mathworks, Natick, MA) image-analysis subroutine developed in house (175, 
200). The analysis consisted of the following steps: (i) removal of background pixels in 
the image based on pixel size and intensities; (ii) determination of the center of the 
image (i.e., where bacteria enter the observation chamber), using the dead cells (red 
fluorescence) as a reference; (iii) location of green cells (i.e., live bacteria expressing 
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GFP) in the images relative to the center, determined by calculating the centroid; and 
(iv) quantification of the number of live cells in 16 µm-wide intervals. There are a total 
of 64 intervals across the width of the chemotaxis chamber. These steps were repeated 
for each image, and the total counts of cells in each image were summed for analysis. 
The quantified live and dead cell counts in each interval were scaled to facilitate plotting 
and comparison.  
 
4.6.5 Chemotaxis migration coefficient (CMC) 
 The migration profile was used to calculate the CMC, which weights the migration 
of cells by the distance they move from the center of the observation chamber, as 
previously described (175, 202).  For example, a cell that moved to the farthest high-
concentration position at the right (interval 64) was given a weighting factor of +1, and a 
cell that moved to the farthest low-concentration position at the left (interval 1) was 
given a weighting factor of -1. Green cells in the middle of the chamber (intervals 31-34) 
were excluded from the analysis: they could be non-motile cells or cells that remained in 
the middle of the z-dimension and thus flowed through the chamber too rapidly to be 
able to respond to the gradients for a significant time.  
 
4.6.6 Capillary assays 
 The capillary assay was performed as previously described (45) except that plastic 
gaskets of the proper diameter and thickness were used to create the chamber, or 
“pond.”. About one sixth (60o) of the circular gasket was removed to provide a portal for 
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entry of the capillary tubes. Capillaries contained either CB alone or CB with the 
indicated concentration of AI-2 or L-serine. The maximum concentration of AI-2 that 
could be used was 1 mM, because the concentration of the stock solution of AI-2 was 
only 3.9 mM. The assay was run for 45 min at 32
o
C, and the number of cells entering the 
capillary was determined by plating dilutions of the capillary contents on LB agar 
containing 50 mg/mL streptomycin and counting colonies after 24 h incubation at 37
o
C. 
 
4.6.7 Computerized docking simulation  
A computer-generated model was generated for the Tsr/LsrB interaction using the 
MBP/Tar simulation as a guide. The most recent high resolution crystal structures for E. 
coli Tsr (http://www.pdb.org/pdb/explore/explore.do?structureId=2D4U) and LsrB in 
complex with AI-2 (89) were docked manually by using the SPOCK software (187) to 
align amino acid residues in AI-2 bound LsrB that were in closest contact with Tsr. 
Steric overlap was held to a minimum during this initial phase of the docking. 
Specifically, we aligned LsrB and Tsr such that residues Thr-61 and Asp-63 of LsrB 
were brought as close as possible to residues Ala-145 and Lys-147 in subunit T‟ of Tsr. 
Visual inspection of the docking model revealed that the steric collisions still present 
could be eliminated by reorientation of the side chains. To allow the side chains to 
repack, we refined the model using the molecular dynamics facilities of the AMBER 
software (188). Molecular dynamics calculations were performed by moving Tsr about 
1.4 Å away from LsrB to eliminate all overlap and by using AMBER to simulate the 
docking. All simulations were carried out by using a distance-dependent dielectric field 
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at an initial temperature of 300 K with a time step of 0.001 ps and by using the default 
force field prescribed by AMBER. 
 
4.6.8 Site-directed mutagenesis of LsrB 
Point mutations were introduced in β2 sheet and α6 and 7 helices of LsrB using 
QuikChange™ Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). Primers were 
designed to replace each amino acid between positions 56-65 and positions 221-236 to 
alanine using principles outlined by P. Carter (210).  Briefly, two synthetic 
oligonucleotide primers containing the desired mutation were designed. The 
oligonucleotide primers, each complementary to opposite strands of the pCA24N-lsrB 
vector, are extended during temperature cycling by using PfuTurbo DNA polymerase. 
Following temperature cycling, the product is treated with Dpn I. The Dpn I 
endonuclease (target sequence: 5´-Gm6ATC-3´) is specific for methylated and 
hemimethylated DNA and is used to digest the parental DNA template and to select for 
mutation-containing synthesized DNA. The lsrB fused into pCA24N was derived from 
E. coli and DNA isolated from almost all E. coli strains is dam methylated and therefore 
susceptible to Dpn I digestion. 
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CHAPTER V 
A MICROFLUIDIC DEVICE FOR INVESTIGATING CONCENTRATION-
DEPENDENT INTERACTION BETWEEN SIGNALS ON BACTERIAL 
BIOFILM FORMATION 
 
5.1 Overview 
 Biofilms are highly organized communities formed by bacteria attached to surfaces. 
They are ubiquitous in nature and are found in a diverse range of environments such as 
medical implants, pipes, and heat exchangers. Biofilm formation often leads to the 
failure of materials and causes infections when occurring inside the human body. 
Biofilm infections are important clinically because of their high tolerance to 
antimicrobial compounds and persistence in spite of sustained host defenses. A key 
feature of biofilm development is that the community is organized in a specific spatio-
temporal sequence, in which different bacterial species are recruited to the developing 
biofilm at different times and are found only in specific locations along the biofilm 
depth. The formation and organization of biofilms has been attributed, in part, to the 
soluble signals present in the biofilm microenvironment. The effects of signals such as 
AI-2 and indole on Escherichia coli biofilm formation have been well characterized. 
While indole inhibits E. coli biofilm formation, we have also shown before how two 
different derivatives of indole (7-hydroxyindole and isatin) have opposite effects on E. 
coli biofilm formation, in that 7-hydroxyindole decreases and isatin increases biofilm 
formation. Most of these biofilm studies were performed in regular flow cells using a 
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single concentration of the signal being investigated. In this Chapter, we report the 
development of a microfluidic model for simultaneously investigating bacterial biofilm 
formation and organization in response to different concentrations of soluble signals (7-
hydroxyindole and isatin), either individually or in combination. A key feature of the 
proposed model is that the gradient concentration of QS molecules is generated in each 
chamber by diffusive mixing of signals in the single mixer connected to the 
microchambers. This model can be used for developing a fundamental understanding of 
events leading to bacterial attachment to surfaces that are important in infections and 
chemicals that influence the biofilm formation or inhibition. 
 
5.2 Introduction 
 Bacteria form biofilms by adhering to almost every surface and developing complex 
communities called biofilms (1). Multicellular aggregates of cells in biofilms are 
encased in an extracellular polymeric substance matrix produced by the bacteria 
themselves (211, 212). Biofilms impact humans in many ways as they can form in 
natural, medical, and industrial settings. For example, formation of biofilms on medical 
devices, such as catheters or implants often result in difficult-to-treat chronic infections 
(213). Inside the human body, complex multispecies commensal biofilms are naturally 
found in the oral cavity intestinal tract (214, 215).  Although a wide number of these 
commensal bacterial species exist and interact with the normal host in symbiosis and 
help in normal functions (e.g., food digestion, immune system development, protection 
from exogenous pathogens) (216), ecological shifts may occur within the microbial 
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community and result in diseases such as dental caries and periodontal disease in the oral 
cavity (217) or ulcerative colitis or bowel disorders in the intestine (61). 
 Bacterial cell-cell communication through chemical signals is one of the mechanisms 
that have been shown to play a role in the development and sustenance of biofilm 
communities (218, 219). Interfering with cell-cell communication has could be a 
promising alternative for disrupting biofilm formation (220). One such chemical signal 
that has been shown to be an important determinant of biofilm formation is the bacterial 
stationary phase signal indole (21). Indole is found at high concentrations (600 μM per 
~10
9
 cells) in E. coli is grown in rich medium (24) and is produced when tryptophan 
undergoes degradation by tnaA which encodes the tryptophanase enzyme. Work from 
our laboratory has shown that indole signaling is a crucial determinant of 
enterohaemorrhagic E. coli (EHEC) O157:H7 infections, as it repels the pathogen, 
decreases motility, decreases adherence to epithelial cells, downregulates the expression 
of genes related to virulence and infection, and decreases its biofilm formation (22). 
Also, we have shown that hydroxylation and oxidation products indoles are interspecies 
biofilm signals that affect EHEC, E. coli K-12, and P. aeruginosa PAO1 by controlling 
biofilm-related genes (22, 23). The hydroxyl- and oxo- byproducts of indole are present 
at high concentrations (24) as many of the bacterial oxygenases, such as toluene o-
monooxygenase (TOM) produced by Burkholderia cepacia G4 (221), readily convert 
indole to oxidized compounds, such as 2-hydroxyindole, 3-hydroxyindole, 4-
hydroxyindole, 7-hydroxyindole, isatin (indole-2,3,-dione), indigo, isoindigo, and 
indirubin (221). Although, indole and 7-hydroxyindole (7-HI) inhibits E. coli biofilm 
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formation (21, 23), isatin, formed by the oxidation of indole and its derivatives, has been 
shown to increase biofilm formation (23). Intriguingly indole and 7-HI both promote P. 
aeruginosa biofilm formation (23), suggesting that the same signal can be used by many 
species differently.  
 It should be noted that these studies, while scientifically rigorous and accurate, tested 
only a single concentration of the different signals due to the low throughput of the flow 
cell used in these studies. However, biofilm formation or dispersal is QS controlled and 
every stage of biofilm cycle (attachment, maturation, aggregation, and dispersal) is 
affected by the concentration of different biofilm-influencing signals around the cells 
(222-224). Hence, different concentrations need to be tested to develop a comprehensive 
understanding of the role of indole and indole-derivatives on biofilm formation or 
inhibition. Therefore, we developed a microfluidic biofilm model that enables high-
throughput investigation of biofilm formation by integrating a diffusive mixing-based 
concentration generator with multiple flow cells in a single experiment. Using the 
microfluidic biofilm model, we simultaneously explored the effects of 7-HI and isatin at 
a range of concentrations, either individually or in combination, to understand their role 
in the dynamics of biofilm formation.  
 Biofilms are constantly or intermittently subjected to fluid shear stress in natural 
environments (225). Conventional studies for investigating biofilm formation under 
conditions of shear utilize macro-scale flow cells in which the biofilm is formed on a 
glass slide and fresh medium or a dilute cell suspension is continuously perfused through 
the system (226). While widely used, this system has the obvious disadvantages of 
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requiring large volumes (limiting when using signals that are not readily available), is 
not suited for high-throughput investigation, and does not facilitate spatial and temporal 
control of bacterial introduction and adhesion. These problems can be addressed in a 
microfluidic flow cell system. Our experimental design required us to simultaneously 
investigate the effect of a range of concentrations of a single signal or combinations of 
multiple signals on EHEC biofilm formation, which precluded the use of previously 
described microfluidic flow cells (30-33). For example, the micro flow cell design used 
by Lee et al. (32) to study Staphylcoccus epidermidis biofilms contains a single channel 
with multiple inlets, and cannot be used for studying the effect of different 
concentrations on biofilm organization as the gradient is created across a single channel; 
also, the inability of the design to separate the cell seeding port from the nutrient media 
inlet creates a possibility of biofouling of the plastic tubes supplying media and 
disrupting the flow dynamics. The design used by Cho et al. (33) to study the self-
organization of E. coli colonies into biofilms, and Kim et al. (30) to study the effect of a 
gradient of antibiotics on P. aeruginosa biofilms have constraints similar to the device 
described by Lee et al (32). The design proposed by Benoit et al. (31) eliminates the use 
of tubes, and thereby, prevents biofouling and is amenable to high-throughput studies 
(simultaneous operation of 24 reactors). However, the non-customizable and bulky 
accessories such as air compressors and electropneumatic regulators that are required do 
not make this device a cost-effective option. Moreover, any manipulation of signal 
concentration needs to be performed manually. The microscale device proposed in this 
Chapter is customizable, contains eight separate microchambers for cultivating biofilms 
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exposed to eight different concentrations of signals through a single gradient mixer. The 
presence of pneumatic valves and a separate cell seeding port that is independent from 
gradient-mixing channels offers complete isolation of the biofilm microchamber from 
the gradient mixer and also the ability to operate the device under flow, batch or semi-
batch conditions. 
 
5.3 Results and discussion 
 
5.3.1 Operation of the µBF device  
 The aim of this study was to develop a microfluidic flow cell (µBF) device for 
investigating the effect of different bacterial signaling molecules on biofilm formation. 
The µBF device consisted of a glass slide and two PDMS layers, a bottom layer with a 
diffusive gradient-mixer and eight microchambers, and a top layer which contains the 
pneumatic elements for controlling microvalves (Fig. 5.1). The eight microchambers 
were used for developing bacterial biofilms and exposing them to different 
concentrations of soluble signals generated on-chip in the gradient-mixer. Eight different 
concentrations of individual signals or combination of multiple signaling molecules can 
be generated in the serpentine network of channels in the diffusive mixer.  
 For seeding cells in the device, bacteria were introduced through the cell inlet in the 
top layer and the connected cell seeding port in the bottom layer into each 
microchamber. During this operation the main inlet valves were closed by applying 
compressed air and seeding valves were opened by applying vacuum (Fig. 5.2A). The 
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main inlet valves connecting the gradient-mixer and microchamber were closed to 
prevent cells seeded into the microchamber bacteria from entering the gradient mixer 
channels. After seeding cells into the microchamber, all three valves (main inlet, main 
outlet, and seeding valves) remained closed so that cells attached to the glass surface 
without flow (i.e., under batch conditions). After attachment of bacteria for 2 h, the inlet 
and outlet valves were opened by applying vacuum (Fig 5.2B) and unattached or loosely 
attached bacteria were removed by flowing culture media. Biofilms were allowed to 
form and develop by perfusing media containing different concentrations of signaling 
molecule(s) into the microchambers.   
 
Fig. 5.1. Microfluidic model of flow cell for studying bacterial biofilm (µBF device).   
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Fig.  5.2. Operation of valves. (A) During cell seeding into the microchambers, the 
seeding valve is opened and main inlet valve is closed to prevent back flow of cells into 
the gradient mixer (B) During biofilm development in the microchamber, the seeding 
valve is closed and main inlet valve is opened for the culture media to flow through the 
microchamber.  
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5.3.2 Effect of range of concentrations of 7-HI and isatin on EHEC biofilm 
 
 Our lab previously demonstrated that indole and 7-HI inhibit EHEC biofilm 
development, but isatin promotes biofilm formation (23). However, we investigated only 
a single concentration of each signaling molecule (e.g. 1000 µM for 7-HI and 250 µM 
for isatin) on EHEC biofilm formation using macroscale flow cells. Indole is shown to 
be an important signal in modulating E. coli biofilm formation (21). Indole can also be 
converted to hydroxyindoles and isatin by oxygenases in strains such as Pseudomonas 
putida PpG7(227), Ralstonia picketti PK01(228), Pseudomonas mendocina KR(229), 
Burkholderia cepacia G4 (221), and these derivatives could also be present in a wide 
concentration range in bacterial communities. Therefore, we used the µBF device to 
investigate the effect of a broad range of concentrations of 7-HI and isatin on EHEC 
biofilm in a single experiment.  
 We tested the effect of eight equally distributed concentrations of 7-HI ranging from 0 
(microchamber 1) to 500 µM (microchamber 8) on EHEC biofilm in LB medium. EHEC 
formed robust biofilm in LB at 37
o
C. After 8 hours, EHEC formed a biofilm with an 
average height of 4.2 ± 0.7 µm and biomass of 3.8 ± 0.4 µm
3
/µm
2 
in microchamber 1 
(i.e., no 7-HI). Between, zero and 357 µM 7-HI, the biofilm height and biomass 
decreased linearly with increasing concentration of 7-HI (Table 5.1). The biofilm 
thickness and biomass formed in microchamber 6 containing 357 µM of 7-HI was ~35- 
and ~42-fold, respectively, less than that observed in microchamber 1. No significant 
biofilm was formed in microchambers 7 and 8 containing 7-HI concentrations above 357 
µM (Fig. 5.3A and Table 5.1). Thus 7-HI concentrations above ~350 µM may be 
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completely inhibiting E. coli biofilm formation. 
 Unlike 7-HI, exposure to isatin increased the formation of EHEC biofilms (Fig. 5.3B 
and Table 5.1). The increase in both biofilm thickness and biomass levels were linear in 
the 0-200 µM range, with microchamber 1 (no isatin) having a biofilm thickness of 5.6 ± 
0.9 µm and biomass of 4.4 ± 0.4 µm
3
/µm
2
, and microchamber 8 (200 µM isatin) having 
a thickness of 13.3 ± 0.6 µm and biomass of 11.2 ± 0.4 µm
3
/µm
2
. These results are 
consistent with prior studies (23) and demonstrate the utility and validity of our 
microfluidic biofilm device for high-throughput biofilm studies. It should be noted that 
although the current prototype allows investigation of biofilm formation under eight 
conditions simultaneously, it can be scaled to 12 to 16 concentrations based on the size 
of the prototype that can fit a single 50 by 22 mm glass slide. 
 7-Hydroxyindole regulates the cysteine synthesis operon (cysADEIJP) (23), and 
overproducing CysB, which positively regulates the biosynthesis of cysteine in E. coli 
(230), decreases EHEC biofilm formation (23). 7-HI was less potent in reducing EHEC 
biofilm formation in the absence of cysteine (23). Hence, increasing 7-HI could be 
increasing the production of cysteine, thereby inhibiting biofilm formation. Similarly, 
isatin regulates AI-2 transporter genes (lsrABCDFGKR) thereby increasing AI-2 levels 
and activity in the cell (23). AI-2 also increased EHEC biofilm formation (23). Isatin 
also induces ﬂagellar genes (ﬂgABCDEFGHIJK and ﬂiAEFGILMNOPQ) and increases 
swimming motility of EHEC (23). Hence, the increase in EHEC biofilm formation with 
increasing concentrations of isatin could be related to the increased motility of the cells 
and increased AI-2 activity. 
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Fig. 5.3. Effect of 7-HI and isatin on EHEC biofilm formation. IMARIS pictures showing the biofilm architecture of EHEC 
formed in microchambers 1, 3, 6, and 8 after 8 h exposure to (A) 7-HI (0-500 µM) (B) Isatin (0-200 µM) (C) 7-HI (500 µM) 
and isatin (200 µM) introduced through same inlet and plain media through the other inlet (D) 7-HI (500 µM) and isatin (200 
µM) introduced through separate inlets. The concentration of 7-HI is shown in yellow and that of isatin is in blue.  
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Table 5.1. COMSTAT analysis showing the variation in average EHEC biofilm height and biomass in LB at 37
o
C upon 8 h 
exposure to (i) a 0-500 µM gradient of 7-HI, (ii) a 0-200 µM gradient of isatin. 
 
Microchamber 
7-HI (0-500 µM) Isatin (0-200 µM) 
Concentration 
(µM) 
Average Biofilm 
Height (µm) 
Biomass 
(µm
3
/µm
2
) 
Concentration 
(µM) 
Average Biofilm 
Height (µm) 
Biomass 
(µm
3
/µm
2
) 
1 0 4.2 ± 0.7 3.8 ± 0.4 0 5.6 ± 0.9 4.4 ± 0.4 
2 71 3.7 ± 0.5 3.4 ± 0.4 29 6.9 ± 0.4 5.6 ± 0.4 
3 143 3.1 ± 0.5 2.5 ± 0.3 57 7.4 ± 0.5 6.2 ± 0.3 
4 214 1.9 ± 0.6 1.7 ± 0.2 86 10.2 ± 1.3 8.8 ± 0.2 
5 286 0.6 ± 0.1 0.41 ± 0.03 114 12.1 ± 0.8 10.1 ± 0.7 
6 357 0.12 ± 0.04 0.09 ± 0.03 143 11.9 ± 0.6 9.8 ± 0.7 
7 429 0.07 ± 0.05 0.03 ± 0.02 171 12.6 ± 0.3 10.7 ± 0.3 
8 500 0.03 ± 0.01 0.02 ± 0.01 200 13.3 ± 0.6 11.2 ± 0.4 
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5.3.3 Effect of combinations of 7-HI and isatin on EHEC biofilm formation 
 In addition to high-throughput investigations of biofilm formation, a second 
advantage of the microfluidic biofilm model is the ability to investigate the effect of 
different combinations of signals on biofilm formation in a high-throughput manner, 
which allows interrogation of the interaction between different signals on biofilm 
formation. This is ecologically and physiologically relevant as biofilms are rarely 
present as mono-cultures in natural environments or in vivo (61, 215, 216) and the 
different signals present may exert divergent effects on bacterial physiology. An 
example of this is evident from the results in Fig. 5.3 as 7-HI and isatin can both be 
generated in a bacterial community from indole, and yet, they exert divergent effects on 
EHEC biofilm formation. Therefore, we used the microfluidic biofilm model to 
investigate the effect of simultaneous exposure (i.e., combination gradient) to 7-HI and 
isatin on EHEC biofilm formation.  
 Two types of combination gradients can be generated in diffusive mixers as signals 
can be introduced in two ways into the diffusive mixer. The first is a competing gradient, 
which is formed when 7-HI and isatin are both introduced through the same inlet and 
media without any signals is introduced through the other inlet. This allows investigation 
of the effect that each signal has on biofilm formation in the presence of increasing 
levels of the other signal, at different concentrations. The second, a cross-mixed 
gradient, is formed when signals are introduced through different inlets and the resultant 
gradient enables investigation of the effect of increasing levels of each signal in the 
presence of decreasing levels of the other signal on biofilm formation.  
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 Using competing gradients, where the concentrations of 7-HI and isatin increased 
simultaneously across the eight chambers from 0-500 µM and 0-200 µM respectively, 
we found that when both the signals were present in concentrations similar in orders of 
magnitude, EHEC biofilm decreases (Table 5.2, Fig. 5.3C). This suggests that the effect 
of 7-HI on EHEC biofilm formation was more dominant than the effect of isatin. Using 
cross-mixed gradients, where the concentrations of 7-HI increased from 0-500 µM and 
isatin decreased from 200-0 µM across the eight chambers, we found that when the 
concentration of isatin was equal to or greater than that of 7-HI, EHEC biofilm increased 
(Table 5.2, panels 1 and 2 in Fig 5.3D) compared to untreated control (panel 1, Fig 
5.3C).  This indicated that isatin is more dominant when it is present at equal or higher 
concentration compared to 7-HI. But, when the 7-HI concentration in the cross-mixed 
gradient exceeded the isatin concentration (panel 3 and 4, Fig 5.3D), 7-HI was more 
dominant than isatin, and the biomass and height of the E. coli biofilm decreased (Table 
5.2, Fig. 5.3C and 5.3D).  Thus, if the isatin concentration exceeds that of 7-HI, E. coli 
biofilm increases and if the concentration of 7-HI exceeds that of isatin (in both 
competing and cross-mixed gradients), E. coli biofilm decreases. 
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Table 5.2. COMSTAT analysis showing the variation in average EHEC biofilm height and biomass in LB at 37
o
C upon 8 h 
exposure to (i) competing gradients of 7-HI and isatin (i.e., 500 µM 7-HI and 200 µM isatin introduced with LB through the 
same media inlet with plain LB introduced through the other inlet) (ii) cross-mixed gradient of 7-HI and isatin (i.e., 500 µM 7-
HI and 200 µM isatin introduced with LB through the different inlets). Data from microchamber 1 for competing gradients (No 
7-HI and isatin treatment) was used as a control for comparing the effect of 7-HI and/or isatin on EHEC biofilm. 
 
Microchamber 
Competing gradients 
7-HI (0-500 µM) + Isatin (0-200 µM) 
Cross-mixed 
7-HI (0-500 µM) + Isatin (200 µM-0) 
7-HI 
 (µM) 
Isatin 
 (µM) 
Average 
Biofilm 
Height (µm) 
Biomass 
(µm
3
/µm
2
) 
7-HI 
 (µM) 
Isatin 
 (µM) 
Average 
Biofilm 
Height (µm) 
Biomass 
(µm
3
/µm
2
) 
1 0 0 4.8 ± 0.5 4.0 ± 0.4 0 200 8.6 ± 0.8 6.3 ± 0.4 
2 71 29 4.5 ± 0.5 3.9 ± 0.4 71 171 6.3 ± 0.2 4.8 ± 0.4 
3 143 57 4.3 ± 0.3 3.6 ± 0.3 143 143  5.6 ± 0.4 4.1 ± 0.3 
4 214 86 3.7 ± 0.6 3.3 ± 0.2 214 114 3.8 ± 0.6 2.6 ± 0.5 
5 286 114 3.3 ± 0.4 2.5 ± 0.4 286 86 3.1 ± 0.3 1.9 ± 0.4 
6 357 143 2.7 ± 0.7 2.1 ± 0.6 357 57 2.2 ± 0.3 1.1 ± 0.4 
7 429 171 2.1 ± 0.4 1.8 ± 0.2 429 29 1.3 ± 0.4 0.06 ± 0.03 
8 500 200 1.2 ± 0.3 1.1 ± 0.3 500 0 0.07 ± 0.02 0.03 ± 0.01 
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Fig. 5.4. Effect of indole derivatives on EHEC biofilm architecture. IMARIS representation showing the biofilm 
architecture of EHEC formed in microchambers 1, 3, 6, and 8 after 8 h exposure to (A) a gradient formed by mixing cell-free 
supernatant of E. coli BW25113 ∆tnaA/pBSKan grown in LB supplemented with kanamycin (50 µg/mL) without and with 500 
µM indole, (B) gradient formed by mixing cell-free supernatant of E. coli BW25113 ∆tnaA/pBSKan-TOM grown in LB 
supplemented with kanamycin (50 µg/mL) without and with 500 µM indole. 
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Fig. 5.5. Effect of indole derivatives on EHEC biofilm thickness and biomass.  
COMSTAT analysis results showing the variation in average (A) EHEC biofilm height 
and (B) biomass across the eight microchambers after 8 h exposure to gradient formed 
my mixing supernatant of E. coli BW25113 ∆tnaA/pBSKan grown in LB supplemented 
with kanamycin (50 µg/mL) without and with 500 µM indole, or gradient formed my 
mixing supernatant of E. coli BW25113 ∆tnaA/pBSKan-TOM grown in LB 
supplemented with kanamycin (50 µg/mL) without and with 500 µM indole. 
 
5.3.4 Effect of indole derivatives on EHEC biofilm 
 The indole produced by bacteria such as E. coli can be further modified (e.g., through 
oxidation or hydroxylation) by other bacteria in the community such as B. cepacia which 
do not synthesize it (221), which, in turn, can lead to the presence of a diverse range of 
modified signals (i.e., indole-like signals) in the biofilm microenvironment However, as 
shown in our prior work (21, 23) and in Fig 5.3B, not all indole derivatives exert the 
same effect on biofilm formation. Thus, a non-indole producing bacterial species present 
in the biofilm can alter the effect of indole on biofilm formation through depletion of the 
parent signal and production of different derivatives that have divergent effects. More 
importantly, the range and identity of these derivatives can vary depending on the 
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bacterial species colonizing the biofilm community.  
 In this work, we studied the effect of a mixture of indole-derivatives (i.e., containing 
various hydroxylated and/or oxidation products of indole produced by E. coli) on EHEC 
biofilm formation.  Spent medium extracted from toluene-o-monooxygenase (TOM) 
negative EHEC ∆tnaA/pBS(Kan) grown in the presence of 1 mM indole to a turbidity at 
600 nm of ~1.0 decreased EHEC biofilm thickness and biomass by only 1.3 fold (Figs 
5.4 A-B), indicating only a modest effect of indole on EHEC biofilm formation. On the 
other hand, spent medium containing different soluble derivatives of indole along with 
some unconverted indole, formed after culturing EHEC ∆tnaA/pBS(Kan)TOM with 
indole to a turbidity at 600 nm of ~1.0, significantly affected EHEC biofilm (Fig. 5.4B) 
by decreasing the thickness and biomass by ~2.3 fold (Fig. 5.5A) and ~3.4 fold (Fig. 
5.5B) respectively. Rui et al. (221) found that in stationary phase cultures of TOM 
expressing E. coli grown overnight  (13-14 h), all indole was converted into indigoid 
compounds such as isoindigo (86%), indirubin (7%), and isatin (6%) after oxidation. 
But, in cultures that are not in the stationary phase (such as what was used in this study), 
indole oxidation may yield a mixture of hydroxyindoles, isatin, and indigoid compounds, 
in which hydroxyindoles slowly dimerize to more indigoids (231). Since the spent 
medium used in our experiments were in mid-exponential phase (turbidity at 600 nm of 
~1.0), they most likely contained hydroxyindoles, isatin, and indigoids (isoindigo, 
indirubin etc.), in addition to unconverted indole. Without knowing the composition of 
the spent medium, it is not clear whether the decrease in EHEC biofilms is because of 
the hydroxyindoles or the indigoids present in the spent medium. The exact composition 
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of the spent media needs to be determined by thin layer chromatography (221).  
 
5.4 Summary 
 In summary, we have developed a simple, user-friendly microfluidic flow cell device 
that precisely measures the effect of a wide range of concentrations of single soluble 
signals or combinations of two or more signals on bacterial biofilm formation. Since 
antibiotic treatments are not effective in complete removal of bacterial biofilms formed 
by pathogens (57), alternative strategies are needed to treat bacterial biofilms. This 
device enables screening of compounds and their concentrations that effectively inhibit 
biofilm formation of pathogenic bacteria. Also, this device can be used to perform 
competition based studies to study the overall effect of two or more compounds on 
biofilm formation and check which compound is most important in controlling biofilm. 
 
5.5 Materials and methods 
 
5.5.1 Bacterial strains, epithelial cells, materials and growth media 
 E. coli O157:H7 (CDC EDL933; referred to as EHEC) was obtained from American 
Type Culture Collection (ATCC 43895, Manassas, VA, USA). The EHEC isogenic 
mutant deficient in indole (ΔtnaA) , and containing plasmids pBS(Kan)TOM (232) and 
pBS(Kan)(232) were constructed in the lab. Plasmids pCM18 (205) was used to 
constitutively express the green fluorescent protein (GFP) in EHEC. Erythromycin (150 
µg mL
−1
) was used for maintaining the pCM18 and kanamycin (50 µg mL
−1
) was used 
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for maintaining pBS(Kan)TOM or pBS(Kan) in EHEC. Isatin, indole, and 7-HI were 
obtained in powdered form from Thermo Fisher Scientific (New Jersey, USA). EHEC 
strains were cultured in either Luria Bertani broth (LB; 10 g L
−1
 tryptone, 10 g L
−1
 NaCl, 
5 g L
−1
 yeast extract) or in M9 minimal medium(233) supplemented with 0.2% glucose 
for biofilm experiments. 
 
5.5.2 Microdevice design and fabrication 
 The PDMS-based µBF device (Fig. 5.1) was fabricated in the Materials 
Characterization Facility at Texas A&M University using soft lithographic techniques as 
described previously (234). The μBF device consists of a glass cover slip and two PDMS 
layers, a bottom layer with a diffusive-mixer and eight microchambers, and a top layer 
which contains the pneumatic elements for opening and closing microvalves that 
separate the diffusive mixer and bacteria seeding ports from the microchambers, as well 
as the inlet and outlets of the microchambers. The top layer also contains a bacterial 
seeding port for introducing bacteria into the microchambers. The diffusive gradient-
mixer in the bottom layer was used to generate different concentrations of 7-HI or isatin 
and to perfuse growth media into the microchambers. The dimension of the diffusive 
mixer was 200 µm (width) x 200 µm (height) and the biofilm microchambers were 8000 
µm (length) x 600 µm (width) x 200 µm (height). All pneumatic channels were 200 µm 
thick. The two PDMS layers were fabricated separately and assembled by sequential 
oxygen plasma treatment and bonding (100 mTorr, 100 W, 40 s) in a plasma etcher. The 
top pneumatic layer membrane was ﬁrst aligned and bonded to the bottom diffusive-
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mixer/microchamber layer, followed by bonding of the combined PDMS layer to a cover 
glass (22 x 50 mm). Tygon tubing (0.01” ID x 0.03” OD, Saint Gobain performance 
plastics, OH, USA) was used for all fluidic connections. Two PicoPlus 11 syringe pumps 
(Harvard Apparatus, MA, USA) were used to separately control fluid flow rates in the 
two layers. A temperature controlled metal slide holder was used to maintain the 
temperature of the device at 37
o
C. Moist air flowed continuously over the device in 
order to maintain humidity and avoid bubble formation inside the microchambers. The 
opening and closing of valves were pneumatically controlled by introducing vacuum or 
compressed air.  
 
5.5.3 Biofilm development in microfluidic devices 
 An overnight culture of EHEC grown in LB at 37
o
C was washed and resuspended in 
M9-glucose media at turbidity at 600 nm of ~1.0. The bacterial suspension was 
introduced into the eight biofilm microchambers through the cell inlet (Fig 5.1). During 
this process, the main inlet valves (Fig. 5.2A) remained closed to prevent cells from 
entering and attaching to the gradient mixing channels (which would disrupt mixing in 
the channels). The main outlet valves and seeding valves were then closed and culture 
was maintained without flow for 2 h to promote attachment of bacteria to the glass 
surface. We found that the cells suspended in M9-glucose media attached better to glass 
compared to LB media. After 2 h, the main inlet and outlet valves were opened (Fig. 
5.2B), and unattached cells were removed by perfusing nutrient rich LB media for robust 
biofilm growth at a flow rate of 8 µL/min. The attached bacteria were allowed to form 
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biofilm at 37
o
C by flowing LB and LB supplemented with a specific concentration of a 
specific signal (i.e., 7-HI or isatin) through the two inlets of the diffusive mixer into the 
microchambers at 8 µL/min for 8 h. For individual treatments, 7-HI concentrations 
across the eight microchambers were 0, 71, 143, 214, 286, 357, 429, and 500 µM 
respectively and isatin concentrations were 0, 29, 57, 86, 114, 143, 171, and 200 µM 
respectively. 7-HI and isatin were cytotoxic beyond 1 mM and 250 µM. Hence 
concentrations used were below this range. 
 
5.5.4 Confocal microscopy 
 Images were taken on a TCS SP5 scanning confocal laser microscope (Leica 
Microsystems, Wetzlar, Germany)
 
using a 40X/0.85 NA dry objective. Z-stack images 
were taken at a zoom level of 2 such that the image covered 90% of width of the 
microchamber. Two individual positions per microchamber covering a total of 70% of 
the microchamber length were chosen for imaging. 3-D reconstruction of the biofilm 
architecture was performed using IMARIS 3D and 4D Real-Time Interactive Data 
Visualization software (Bitplane Inc., CT, USA). Biomass and average biofilm height 
were obtained using the COMSTAT image-processing software.     
 
5.5.5. Generation of spent medium containing soluble derivatives of indole 
oxidation and hydroxylation by TOM   
 EHEC ΔtnaA/pBS(Kan)TOM producing wild-type toluene o-monooxygenase 
(TOM) of Burkholderia cepacia G4 and EHEC ΔtnaA/ pBS(Kan) that does not produce 
114 
 
 
TOM were grown overnight separately at 37
o
C in LB supplemented with kanamycin (50 
µg mL
−1
). Overnight cultures of both strains were diluted in flasks containing 100 mL 
LB or 100 mL LB with 1 mM indole to a turbidity at 600 nm of 0.05 and grown until 
turbidity at 600 nm of ~1. Since the ΔtnaA strain of EHEC does not produce any indole, 
TOM converts most of the externally added indole into hydroxylated products such as 2-
HI, 3-HI, or 7-HI, or oxidation products such as isatin, indigo, isoindigo, and indirubin 
(221). The cultures were then centrifuged at 10,000xg for 10 minutes to remove cell 
material and insoluble byproducts of indole metabolism to obtain a cell-free spent 
medium containing a mixture of different soluble indole byproducts. Cell-free 
supernatants from strains lacking the TOM enzyme or without any external indole 
addition were also similarly obtained. 
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CHAPTER VI 
 
SYNTHETIC QUORUM SENSING CIRCUIT TO CONTROL CONSORTIAL 
BIOFILM FORMATION AND DISPERSAL IN A MICROFLUIDIC DEVICE 
 
6.1 Overview 
 Bacteria grow primarily as biofilms, and to utilize them for chemical transformations 
in biorefineries, they periodically need to be replaced. Previously, we engineered global 
regulator Hha and cyclic diguanylate-binding BdcA to create proteins that enable biofilm 
dispersal. Here, we devise a biofilm circuit that utilizes these two dispersal proteins 
along with a population-driven quorum sensing switch. With this synthetic circuit, in a 
novel microfluidic channel, we (i) formed an initial colonizer biofilm, (ii) introduced a 
second cell type (dispersers) into this existing biofilm, (iii) formed a robust dual-species 
biofilm, (iv) displaced the initial colonizer cells in the biofilm with an extra-cellular 
signal from the disperser cells, and (v) removed the disperser biofilm with a chemically-
induced switch. Therefore, for the first time, cells have been engineered that are able to 
displace an existing biofilm and then be removed on command allowing one to control 
consortial biofilm formation for various applications.  
 
 
 
 ____________  
* Submitted in part as “Synthetic quorum sensing circuit to control consortial biofilm 
formation and dispersal in a microfluidic device” by Seok Hoon Hong*, Manjunath 
Hegde*, Jeongyun Kim*, Arul Jayaraman, and Thomas K. Wood, Nature Methods (In 
revision). * These authors contributed equally to this work. 
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6.2 Introduction 
  
 Biofilms are groups of cells at an interface cemented together by polysaccharides, 
protein, DNA, and lipids (60). Biofilms are related to most bacterial chronic 
inflammatory and infectious diseases (235) as well as involved in biocorrosion (236) and 
biofouling (237) in diverse areas. They also may be used for beneficial applications such 
as bioremediation and hold much potential for chemical transformations in biorefineries 
(238). For these applications, compared to monocultures, mixed populations have the 
advantages of being able to perform more complex transformations  (e.g., those 
requiring multiple steps), and they are more resistant to environmental stress (239). For 
these reasons, consortia have been heralded as the new frontier in synthetic biology 
(239). However, to date, it has not been possible to control consortial biofilm formation. 
 Based on an understanding of signals and regulatory networks during biofilm 
development(240), biofilms have been engineered by manipulating 
extracellular/intercellular signals and regulators (238). The first engineered biofilm was 
a consortium where Bacillus subtilis was engineered to secrete the peptide antimicrobials 
indolicidin and bactenecin to inhibit the growth of sulfate-reducing bacteria and thereby 
decrease corrosion (241). Also, the first synthetic signaling circuit to control biofilm 
formation was developed for Escherichia coli and Pseudomonas fluorescens by 
manipulating the extracellular concentration of the signal indole produced by E. coli(21); 
indole is a biofilm inhibitor for E. coli. In addition, using directed evolution, SdiA was 
reconfigured to decrease biofilm formation by increasing indole(242), and the global 
regulator H-NS was evolved to decrease biofilm formation via prophage excision and 
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cell death(243).   
 To remove existing biofilms, T7 bacteriophage was engineered to produce dispersin B 
of Actinobacillus actinomycetemcomitans to disrupt the glycosidic linkages of polymeric 
β-1,6-N-acetyl-D-glucosamine found in the biofilm matrix during bacteriophage 
infection (244). In addition, global transcriptional regulator Hha was engineered using 
protein engineering to enhance biofilm dispersal primarily by inducing protease HslV 
(245), and BdcA, which increases biofilm dispersal by decreasing the concentration of 
the second messenger cyclic diguanylate (c-di-GMP) by binding it, was engineered for 
nearly complete dispersal of biofilms(246). Therefore, new genetic modules are 
available for manipulating biofilms(238).   
 Synthetic biology is an emerging field to develop biological systems that perform 
novel functions by assembling genetic modules(247). The genetic modules include 
switches, cascades, pulse generators, time-delayed circuits, oscillators, spatial patterning, 
and logic formulas, and they can be utilized to control transcription, translation, and 
post-translational operations in order to tune gene expression, protein production, 
metabolism, and cell-cell communication(248). Among these genetic modules, bacterial 
quorum sensing (QS) systems are becoming important components of a wide variety of 
engineered biological devices(249), since autoinducers are useful as input signals 
because most are small, diffuse freely in aqueous media, and are easily imported by 
cells(250). Because the engineered cells synthesize their own QS signals, they are able to 
monitor their cell density and modulate their activities(251) accordingly without  
supervision. Hence, QS based circuits have a wide range of potential engineering 
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applications such as production of biochemicals, tissue engineering, and mixed-species 
fermentations as well as developing biosensors and controlling biofouling (250). For 
example, LuxI from Vibrio fischeri, which produces N-(3-oxo-hexanoyl)-L-homoserine 
lactone (3oC6HSL) and AiiA from Bacillus thuringiensis, which degrades 3oC6HSL, 
were utilized to generate synchronized oscillations(252). Also, the LuxI/LuxR QS 
system was coupled to the production of a toxin protein CcdB to induce cell death at 
high cell densities(253).   
 The two best-characterized QS systems of Pseudomonas aeruginosa are the 
LasI/LasR and RhlI/RhlR systems, which regulate biofilm formation, virulence, 
swarming motility, and antibiotic efflux pumps(254).  LasI produces autoinducer 
molecule, N-(3-oxo-dodecanoyl)-L-homoserine lactone (3oC12HSL), which is sensed by 
LasR(255).  Likewise, RhlI produces N-butyryl-L-homoserine lactone (C4HSL) that is 
sensed by RhlR(255). The LasI/LasR and RhlI/RhlR QS systems have been used to 
engineer bidirectional communication(256), and the LasI/LasR QS system was used to 
both construct a predator-prey ecosystem(257) and create a synthetic ecosystem in E. 
coli(258). Furthermore, the RhlI/RhlR QS system was utilized to demonstrate roles for 
self-organization and aggregation in a synthetic biofilm consortium(259). Hence, 
synthetic QS circuit systems have potential in that population-driven QS switches may 
be utilized to develop synthetic genetic networks for a variety of applications.  
 Since biofilm formation and dispersal are ultimately genetic processes, they may be 
manipulated like other genetic systems(238) using the tools of synthetic biology(248) 
and directed evolution. In this work, our goal was to control biofilm displacement via a 
119 
 
 
population-driven QS switch coupled to engineered biofilm dispersal proteins. 
Controlling biofilm dispersal creates a synthetic biological platform for sophisticated 
patterning of biofilms for engineering applications. The LasI/LasR QS module of P. 
aeruginosa was combined with engineered Hha (245) and BdcA (246) biofilm dispersal 
proteins, and the system was utilized to selectively remove one type of cell from an 
existing biofilm, and then remove the second biofilm to create a surface ready for 
additional biofilms.  
 
6.3 Results 
 
6.3.1 Microfluidic biofilm engineering (µBE) circuit 
 The µBE signaling circuit was constructed in E. coli using two engineered biofilm-
dispersing proteins, Hha13D6(245) and BdcAE50Q(246), along with the P. aeruginosa 
LasI/LasR QS system (Fig. 6.1a). E. coli hha (260) was used as the host since deletion 
of hha increases biofilm formation(261) and provides a background in which there is no 
wild-type Hha.  Lactococcal promoter CP25(262) was used as the strong constitutive 
promoter for two of the three proteins on each plasmid. To obtains high concentrations 
of intercellular signal 3oC12HSL and regulator LasR, a synthetic ribosomal binding site 
(RBS II) (262) was first utilized. However, high expression of lasI or lasR was 
deleterious; thus, we used the native RBS of these genes. All the cloned genes for the 
two cell types were placed on a single plasmid (pCA24N derivative, Fig. 6.2) to avoid 
plasmid instability and so that a single antibiotic could be used to maintain the key 
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plasmid during growth of the consortia.   
 In the µBE circuit, disperser cells (lasI
+
, hha13D6
+
, gfp
+
 via E. coli hha/pHha13D6-
gfp-lasI) produce constitutively green fluorescent protein (GFP) and the quorum-sensing 
signal 3oC12HSL and have hha13D6 induced upon addition of isopropyl--D-
thiogalactopyranoside (IPTG) (Fig. 6.1a). The initial colonizer cells (lasR
+
, bdcAE50Q
+
, 
rfp
+
 via E. coli hha/pBdcAE50Q-rfp-lasR) produce constitutively red fluorescent protein 
(RFP) and regulator LasR, the receptor of 3oC12HSL. The initial colonizer cells also 
have bdcAE50Q under the control of the lasI promoter which is activated via the 
3oC12HSL + LasR complex (263) (Fig. 6.1a). Thus, disperser cells produce the 
signaling molecule 3oC12HSL, and the initial colonizer biofilm-forming cells sense it 
and disperse when the disperser cells reach a quorum.   
 Since we desire the disperser cells to supplant the initial colonizer cells, we checked 
the specific growth rates of the two strains to see if they are comparable; the disperser 
cells grew 14% slower than initial colonizer cells in rich medium (LB glucose, disperser = 
1.13 ± 0.08 h
-1
 and initial colonizer = 1.31 ± 0.05 h
-1
). The slower growth of the disperser 
cells is most likely due to leaky expression of toxin hha13D6 from the T5-lac promoter 
(264). Corroborating this difference in cell growth, disperser cells formed biofilms more 
slowly compared to initial colonizer cells: the biomass of initial colonizer cells after 9 h 
was 5.7 ± 0.1 m3/m2 (Fig. 6.3a) while the biomass of the disperser cells after 9 h was 
4.1 ± 0.1 m3/m2 (Fig. 6.3b). 
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Fig. 6.1.  µBE metabolic circuit and microfluidic device. (a) The two E. coli cell types 
communicate by using the LasI/LasR QS module. In the disperser cell, the LasI protein 
is constitutively produced and synthesizes 3oC12HSL. 3oC12HSL freely diffuses into 
the initial colonizer cell and makes a complex with LasR, and the 3oC12HSL + LasR 
complex induces biofilm dispersal protein BdcAE50Q by activating the lasI promoter. 
The biofilm dispersal protein Hha13D6 in the disperser cell is induced upon adding 
IPTG. Plasmid maps for the synthetic µBE circuit are shown in Fig. 2. (b) The novel 
microfluidic device is shown with its two PDMS layers, a bottom layer with a diffusive-
mixer and eight microchambers, and a top layer containing a second diffusive mixer and 
the pneumatic elements to control microvalves. The diffusive mixer in the bottom layer 
was used to generate different concentrations of dispersal signals (e.g., IPTG for 
removing disperser cells and 3oC12HSL for dispersing initial colonizer cells) and to 
perfuse growth media into the biofilm microchambers. The mixer in the top layer was 
used to introduce bacteria into the microchambers at different cell densities. 
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6.3.2 Disperser cells produce 3oC12HSL 
To confirm the disperser µBE circuit synthesizes 3oC12HSL, we measured the 
3oC12HSL concentration of the disperser cells (E. coli hha/pHha13D6-gfp-lasI) in the 
biofilm using a lacZ reporter (lasB-lacZ translational fusion) that is activated by 
3oC12HSL (265). In flow-cells, disperser cells in biofilms produced 13-fold higher 
concentrations of 3oC12HSL compared to the planktonic cells in the effluent (6.7 ± 3 
M vs. 0.5 ± 0.2 M) and produced 48-fold higher concentrations of 3oC12HSL 
compared to planktonic cells in shake flasks (0.1 ± 0.1 M). The negative control (no 
lasI) had no detectable 3oC12HSL. These results confirm that autoinducer 
concentrations in biofilms are higher than in planktonic cultures (266) and compare well 
to levels of 3oC12HSL produced in P. aeruginosa biofilms (1 (267) to 600 µM (266)). 
Since maximum activity of the lasI promoter is obtained with 0.1 µM of 3oC12HSL 
with LasR (263), 3oC12HSL production in the disperser biofilms should induce the lasI 
promoter in the initial colonizer cells to express bdcAE50Q to disperse the initial 
colonizer biofilms. Moreover, since 3oC12HSL diffusion is significantly slower 
compared to C4HSL diffusion (268), local concentrations of 3oC12HSL in biofilms may 
be much higher than the 3oC12HSL concentration measured here.  
 
6.3.3 3oC12HSL disperses the initial colonizer biofilm  
 To demonstrate that 3oC12HSL disperses biofilms produced by the initial colonizer 
cells (E. coli hha/pBdcAE50Q-rfp-lasR) by binding LasR and inducing bdcAE50Q, 
exogenous 3oC12HSL at different concentrations was added to biofilms formed by the 
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initial colonizer cells in microfluidic channels. As expected, the initial colonizer biofilms 
were dispersed upon adding 3oC12HSL in a dose-dependent manner (Fig. 6.3c); nearly 
complete biofilm dispersal was obtained at 500 µM of 3oC12HSL (Fig. 6.4a). In 
contrast, there was no dispersal in the absence of 3oC12HSL (Fig. 6.4b), and the initial 
colonizer cells formed thick biofilms (10.8 ± 0.6 m3/m2) (Fig. 6.3c). Hence, initial 
colonizer cells recognize 3oC12HSL and this signal may be used to disperse initial 
colonizer biofilms. 
 
6.3.4 IPTG removes the disperser biofilm 
 To demonstrate that IPTG disperses biofilms produced by disperser cells by inducing 
hha13D6, exogenous IPTG at different concentrations was added to biofilms formed by 
disperser cells in microfluidic channels. As expected, disperser biofilms were dispersed 
upon adding IPTG in a dose-dependent manner (Fig. 6.3d) with nearly complete biofilm 
dispersal at 2 mM IPTG (Fig. 6.4c); hence, we used 2 mM IPTG in subsequent 
experiments. In contrast, there was no dispersal in the absence of hha13D6 (Fig. 6.4d). 
Thus, the disperser cell produces 3oC12HSL at concentrations adequate to disperse the 
initial colonizer biofilm and has active hha13D6 to disperse its own biofilm upon IPTG 
addition. Taken together, both disperser and initial colonizer cells were constructed to 
allow us to manipulate biofilm dispersal using a population-driven switch. 
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Fig. 6.2. Plasmid maps of the disperser plasmid and the initial colonizer plasmid that are used to create the µBE circuit. 
(a) pHha13D6-gfp-lasI with hha13D6 under control of the T5-lac promoter and gfp and lasI under control of the constitutive 
CP25 promoter. (b) pBdcAE50Q-rfp-lasR with bdcAE50Q under control of the lasI promoter and rfp and lasR under control of 
the constitutive CP25 promoter. cat encodes chloramphenicol acetyltransferase, lacI^q encodes a repressor mutant of the lac 
operator, and rrnB-T1 indicates the rrnB T1 transcription termination sequence. 
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Fig. 6.3. Biomass of initial colonizer and disperser biofilms. (a) Biomass of initial 
colonizer biofilms (BdcAE50Q
+
, LasR
+
) with 500 µM of 3oC12HSL for 10 h. (b) 
Biomass of disperser biofilms (Hha13D6
+
, LasI
+
) with 2 mM of IPTG for 10 h. (c) 
Biomass after 19 for the initial colonizer biofilms with different concentrations of 
3oC12HSL (0, 71, 143, 214, 286, 357, 429, and 500 µM for 10 h). (d) Biomass after 19 
h for the disperser biofilms with different concentrations of IPTG (0, 0.3, 0.6, 0.9, 1.1, 
1.4, 1.7, and 2.0 µM for 10 h). Robust biofilms at 9 h were formed by seeding the initial 
colonizer or the disperser cells into microchambers for (a), (b), (c), and (d). (e) Biomass 
of the initial colonizer (BdcAE50Q
+
, LasR
+
) and disperser (Hha13D6
+
, LasI
+
) biofilms. 
After 44 h, 2 mM of IPTG was added to remove the disperser biofilm for an additional 
18 h. (f) Biomass of the initial colonizer (BdcAE50Q
+
, LasR
+
) and the no LasI disperser 
control (Hha13D6
+
, LasI
-
) biofilms. After 40 h, 2 mM of IPTG was introduced to 
disperse the no LasI disperser control biofilm for an additional 20 h. The initial colonizer 
biofilms were formed by seeding for 9 h, then disperser cells were seeded for 5 h to form 
both initial colonizer and disperser biofilms for (e) and (f).  
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Fig. 6.4. Dispersal of mono-species biofilms. Initial colonizer biofilms (BdcAE50Q
+
, LasR
+
) were formed by seeding for 9 h, 
then 3oC12HSL (500 µM) was added for 10 h to induce biofilm dispersal (a) or not added (b). Disperser biofilms (Hha13D6
+
, 
LasI
+
) were formed by seeding disperser cells for 9 h, and then 2 mM of IPTG was added for 10 h to induce biofilm dispersal 
(c) or not added (d). Scale bar indicates 20 µm. 
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6.3.5 Engineered BdcA and Hha are necessary for biofilm dispersal 
 To confirm that the biofilm dispersal upon addition of 3oC12HSL and IPTG is the 
result of production of the engineered biofilm dispersal proteins, we performed dispersal 
experiments of initial colonizer cells that lack bdcAE50Q and disperser cells that lack 
hha13D6. As expected, initial colonizer biofilms formed without bdcAE50Q (via E. coli 
hha/pRFP-lasR) did not disperse in the presence of 3oC12HSL (Fig. 6.5a), while initial 
colonizer biofilms formed with bdcAE50Q dispersed with 3oC12HSL (Fig. 6.4a). 
Similarly, disperser biofilms formed without hha13D6 (via E. coli hha/pGFP-lasI) did 
not disperse upon addition of IPTG (Fig. 6.5b), while disperser biofilms formed with 
hha13D6 dispersed with IPTG (Fig. 6.4c). Taken together, BdcAE50Q and Hha13D6 
are necessary to disperse the initial colonizer and disperser biofilms, respectively.    
 
6.3.6 Disperser cells displace initial colonizer biofilms 
 Having verified the disperser and initial colonizer cell elements of the µBE signaling 
circuit, we combined both cell types to form a consortial biofilm and investigated 
whether the disperser cells could displace the initial colonizer cells. First, robust biofilms 
of initial colonizer cells were formed for 9 h, and then disperser cells were added to the 
initial colonizer biofilms for 5 h to form the biofilm consortium (Fig. 6.6a).  Since 
disperser cells synthesize 3oC12HSL constitutively, 3oC12HSL should bind to LasR 
when the concentration of 3oC12HSL is increased as the disperser biofilms mature. 
Then, the 3oC12HSL + LasR complex should induce dispersal of initial colonizer 
biofilms by switching on bdcAE50Q under control of the lasI promoter. As expected, the 
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initial colonizer biofilms were displaced from the surface as the disperser cells grew (Fig. 
6.6a). After 44 h, 80% of the maximum initial colonizer biofilm formed was removed 
(Fig. 6.3e, Fig. 6.6a). The displacement of the initial colonizer cells by the disperser 
cells was accomplished by the production of 3oC12HSL from the disperser biofilms not 
by shear force since the disperser biofilms that lack LasI did not reduce initial colonizer 
biofilms; i.e., both no lasI disperser and initial colonizer biofilms grew when 3oC12HSL 
was not produced (Fig. 6.6b), and the biofilm became essentially that of the faster-
growing initial colonizer cells after 40 h (Fig. 6.3f, Fig. 6.6b). Hence, the disperser cells  
completely displaced the initial colonizer biofilm via the population-driven synthetic 
µBE systems.  
 The second key element of our design was the removal of the disperser biofilm; we 
found we could remove the disperser biofilm by inducing Hha13D6 with IPTG (Fig. 
6.6a). After 62 h (18 h with 2 mM IPTG), 92% of the maximum disperser biofilm was 
removed (Fig. 6.3e).  
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Fig. 6.5. Biofilms formed by cells that lack their respective biofilm dispersal proteins in the presence of 3oC12HSL or 
IPTG.  (a) Initial colonizer biofilms that lack BdcA (BdcAE50Q
-
, LasR
+
 via E. coli hha/pRFP-lasR) with 500 µM of 
3oC12HSL for 10 h. (b) Disperser biofilms that lack Hha (Hha13D6
-
, LasI
+
 via E. coli hha/pGFP-lasI) with 2 mM of IPTG for 
10 h. Robust biofilms at 9 h were formed by seeding initial colonizer or disperser cells into microchambers. Scale bar indicates 
20 µm.    
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Fig. 6.6.  Dispersal of dual-species biofilms. (a) An initial colonizer biofilm (BdcAE50Q
+
, LasR
+
) was formed by seeding for 
9 h (red), and then disperser cells (green) were seeded for 5 h to form both initial colonizer and disperser biofilms. After 44 h, 
2 mM of IPTG was added for an additional 18 h to remove the disperser biofilm. (b) Initial colonizer biofilms (BdcAE50Q
+
, 
LasR
+
) were formed by seeding for 9 h, then control disperser which lack LasI were seeded for 5 h to form both initial 
colonizer and control disperser biofilms. After 40 h, 2 mM of IPTG was introduced for an additional 20 h to try to disperse the 
no lasI disperser biofilms. Scale bar indicates 20 µm.     
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6.4 Discussion 
 We developed a synthetic µBE system by combining a QS signaling module with 
two engineered biofilm dispersal proteins. With this synthetic circuit, in a microfluidic 
channel, we (i) formed an initial colonizer biofilm with cells tagged red, (ii) introduced a 
second cell type (dispersers, tagged green) into this existing biofilm, (iii) created a 
means of communication between the two cell types, (iv) formed a robust biofilm with 
the disperser cells in an existing initial colonizer biofilm, (v) displaced the initial 
colonizer cells in the biofilm with a QS signal from the disperser cells, and (vi) removed 
the disperser cells with a chemically-induced switch.  Our work demonstrates that 
biofilms can be formed, that new cells may be engineered to integrate and then replace 
the initial colonizer biofilm and that both cell types may be removed which is a 
promising strategy for applications requiring different kinds of engineered cells such as 
creating a biorefinery.  
 Although some of the biofilm may be dispersed naturally upon changes in 
environmental conditions (e.g., nutrition level and oxygen depletion)(269), it is a 
significant challenge to remove biofilms (270, 271) since cells in biofilms are cemented 
in place by the secreted polymer matrix consisting of polysaccharide, protein, DNA, and 
lipids (60). The matrix holds bacterial cells together and forms a protective barrier 
conferring resistance to killing by nonspecific and specific host defenses during infection 
and conferring tolerance to various antimicrobial agents such as disinfectants and 
antibiotics (60). Thus, the defensive nature of the biofilm colony makes most biofilms 
difficult or impossible to eradicate (269); hence, our demonstration that both the initial 
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colonizer and disperser biofilms may be nearly completely removed is highly significant.  
 To preferentially remove one type of cell in a biofilm, in our system it requires that 
the second cell elicit robust growth such that it can attach to an existing biofilm and 
propagate, that it flourishes, that it communicates to another cell as the QS signals 
generated within the biofilm must be perceived at a relatively high local concentration 
compared to planktonic cultures (266), and that it displaces the existing biofilm without 
itself being displaced but instead it forms a strong biofilm. Here, we produced the QS 
signal in the biofilm itself to remove the initial colonizer cells. As the signal 
accumulated, the engineered BdcA in the initial colonizer cells reduces c-di-GMP levels 
which results in a cascade of events, such as an increase in motility and reduction in 
adhesion production, that allows the initial colonizer cells to disperse (246).   
 As the initial colonizer cells disperse, the disperser cells must form a robust biofilm. 
After the disperser biofilm is formed, the engineered Hha protein must be able to cause 
dispersal since it induces cell lysis which leads to dispersal (245). Therefore, our 
synthetic µBE system provides a useful platform for the removal of existing deleterious 
biofilms via generating signaling molecules in situ.  In addition, since the disperser cells 
grow more slowly than the initial colonizer ones, the disperser cells cannot displace the 
initial colonizer biofilm based on a difference in growth rates. This demonstrates clearly 
that QS circuit was required to complete this feat of progressive biofilm 
development/dispersal. Since, several biofilm dispersal signals have been identified 
including the auto-inducing peptide of the agr QS system of Staphylococcus aureus 
(272), changes in carbon sources (273), reduction in the concentration of c-di-GMP(246) 
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(as utilized here with BdcA), surfactant (274), cis-2-decenoic acid (275), as well as D-
amino acids (276), we envision that other biofilm dispersal mechanisms may also be 
utilized to control biofilms.  
 The µBE device described here offers several advantages over the commercially 
available BioFlux device developed by Benoit et al. (31) and other microfluidic devices 
used for biofilm study (277). With our device, we can (i) precisely control the 
development of biofilm by intermittent flow of nutrients, (ii) completely isolate the 
biofilm from the media inlet and gradient generating channels using the pneumatic 
valves, and (iii) sequentially introduce different kinds of cell into the biofilm chamber. 
Of course, the ability to study a range of concentrations simultaneously with the eight 
channels (e.g., Fig. 6.3cd) was instrumental in analyzing the effect of various 
concentrations of 3oC12HSL and IPTG.  
 Bacterial QS systems have the attractive design features that they utilize diffusible 
signals(250). Here we show, for the first time, that a QS system may be utilized with 
biofilm dispersal proteins to control consortial biofilm formation; i.e., that an existing 
biofilm may be formed and then replaced by another biofilm which then may be 
removed. These types of synthetic QS circuits may be used to pattern biofilms by 
facilitating the re-use of platforms and to create sophisticated reactor systems that will be 
used to form bio-refineries.  Furthermore, these systems may be adopted in industrial 
and clinical processing as an alternative strategy to overcome the current limitations of 
biofilm control.  
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6.5 Materials and methods 
 
6.5.1 Bacterial strains and growth conditions  
 The bacterial strains and plasmids used in this study are listed in Table 6.1 and were 
cultured at 37
o
C.  LB (278) with 0.2% glucose (LB-glucose) was used in all of the non-
microfluidic experiments, and both M9(278) supplemented with 0.2% glucose (M9-
glucose) and LB glucose were used in the microfluidic device. Kanamycin (50µg/mL) 
was used for overnight cultures, chloramphenicol (100 µg/mL) was used for maintaining 
the pCA24N-based plasmids, and erythromycin (300 µg/mL) was used for maintaining 
the pCM18-based plasmids.   
 
6.5.2 Plasmid construction 
 All primers used for cloning are listed in Table 6.2.  Plasmid pHha13D6-gfp-lasI 
(Fig. 6.2a) encodes hha13D6 (245) under the control of the IPTG-inducible T5-lac 
promoter, as well as gfp and lasI under the control of constitutive CP25 promoter. To 
form this plasmid, gfp was amplified by three rounds of PCR: the first PCR with primers 
gfp-F3 and gfp-R and template pCM18 (262) was to amplify gfp with the same RBS of 
rfp, and the second PCR with primers gfp-F2 and gfp-R using the first PCR product as a 
template and the third PCR with primers gfp-F1 and gfp-R using the second PCR 
product as a template were performed to include the constitutive CP25 promoter of 
pCM18.  pHha13D6-gfp was constructed by cloning the third PCR product into 
pCA24N-hha13D6 (245) using the NotI and BlpI restriction sites after hha13D6. 
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Table  6.1. Strains and plasmids used in this study. Km
R
, Cm
R
, Em
R
, and Ap
R
 are kanamycin, chloramphenicol, erythromycin, 
and ampicillin resistant, respectively.  
 
Strains and plasmids Genotype/relevant characteristics Source 
Strains   
E. coli hha BW25113 hha Ω KmR (260) 
E. coli MG4/pKDT17 Ap
R
, PlasB::lasB
+
-lacZ
+ 
translational fusion, Plac::lasR
+
  (265) 
P. aeruginosa PAO1 Wild-type T. McDermott 
Plasmids   
pCA24N-hha13D6 Cm
R
; lacI
q
, pCA24N PT5-lac::hha13D6
+
 (245) 
pHha13D6-gfp Cm
R
; lacI
q
, pCA24N PT5-lac::hha13D6
+ 
PCP25::gfp
+
 This study 
pHha13D6-gfp-lasI Cm
R
; lacI
q
, pCA24N PT5-lac::hha13D6
+ 
PCP25::gfp
+
-lasI
+
 This study 
pCA24N-bdcAE50Q Cm
R
; lacI
q
, pCA24N PT5-lac::bdcAE50Q
+
 (246) 
pBdcAE50Q Cm
R
; lacI
q
, pCA24N PlasI::bdcAE50Q
+
 This study 
pBdcAE50Q-rfp-lasR Cm
R
; lacI
q
, pCA24N PlasI::bdcAE50Q
+ 
PCP25::rfp
+
-lasR
+
 This study 
pCM18 Em
R
, PCP25::gfp
+
 (262) 
pGFP-lasI Em
R
, PCP25::gfp
+
-lasI
+
 This study 
pCM18-X Em
R
, gfp-disrupted This study 
pRFP-lasR Em
R
, PCP25::rfp
+
-lasR
+
 This study 
pDsRed-Express Ap
R
, Plac::rfp
+
 Clontech 
pDsRed-lasR Ap
R
, Plac::rfp
+
-lasR
+
 This study 
pDsRed-BlpIX-lasR Ap
R
, Plac::rfp
+
-lasR
+
 (BlpI site disrupted) This study 
  
 
 
                                                                                                                                         1
3
8
 
Table 6.2. Primers used for constructing plasmids for the µBE circuit. Underlined italic text indicates the restriction enzyme 
sites: AvaI in plasI-F, BlpI in lasI-F, lasI-R, rfp-lasR-F1, rfp-lasR-F3, and rfp-lasR-R, BseRI in plasI-R, and NotI in gfp-F1. 
Italicized bold text indicates the site-directed mutation for disruption of the BlpI restriction site (5‟-GCTGAGC to 5‟-
TCTGAGC) in BlpI-X-F and BlpI-X-R. Underlined bold text indicates the site-directed mutation site for the codon 
corresponding to truncation at GFP Y66 (5‟-TAT to 5‟-TAA for Y66X) in gfpX-F and gfpX-R. 
 
Primer Name Primer Sequence (listed 5’ to 3’) 
 
Construction of the plasmid for the disperser circuit (pHha13D6-gfp-lasI) 
gfp-F1 GGACTCGCGGCCGCTAAGGGCTTTGGCAGTTTATTCTTGACATGTAGTGAGGGGGCTGGT 
gfp-F2 ACATGTAGTGAGGGGGCTGGTATAATAAAATAGTACTGTTCGGGTGAGCGGATAACAATT 
gfp-F3 TTCGGGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGCGTAAAGGAGAAGAACTT 
lasI-F CCTGCAGCTGAGCTTCTTCAGCTTCCTATTTGGAGGAAGTG 
lasI-R GCTCGACGGCTCAGCAGGTCCCCGTCATGAAACCGCCAGTCGC 
 
Construction of the plasmid for the initial colonizer circuit (pBdcAE50Q-rfp-lasR ) 
plasI-F CGACGCCGCTCGAGGGGCTGTGTTCTCTCGTGTG 
plasI-R GCCGTGCATAGTTAATTTCTCCTCTTTAATGGAAGCTGAAGAATTTATGC 
BlpI-X-F GTGCTCGCGGCGAACTCGGCGCTCTGAGCCTCAGCGTGGAAGCGG 
BlpI-X-R CCGCTTCCACGCTGAGGCTCAGAGCGCCGAGTTCGCCGCGAGCAC 
BlpI-X-seq-F GAACGCCTTCATCGTCGGCAACTACC 
rfp-lasR-F1 GGACTCGCTGAGCGCTTTGGCAGTTTATTCTTGACATGTAGTGAGGGGGCTGGTATAATA 
rfp-lasR-F2 GTGAGGGGGCTGGTATAATAAAATAGTACTGTTCGGGTGAGCGGATAACAATTTCACAC 
rfp-lasR-F3 CCGGACTCGCTGAGCATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGC 
rfp-lasR-R GCTCGACGGCTCAGCAGGTCCCGCTCAGAGAGTAATAAGACCC 
gfpX-F CAACACTTGTCACTACTTTCGGTTAAGGTGTTCAATGCTTTGCGAGATAC 
gfpX-R GTATCTCGCAAAGCATTGAACACCTTAACCGAAAGTAGTGACAAGTGTTG 
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 The final construct pHha13D6-gfp-lasI was formed by cloning lasI with its native 
RBS from the P. aeruginosa PAO1 chromosome by using the lasI-F and lasI-R primers; 
the PCR product was cloned into pHha13D6-gfp using the BlpI restriction site. As a 
control plasmid for producing GFP and LasI but not producing Hha13D6, pGFP-lasI 
was constructed by inserting lasI into pCM18 using lasI-F and las-R primers.   
 Plasmid pBdcAE50Q-rfp-lasR (Fig. 6.2b) encodes bdcAE50Q (246) under the 
control of the lasI promoter, as well as rfp and lasR under the control of the constitutive 
CP25 promoter.  pBdcAE50Q was constructed by replacing the T5-lac promoter in 
pCA24N-bdcAE50Q (246) with the lasI promoter from P. aeruginosa using the plasI-F 
and plasI-R primers; the PCR fragment was cloned into the Ava1 and BseRI restriction 
sites. Plasmid pDsRed-lasR was constructed by inserting lasR and its native RBS into 
the NotI site downstream of the rfp sequence in pDsRed-Express (Clontech, CA, USA) 
using the lasR-F and lasR-R primers. Since a BlpI restriction site lies within lasR but 
was required for the next cloning steps, the BlpI site in pDsRed-lasR was disrupted by 
site-directed mutagenesis (245) (5‟-GCTGAGC to 5‟-TCTGAGC) using the BlpIX-F 
and BlpIX-R primers (this mutation did not change the aa sequence), to form pDsRed-
BlpIX-lasR. rfp and lasR were amplified from pDsRed-BlpIX-lasR by two rounds of 
PCR to include the constitutive CP25 promoter of pCM18: the first PCR was performed 
using the rfp-lasR-F2 and rfp-lasR-R primers and the second PCR was performed using 
the rfp-lasR-F1 and rfp-lasR-R primers with the first PCR product. The final construct 
pBdcAE50Q-rfp-lasR was formed by inserting the rfp and lasR PCR products into the 
BlpI site downstream of bdcAE50Q in pBdcAE50Q. As a control plasmid for producing 
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RFP and LasR but not producing BdcAE50Q, pRFP-lasR was constructed by inserting 
rfp and lasR using the rfp-lasR-F3 and rfp-lasR-R primers into pCM18-X in which gfp 
was disrupted by introducing a truncation at Y66 of GFP using the gfpX-F and gfpX-R 
primers in pCM18.  All plasmids were confirmed by PCR and DNA sequencing.  
 
6.5.3 Microfluidic device fabrication 
 The poly(dimethyl)siloxane (PDMS)-based µBE device (Fig. 6.1b) was fabricated in 
the Materials Characterization Facility at Texas A&M University using conventional 
soft lithographic techniques as described previously (234). The μBE device consists of a 
glass slide and two layers, a bottom layer with a diffusive-mixer and eight 
microchambers, and a top layer which contains the pneumatic elements for controlling 
microvalves and a second diffusive mixer. The diffusive mixer in the bottom layer was 
used to generate different concentrations of dispersal signals (e.g., IPTG for removing 
disperser cells) and to perfuse growth media into the biofilm microchambers. The mixer 
in the top layer was used to introduce bacteria into the microchambers at different cell 
densities (Fig. 6.1b). The dimensions of the diffusive mixers in both the top and bottom 
layers were 100 µm (width) × 150 µm (height) and 200 µm (width) × 200 µm (height) 
respectively, and the biofilm microchambers were 600 µm (width) × 150 µm (height). 
All pneumatic channels were 200 µm thick. The two layers were fabricated separately 
and assembled by sequential oxygen plasma treatment and bonding (100 mTorr, 100 W, 
40 s) in a reactive ion etcher. The top pneumatic layer was ﬁrst aligned and bonded to 
the bottom diffusive-mixer/microchamber membrane layer followed by bonding of the 
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combined PDMS layer to a cover glass (22 x 50 mm). Tygon tubing (0.01” ID × 0.03” 
OD, Saint Gobain performance plastics, OH, USA) was used for all fluidic connections. 
Two PicoPlus 11 syringe pumps (Harvard Apparatus, MA, USA) were used for each 
experiment to separately control fluid flow rates in the two layers. A temperature 
controlled micro-incubator was used to maintain the temperature of the device at 37
o
C. 
Moist air flowed continuously over the device in order to maintain humidity and avoid 
bubble formation inside the microchambers. The opening and closing of valves were 
pneumatically controlled by introducing vacuum or compressed air through the solenoid 
valves. The operation of solenoid valves and syringe pumps were remotely controlled 
through programs developed in-house for the LabVIEW platform (National Instruments, 
TX, USA). 
 
6.5.4 Microfluidic biofilm experiments 
 For mono-species biofilm dispersal experiments, overnight cultures were washed and 
resuspended in M9 medium supplemented with glucose (0.2%) at a turbidity at 600 nm 
of ~1.0. The bacterial suspension was introduced into the eight biofilm microchambers 
through the top layer in the PDMS device (Fig. 6.1b). During this process, the main inlet 
valves (Fig. 6.1b) remained closed to prevent cells from entering and forming biofilm in 
the gradient mixing channels and to ensure proper mixing of dispersal signals before 
they enter the microchambers. The main outlet valves and seeding valves were then 
closed, and the culture was maintained without flow for 2 h to enable attachment of 
bacteria to the glass surface (seeding). After 2 h, main inlet and outlet valves were 
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opened, unattached cells were removed, and the attached bacteria were allowed to grow 
by flowing LB-glucose at 2 µL/min. After 3 h, the medium was switched from LB-
glucose to M9-glucose for 3 h because we found that a sudden depletion of nutrients 
promoted rapid development of biofilms. The biofilm was then developed for another 3 
h by introducing LB-glucose into the chambers in a semi-batch mode (55 min static and 
5 min flow). Thus, within 9 h after seeding, a robust and mature biofilm was formed. To 
disperse the biofilm, LB-glucose and LB-glucose containing a single concentration of 
the dispersal signal (IPTG for disperser cells and 3oC12HSL for initial colonizer cells) 
was introduced through the two media inlets and allowed to mix in the serpentine 
gradient generating channels to form eight concentrations of the dispersal signal in LB-
glucose medium. Each stream leaving the diffusive mixer was used to perfuse a specific 
biofilm microchamber for 10 h.  
 For dual-species biofilm dispersal experiments, initial colonizer cell biofilm was 
developed uniformly across all eight microchambers for 9 h as for mono-species 
biofilms. During this 9 h period, unattached initial colonizer cells were continuously 
removed from the cell mixer and connecter tubing through the cell outlet by flowing M9 
medium at 8 µL/min. After formation of the initial colonizer biofilm, disperser cells 
(turbidity at 600 nm of 2.0 in M9-glucose) were continuously perfused into the 
microchamber for 5 h to allow disperser cells to colonize the initial colonizer biofilm as 
well as the glass surface in vacant regions. After 5 h, LB-glucose was introduced into the 
microchamber in semi-batch mode (55 min static and 5 min flow) for 28-30 h. The static 
condition ensured biofilm development and build-up of 3oC12HSL needed for induction 
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of the BdcAE50Q dispersal protein in initial colonizer cells. To remove the disperser cell 
biofilm, LB-glucose containing 2 mM IPTG was introduced in semi-batch mode for 18 
to 20 h.  
 
6.5.5 Confocal microscopy 
 Images were taken every 1 to 2 h using a 40X/0.85 NA dry objective with a TCS 
SP5 scanning confocal laser microscope (Leica Microsystems, Wetzlar, Germany)(21). 
Z-stack images were taken at a zoom level of 2 such that the image covered 90% of 
width of the microchamber. Two individual positions per microchamber covering a total 
of 70% of the channel length were chosen for imaging. Using the confocal z-stack 
images, 3-D reconstruction of the biofilm architecture was performed using IMARIS 3D 
and 4D Real-Time Interactive Data Visualization software (Bitplane Inc., CT, USA). 
Biomass and average biofilm height were obtained using COMSTAT image-processing 
software(279). 
 
6.5.6 Flow-cell biofilm experiments and biofilm volume analysis 
 Overnight cultures were diluted to a turbidity at 600 nm of 0.05 in LB-glucose and 
pumped through the flow-cell (BST model FC81, Biosurface Technologies, MT, USA) 
at 10 mL/h for 2 h, then LB-glucose was pumped for 48 h to form biofilms. The biofilms 
on the glass slides were visualized after robust biofilms were formed (48 h) using a 
confocal microscope. COMSTAT was used to analyze the biofilms formed at 13 
positions. Biofilm volume was calculated by multiplying biofilm biomass and the 
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surface area (1400 mm
2
) of the flow-cell.  
 
6.5.7 3oC12HSL assay in biofilms  
 The flow-cell was disassembled, and biofilms samples were collected by wiping the 
coverslip, glass slides, and four sides of the flow-cell with paper towels (Kimwipes, 1.5 
cm × 1.5 cm). This was repeated three times to ensure all biofilm cells were collected. 
The biofilm cells were resuspended in 5 mL of dH2O, mixed, and centrifuged. The 
biofilm cells were resuspended in 3 mL of dH2O and sonicated twice using a 60 Sonic 
Dismembrator (Fisher Scientific, PA, USA) at level 10 for 15 sec. 3oC12HSL was 
extracted as described previously(280) with slight modifications. The samples were 
extracted three times with a half volume of dichloromethane. The aqueous residue was 
removed after freezing the samples for 3 h at -20ºC. The solvent was evaporated via 
rotary evaporation, and the residue was resuspended in 200 µL of ethyl acetate. E. coli 
MG4/pKDT17 was used to assay the 3oC12HSL levels(265). This reporter strain 
contains a copy of the lasR gene as well as a lasB::lacZ fusion.  β-galactosidase activity 
was measured as described previously(281). Synthetic 3oC12HSL (Sigma-Aldrich, MO, 
USA) was used as the standard (Fig. 6.7), and planktonic cultures of E. coli 
hha/pHha13D6-gfp, which does not produce 3oC12HSL, was used as a negative control. 
As additional controls, effluent from the flow-cell and planktonic cultures were used to 
compare with 3oC12HSL concentrations from the biofilm.   
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Figure 6.7. Standard curve for determining 3oC12HSL concentrations. β-
galactosidase activity was measured using reporter E. coli MG4/pKDT17 upon adding 
different amounts of 3oC12HSL.  
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CHAPTER VII  
CONCLUSIONS AND RECOMMENDATIONS 
  
7.1 Conclusions  
 We showed that norepinephrine (NE) is an important host signal produced during 
stress that increases P. aeruginosa growth, motility, attachment, and virulence, all of 
which are integral to infection (Chapter III). Based on this, we hypothesize the P. 
aeruginosa causes gut-derived sepsis during chronic stress, by utilizing the NE released 
in the gut to produce more motile, more adherent, and potentially more virulent cells. 
Our data also showed that the actions of NE are mediated primarily through the LasR, 
and not the RhlR QS system.  
 We also investigated the molecular mechanism involved in the chemo-sensing of the 
bacterial cell-cell communication molecule autoinducer-2 by E. coli and S. typhimurium 
(Chapter IV). We performed different chemotaxis assays (capillary, microPlug and 
microFlow assays) to demonstrate that AI-2 is a potent attractant for E. coli and S. 
typhimurium and that the Tsr chemoreceptor and LsrB are necessary for sensing AI-2, 
although uptake of AI-2 into the cytoplasm is not required. We concluded that LsrB, 
when bound to AI-2, interacts directly with the periplasmic domain of Tsr primarily at 
the Thr-61 and Asp-63 residues of LsrB, making LsrB the first known periplasmic-
protein partner for Tsr. Thus, we propose that chemotaxis toward a bacterial 
communication signal like AI-2 may be an important virulence factor within the 
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gastrointestinal (GI) tract that could help free-swimming, planktonic bacteria colonize 
developing biofilms. 
 We developed a simple user-friendly microfluidic flow cell device (µBF device, 
Chapter V) that is customizable and contains eight separate microchambers for 
cultivating biofilms exposed to eight different concentrations of signals through a single 
gradient mixer. The presence of pneumatic valves and a separate cell seeding port that is 
independent from gradient-mixing channels offered complete isolation of the biofilm 
microchamber from the gradient mixer, and also performed well under flow, batch or 
semi-batch conditions. The µBF device we fabricated can precisely measure the effect of 
a wide range of concentrations of single or combinations of two or more soluble signals 
on bacterial biofilm formation and development. The device enabled screening of 
compounds and their concentrations that effectively inhibit biofilm formation of 
pathogenic bacteria. Also, we showed that the µBF device can be used to perform 
competition based studies to study the overall effect of two or more compounds on 
biofilm formation (e.g., 7-HI vs. isatin) and check which compound is most important in 
controlling biofilm. 
 We also upgraded the µBF device by adding a second top layer that contains a 
gradient mixer and a few other features and named it the microfluidic biofilm 
engineering (µBE) device. We used this µBE device to manipulate E. coli biofilm 
formation using tools of synthetic biology and protein engineering. We constructed a 
synthetic biofilm circuit that utilizes the Hha and BdcA dispersal proteins of E. coli 
along with a quorum sensing (QS) switch that works based on the accumulation of the 
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signal N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-o-C12HSL) and implemented it in 
the µBE device. We showed that a QS system may be utilized with biofilm dispersal 
proteins to control consortial biofilm formation by removing an existing biofilm and 
then removing the biofilm that displaced the first one. These types of synthetic QS 
circuits may be used to pattern biofilms by facilitating the re-use of platforms and to 
create sophisticated reactor systems that will be used to form bio-refineries. 
 
7.2 Recommendations  
The μBF device has significant potential for studying the role of inter- and intra-
kingdom signaling on bacterial biofilm formation and colonization and for quantitatively 
investigating bacterial chemotaxis, especially repellent taxis. The μBF prototype can be 
modified for investigating the role of signal-mediated bacterial chemotaxis in 
colonization and biofilm formation in the GI tract. For example, we can use the device to 
test the hypothesis that recognition of AI-2 and the resultant migration (i.e., chemotaxis) 
toward it contribute to recruitment of planktonic bacteria to bacterial communities. The 
effective concentration of AI-2 from a biofilm that planktonic bacteria encounter is not 
accurately known; therefore, we will create AI-2 concentration gradients arising from a 
biofilm with a microfluidic concentration generator and investigate if motile E. coli is 
recruited from the planktonic phase to colonize a surface. The modified μBF device will 
consist of three layers (Fig. 7.1A). The bottom layer (biofilm module) will be similar to 
the top layer of the μBF device with eight biofilm chambers where AI-2 can be 
introduced or  
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Fig 7.1. Using the μBF device to monitor the biofilm formation and recruitment of 
planktonic bacteria to an existing biofilm. (A) The dual-microchamber construction 
used to examine attraction of planktonic cells to biofilm, in which the upper chambers 
can be used to flow motile bacteria, and the lower chambers can be used to flow AI-2 or 
to form a biofilm. A permeable membrane will separate the two chambers. Diffusion of 
AI-2 through the membrane is indicated by arrows. (B) Response of planktonic cell 
expressing GFP to AI-2 producing biofilms, whose cells express RFP; the arrows 
indicate relative strengths of AI-2 generation. Cells should accumulate at the membrane 
above AI-2 generating biofilm clusters. The cells are shown adhering to the membrane. 
(C) The same experiment in B except that cells will be allowed direct access to the 
developing biofilm; in this case, the planktonic cells are actually forming and joining the 
biofilms.  
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where bacteria can be cultured and biofilm communities developed. The top layer will 
also have an additional module containing eight chemotaxis microchambers identical to 
the biofilm chambers in the bottom layer. The two layers will be separated by a porous 
PDMS or agarose membrane. The device will be aligned such that each chemotaxis 
chamber is directly underneath a single biofilm chamber. When a stream containing a 
specific concentration of AI-2 flows through the bottom layer (Fig. 7.1B) or AI-2 
producing biofilms are present in the bottom biofilm chambers, AI-2 will diffuse through 
the porous membrane so that cells in the top layer are exposed to it. If an attractant 
signal is produced, bacteria should accumulate on or near the membrane.  
 We discovered through our in vitro studies that human stress hormone NE is an 
inter-kingdom signal that increases pathogenesis of P. aeruginosa (Chapter III).  
Building on these results, we need to investigate if NE produced in vivo in the gut during 
chronic stress actually contributes to P. aeruginosa gut-derived sepsis by increasing its 
colonization and virulence.  We can develop a P. aeruginosa sepsis model in rats to 
determine the regions in the gut the pathogen colonizes when the animal is stressed (e.g., 
burn injury) and extract tissue samples to measure the concentration of NE in those 
regions. If this is not a feasible option, microfluidic devices can be designed to mimic 
the actual in vivo environment (282). The modified µBF (Fig. 7.1A) with dual-
microchamber construction can be used to examine attraction of planktonic cells P. 
aeruginosa cells to NE and intestinal epithelial cells, in which the upper chambers can 
be used to flow bacteria, and the lower chambers can be used to cultivate mucus 
producing intestinal epithelial cell line in the presence of different concentrations of NE. 
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Different concentrations of NE can diffuse through the permeable membrane that 
separates the two chambers and generate gradients of different strength, thereby 
generating an environment similar to that seen in vivo where the concentrations of 
signals are not uniform (283). 
 In Chapter IV, we performed different chemotaxis assays (capillary, microPlug and 
microFlow assays) to investigate the molecular mechanism involved in the chemo-
sensing of the bacterial cell-cell communication molecule AI-2 by E. coli and S. 
typhimurium and demonstrated that AI-2 is a potent attractant for E. coli and S. 
typhimurium and that the Tsr chemoreceptor and LsrB are necessary for sensing AI-2, 
although uptake of AI-2 into the cytoplasm is not required. Similarly, we can perform 
chemotaxis assays on chemoreceptor knockout mutants available in our lab to 
investigate how pathogens such as EHEC and S. typhimurium sense inter-kingdom 
signals such as human hormones such as NE, dopamine, and serotonin, and intra-
kingdom signals such as indole, hydroxyindoles, isatin, and homoserine lactones (Fig 
7.2). 
 
Fig 7.2. Recognition of inter- and intra-kingdom signals by E. coli chemoreceptors 
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APPENDIX 
Table I. Complete list of differentially-expressed genes above the statistically significant cut-off fold change of 4.0 (based on 
the standard deviation of the fold changes of all the genes) in suspension cells of PA14 grown in serum-RPMI medium at 37 
o
C for 7 h with and without 50 µM NE. Complete data for the 50 µM DNA microarrays are available using GEO series 
accession number GSE 13326.   
 
Locus tag Gene 
name 
Alternate Gene 
Name 
NE vs. control 
 (50 µM) 
Descriptions 
PA0030     4.0 hypothetical protein 
PA0128   phnA  4.0 conserved hypothetical protein 
PA0322     6.1 probable transporter 
PA0439   dypB  4.0 probable oxidoreductase 
PA0443     7.5 probable transporter 
PA0447 gcdH   4.0 glutaryl-CoA dehydrogenase 
PA0510   nirE  6.1 probable uroporphyrin-III c-methyltransferase 
PA0512   nirH  6.5 conserved hypothetical protein 
PA0513   nirG  10.6 probable transcriptional regulator 
PA0514 nirL   9.2 heme d1 biosynthesis protein NirL 
PA0515   nirD  11.3 probable transcriptional regulator 
PA0516 nirF   6.1 heme d1 biosynthesis protein NirF 
PA0517 nirC   14.9 probable c-type cytochrome precursor 
PA0518 nirM   12.1 cytochrome c-551 precursor 
PA0519 nirS   16.0 nitrite reductase precursor 
PA0523 norC   45.3 nitric-oxide reductase subunit C 
PA0524 norB   39.4 nitric-oxide reductase subunit B 
PA0525   norD  4.0 probable dinitrification protein NorD 
PA0526     6.5 hypothetical protein 
PA0672 hemO pigA  -5.3 heme oxygenase 
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PA0707 toxR regA  -7.5 transcriptional regulator ToxR 
PA0713     4.9 hypothetical protein 
PA0714     4.6 hypothetical protein 
PA0876     4.0 probable transcriptional regulator 
PA0880     5.7 probable ring-cleaving dioxygenase 
PA0884   dctP  4.0 probable C4-dicarboxylate-binding periplasmic protein 
PA0918     4.6 cytochrome b561 
PA0985     -9.2 probable colicin-like toxin 
PA0993 cupC2   5.3 chaperone CupC2 
PA1123     8.0 hypothetical protein 
PA1134     -5.7 hypothetical protein 
PA1148 toxA eta  -8.0 exotoxin A precursor 
PA1172 napC   13.9 cytochrome c-type protein NapC 
PA1173 napB   16.0 cytochrome c-type protein NapB precursor 
PA1174 napA   9.8 periplasmic nitrate reductase protein NapA 
PA1212     6.1 probable major facilitator superfamily (MFS) transporter 
PA1216     7.5 hypothetical protein 
PA1217     5.7 probable 2-isopropylmalate synthase 
PA1218     4.6 hypothetical protein 
PA1236     8.0 probable major facilitator superfamily (MFS) transporter 
PA1246 aprD   -4.0 alkaline protease secretion protein AprD 
PA1254     4.6 probable dihydrodipicolinate synthetase 
PA1300     -9.8 probable sigma-70 factor, ECF subfamily 
PA1301     -5.3 probable transmembrane sensor 
PA1485     4.0 probable amino acid permease 
PA1540     4.0 conserved hypothetical protein 
PA1542     4.6 hypothetical protein 
PA1550     6.1 hypothetical protein 
PA1551   fixG  7.0 probable ferredoxin 
PA1555   ccoP  7.5 probable cytochrome c 
PA1556   ccoO  5.7 probable cytochrome c oxidase subunit 
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PA1601     4.0 probable aldehyde dehydrogenase 
PA1632 kdpF   4.0 KdpF protein 
PA1740     4.9 hypothetical protein 
PA1746     4.9 hypothetical protein 
PA1879     4.0 hypothetical protein 
PA1897     5.3 hypothetical protein 
PA1919 nrdG  4.3 class III (anaerobic) ribonucleoside-triphosphate reductase 
activating protein, 'activase', NrdG 
PA1984   exaC1  -10.6 probable aldehyde dehydrogenase 
PA2033     -10.6 hypothetical protein 
PA2034     -10.6 hypothetical protein 
PA2116     -5.7 conserved hypothetical protein 
PA2147 katE   9.8 catalase HPII 
PA2169     5.3 hypothetical protein 
PA2171     6.5 hypothetical protein 
PA2172     8.0 hypothetical protein 
PA2173     4.3 hypothetical protein 
PA2262   kguT  7.0 probable 2-ketogluconate transporter 
PA2329     4.6 probable ATP-binding component of ABC transporter 
PA2330     4.3 hypothetical protein 
PA2331     9.2 hypothetical protein 
PA2377     -8.6 hypothetical protein 
PA2382 lldA   -7.0 L-lactate dehydrogenase 
PA2383     -4.6 probable transcriptional regulator 
PA2384     -4.3 hypothetical protein 
PA2385 pvdQ   -13.9 PvdQ 
PA2386 pvdA   -9.8 L-ornithine N5-oxygenase 
PA2389     -7.0 conserved hypothetical protein 
PA2390     -6.1 probable ATP-binding/permease fusion ABC transporter 
PA2391 opmQ   -5.3 probable outer membrane protein precursor 
PA2392 pvdP   -10.6 PvdP 
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PA2393     -13.9 probable dipeptidase precursor 
PA2394 pvdN   -14.9 PvdN 
PA2395 pvdO   -14.9 PvdO 
PA2396 pvdF   -8.6 pyoverdine synthetase F 
PA2397 pvdE   -12.1 pyoverdine biosynthesis protein PvdE 
PA2398 fpvA   -9.2 ferripyoverdine receptor 
PA2399 pvdD   -8.6 pyoverdine synthetase D 
PA2400 pvdJ PA2401  -7.5 PvdJ 
PA2402     -8.0 probable non-ribosomal peptide synthetase 
PA2411     -7.0 probable thioesterase 
PA2412     -6.1 conserved hypothetical protein 
PA2413 pvdH   -13.0 L-2,4-diaminobutyrate:2-ketoglutarate 4-aminotransferase 
PA2424 pvdL   -9.8 PvdL 
PA2425 pvdG   -12.1 PvdG 
PA2426 pvdS   -7.5 sigma factor PvdS 
PA2427     -9.8 hypothetical protein 
PA2444 glyA2   -11.3 serine hydroxymethyltransferase 
PA2445 gcvP2   -10.6 glycine cleavage system protein P2 
PA2446 gcvH2   -11.3 glycine cleavage system protein H2 
PA2451     -6.5 hypothetical protein 
PA2452     -9.2 hypothetical protein 
PA2563     4.3 probable sulfate transporter 
PA2567     4.3 hypothetical protein 
PA2570 lecA pa1L  4.9 LecA 
PA2664 fhp   4.0 Flavohemoprotein 
PA2924 hisQ   4.3 histidine transport system permease HisQ 
PA3032 snr1   4.3 cytochrome c Snr1 
PA3218     8.0 hypothetical protein 
PA3234   yjcG  4.3 probable sodium:solute symporter 
PA3235   yjcH  6.1 conserved hypothetical protein 
PA3391 nosR   18.4 regulatory protein NosR 
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PA3392 nosZ   4.0 nitrous-oxide reductase precursor 
PA3405 hasE   -6.1 metalloprotease secretion protein 
PA3406 hasD   -4.3 transport protein HasD 
PA3407 hasAp   -42.2 heme acquisition protein HasAp 
PA3408 hasR   -16.0 Haem uptake outer membrane receptor HasR precursor 
PA3442   ycbE  5.3 probable ATP-binding component of ABC transporter 
PA3719     4.3 hypothetical protein 
PA3721     7.0 probable transcriptional regulator 
PA3775     4.9 hypothetical protein 
PA3784     9.2 hypothetical protein 
PA3785     13.9 conserved hypothetical protein 
PA3789     11.3 hypothetical protein 
PA3790 oprC   4.6 Putative copper transport outer membrane porin precursor 
PA3870 moaA1   34.3 molybdopterin biosynthetic protein A1 
PA3871   nifM  14.9 probable peptidyl-prolyl cis-trans isomerase, PpiC-type 
PA3872 narI   13.0 respiratory nitrate reductase gamma chain 
PA3873 narJ   13.0 respiratory nitrate reductase delta chain 
PA3874 narH   24.3 respiratory nitrate reductase beta chain 
PA3875 narG   26.0 respiratory nitrate reductase alpha chain 
PA3876 narK2   32.0 nitrite extrusion protein 2 
PA3877 narK1   21.1 nitrite extrusion protein 1 
PA3911   yhbT  14.9 conserved hypothetical protein 
PA3912   yhbV  27.9 conserved hypothetical protein 
PA3913   yhbU  39.4 probable protease 
PA3914 moeA1   207.9 molybdenum cofactor biosynthetic protein A1 
PA3915 moaB1   64.0 molybdopterin biosynthetic protein B1 
PA3916 moaE   5.3 molybdopterin converting factor, large subunit 
PA3917 moaD   5.7 molybdopterin converting factor, small subunit 
PA3918 moaC   5.7 molybdopterin biosynthetic protein C 
PA4038     4.3 hypothetical protein 
PA4072     11.3 probable amino acid permease 
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PA4078     4.3 probable nonribosomal peptide synthetase 
PA4079     4.6 probable dehydrogenase 
PA4080   rcsB  4.6 probable response regulator 
PA4081 cupB6   4.0 fimbrial subunit CupB6 
PA4084 cupB3 htrE  11.3 usher CupB3 
PA4127 hpcG hpaH  4.6 2-oxo-hept-3-ene-1,7-dioate hydratase 
PA4129     5.3 hypothetical protein 
PA4130     7.0 probable sulfite or nitrite reductase 
PA4131     12.1 probable iron-sulfur protein 
PA4132     7.5 conserved hypothetical protein 
PA4133   ccoN  22.6 cytochrome c oxidase subunit (cbb3-type) 
PA4134     22.6 hypothetical protein 
PA4137   opdL  6.1 probable porin 
PA4152   acoC  8.6 probable hydrolase 
PA4236 katA catA  4.6 Catalase 
PA4351     6.5 probable acyltransferase 
PA4357   yhgG  4.9 conserved hypothetical protein 
PA4467     -14.9 hypothetical protein 
PA4468 sodM sodA  -12.1 superoxide dismutase 
PA4469     -13.0 hypothetical protein 
PA4470 fumC1   -16.0 fumarate hydratase 
PA4471   fagA  -13.0 hypothetical protein 
PA4570     -7.0 hypothetical protein 
PA4587 ccpR   8.6 cytochrome c551 peroxidase precursor 
PA4635   mgtC  4.3 conserved hypothetical protein 
PA4652     4.0 hypothetical protein 
PA4810 fdnI fdhI 14.9 nitrate-inducible formate dehydrogenase, gamma subunit 
PA4811 fdnH fdhH  52.0 nitrate-inducible formate dehydrogenase, beta subunit 
PA4812 fdnG fdhG  12.1 formate dehydrogenase-O, major subunit 
PA4818     5.7 conserved hypothetical protein 
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PA4880     6.1 probable bacterioferritin 
PA4895     -4.9 probable transmembrane sensor 
PA4896     -4.9 probable sigma-70 factor, ECF subfamily 
PA5053 hslV   5.3 heat shock protein HslV 
PA5054 hslU   4.0 heat shock protein HslU 
PA5150     -4.3 probable short-chain dehydrogenase 
PA5383   yeiH  5.7 conserved hypothetical protein 
PA5388     5.3 hypothetical protein 
PA5415 glyA1   -4.3 serine hydroxymethyltransferase 
PA5427 adhA   4.3 alcohol dehydrogenase 
PA5548     4.6 probable major facilitator superfamily (MFS) transporter 
PA5566     4.6 hypothetical protein 
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Table II. Complete list of differentially-expressed genes above the statistically significant cut-off fold change of 2.0 (based on 
the standard deviation of the fold changes of all the genes) in suspension cells of PA14 grown in serum-RPMI medium at 37 
o
C for 7 h with and without 500 µM NE. Complete data for the 50 µM DNA microarrays are available using GEO series 
accession number GSE 13326.  
 
Locus 
tag 
Gene 
name 
Alternate 
gene 
name 
NE vs. 
control  
(500 µM) 
Description 
PA0026 plcB   4 phospholipase C 
PA0044 exoT   2.1 Exoenzyme T 
PA0491     2.0 probable transcriptional regulator 
PA0501 bioF   3.0 8-amino-7-oxononanoate synthase 
PA0502   bioH 3.7 probable biotin biosynthesis protein bioH 
PA0503   bioC 2.1 probable biotin synthesis protein BioC 
PA0508     4.6 probable acyl-CoA dehydrogenase 
PA0509 nirN   2.8 probable c-type cytochrome 
PA0510   nirE 3.0 probable uroporphyrin-III c-methyltransferase 
PA0512   nirH 2.0 conserved hypothetical protein 
PA0513   nirG  3.5 probable transcriptional regulator 
PA0514 nirL   3.0 heme d1 biosynthesis protein NirL 
PA0515   nirD  4.3 probable transcriptional regulator 
PA0516 nirF   2.0 heme d1 biosynthesis protein NirF 
PA0517 nirC   2.5 probable c-type cytochrome precursor 
PA0518 nirM   2.3 cytochrome c-551 precursor 
PA0519 nirS   4.0 nitrite reductase precursor 
PA0523 norC   3.7 nitric-oxide reductase subunit C 
PA0524 norB   4.0 nitric-oxide reductase subunit B 
PA0527 dnr   2.0 transcriptional regulator Dnr 
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PA0537     2.0 conserved hypothetical protein 
PA0550   ygbM 2.0 conserved hypothetical protein 
PA0584 cca   2.0 tRNA nucleotidyl transferase 
PA0593 pdxA   2.0 pyridoxal phosphate biosynthetic protein PdxA 
PA0639     2.0 conserved hypothetical protein 
PA0659     2.0 hypothetical protein 
PA0664     2.0 hypothetical protein 
PA0713     2.0 hypothetical protein 
PA0884   dctP  2.0 probable C4-dicarboxylate-binding periplasmic protein 
PA0927 ldhA ldhD 2.0 D-lactate dehydrogenase (fermentative) 
PA0949 wrbA   2.0 Trp repressor binding protein WrbA 
PA0950     2.0 probable arsenate reductase 
PA0997 pqsB   2.6 Beta-keto-acyl carrier protein synthase 
PA1000 pqsE   4.3 Quinolone signal response protein 
PA1003 mvfR   3 Transcriptional regulator MvfR 
PA1029     2.0 hypothetical protein 
PA1058   phaF 2.0 conserved hypothetical protein 
PA1070 braG   -8.6 branched-chain amino acid transport protein BraG 
PA1071 braF   -17.2 branched-chain amino acid transport protein BraF 
PA1072 braE   -14.9 branched-chain amino acid transport protein BraE 
PA1073 braD   -14.9 branched-chain amino acid transport protein BraD 
PA1074 braC   -8.6 branched-chain amino acid transport protein BraC 
PA1075     -8.6 hypothetical protein 
PA1076     -17.2 hypothetical protein 
PA1077 flgB   -27.9 flagellar basal-body rod protein FlgB 
PA1078 flgC   2.6 flagellar basal-body rod protein FlgC 
PA1079 flgD   2.3 flagellar basal-body rod modification protein FlgD 
PA1082 flgG   2.0 flagellar basal-body rod protein FlgG 
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PA1083 flgH   -4.6 flagellar L-ring protein precursor FlgH 
PA1084 flgI   -4.6 flagellar P-ring protein precursor FlgI 
PA1085 flgJ   -4.6 flagellar protein FlgJ 
PA1087 flgL Flak 2.1 flagellar hook-associated protein type 3 FlgL 
PA1092 fliC   2.3 flagellin type B 
PA1094 fliD   2.0 flagellar capping protein FliD 
PA1095   fliS  2.3 hypothetical protein 
PA1097 fleQ   2.5 transcriptional regulator FleQ 
PA1098 fleS   2.3 two-component sensor 
PA1099 fleR   4.3 two-component response regulator 
PA1101 fliF   2.1 Flagella M-ring outer membrane protein precursor 
PA1103   fliH  2.8 probable flagellar assembly protein 
PA1130 rhlC   2.8 Rhamnosyltransferase 2 
PA1133     2.0 hypothetical protein 
PA1138     2.0 probable transcriptional regulator 
PA1162 dapE   2.0 succinyl-diaminopimelate desuccinylase 
PA1174 napA   2.0 periplasmic nitrate reductase protein NapA 
PA1176 napF   2.0 ferredoxin protein NapF 
PA1177 napE   2.0 periplasmic nitrate reductase protein NapE 
PA1190   yohC 2.0 conserved hypothetical protein 
PA1247 aprE   -2.6 Alkaline protease secretion protein AprE 
PA1249 aprA   -2.1 Alkaline metalloproteinase precursor 
PA1313     2.0 probable major facilitator superfamily (MFS) transporter 
PA1359     2.0 probable transcriptional regulator 
PA1376 aceK   2.0 isocitrate dehydrogenase kinase/phosphatase 
PA1416     2.0 conserved hypothetical protein 
PA1428   yjaB  2.0 conserved hypothetical protein 
PA1455 fliA rpoF 2.0 sigma factor FliA 
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PA1474     2.0 hypothetical protein 
PA1485     2.0 probable amino acid permease 
PA1498 pykF pyk-I 2.0 pyruvate kinase I 
PA1533     2.0 conserved hypothetical protein 
PA1541     2.0 probable drug efflux transporter 
PA1614 gpsA gpdA 2.0 glycerol-3-phosphate dehydrogenase, biosynthetic 
PA1651     2.0 probable transporter 
PA1654     2.0 probable aminotransferase 
PA1670 stp1   2.0 serine/threonine phosphoprotein phosphatase Stp1 
PA1679     2.0 hypothetical protein 
PA1680     2.0 hypothetical protein 
PA1681 aroC   2.0 chorismate synthase 
PA1690 pscU   2.0 translocation protein in type III secretion 
PA1691 pscT   -4.3 translocation protein in type III secretion 
PA1692   pscS  -2.5 probable translocation protein in type III secretion 
PA1693 pscR   -2.5 translocation protein in type III secretion 
PA1694 pscQ   -2.1 translocation protein in type III secretion 
PA1695 pscP   2.0 translocation protein in type III secretion 
PA1696 pscO   2.0 translocation protein in type III secretion 
PA1697   pscN -2.1 ATP synthase in type III secretion system 
PA1698 popN   -2.0 Type III secretion outer membrane protein PopN precursor 
PA1699   pcr1  2.8 conserved hypothetical protein in type III secretion 
PA1700   pcr2  2.3 conserved hypothetical protein in type III secretion 
PA1705 pcrG   -2.5 regulator in type III secretion 
PA1708 popB pepB 2.6 translocator protein PopB 
PA1709 popD pepD  4.6 Translocator outer membrane protein PopD precursor 
PA1710 exsC   2.1 Exoenzyme S synthesis protein C precursor. 
PA1711 exsE   3.7 ExsE 
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PA1712 exsB   3.7 Exoenzyme S synthesis protein B 
PA1713 exsA   2.1 transcriptional regulator ExsA 
PA1714 exsD   3.0 ExsD 
PA1715 pscB   3.5 type III export apparatus protein 
PA1718 pscE   -2.1 type III export protein PscE 
PA1720 pscG   -2.0 type III export protein PscG 
PA1723 pscJ   3.3 type III export protein PscJ 
PA1724 pscK   3.3 type III export protein PscK 
PA1725 pscL   4.6 type III export protein PscL 
PA1726 bglX   2.1 periplasmic beta-glucosidase 
PA1727     2.6 conserved hypothetical protein 
PA1728     3.0 hypothetical protein 
PA1729     3.7 conserved hypothetical protein 
PA1790     2.0 hypothetical protein 
PA1795 cysS   2.0 cysteinyl-tRNA synthetase 
PA1814     -11.3 hypothetical protein 
PA1819   yjdE  2.0 probable amino acid permease 
PA1871 lasA   6.5 LasA protease precursor 
PA1898 qscR   2.5 Quorum-sensing control repressor 
PA1901 phzC2   2.5 Phenazine biosynthesis protein PhzC 
PA1902 phzD2   2 Phenazine biosynthesis protein PhzD 
PA1903 phzE2   2.3 Phenazine biosynthesis protein PhzE 
PA1904 phzF2   3.3 Probable phenazine biosynthesis protein 
PA1909     2.0 hypothetical protein 
PA1919 nrdG   -13.0 class III (anaerobic) ribonucleoside-triphosphate reductase activating protein, 
'activase', NrdG  
PA1949 rbsR   2.0 ribose operon repressor RbsR 
PA2007 maiA   2.0 maleylacetoacetate isomerase 
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PA2031     2.0 hypothetical protein 
PA2055     2.0 probable major facilitator superfamily (MFS) transporter 
PA2066     -11.3 hypothetical protein 
PA2156   ybhP  2.0 conserved hypothetical protein 
PA2167     2.0 hypothetical protein 
PA2249 bkdB   2.0 branched-chain alpha-keto acid dehydrogenase (lipoamide component) 
PA2285     2.0 hypothetical protein 
PA2290 gcd   2.0 glucose dehydrogenase 
PA2338   mtlE  2.0 probable binding protein component of ABC maltose/mannitol transporter 
PA2380     2.0 hypothetical protein 
PA2399 pvdD   2.3 Pyoverdine synthetase D 
PA2426 pvdS   -2.1 Sigma factor PvdS 
PA2499   ykoA  2.0 probable deaminase 
PA2510 catR   2.0 transcriptional regulator CatR 
PA2586 gacA   2.0 response regulator GacA 
PA2663     2.0 hypothetical protein 
PA2681     -19.7 probable transcriptional regulator 
PA2688 pfeA   2.0 Ferric enterobactin receptor, outer membrane protein PfeA precursor 
PA2737     2.0 conserved hypothetical protein 
PA2741 rplT   -3.7 50S ribosomal protein L20 
PA2742 rpmI   -4.6 50S ribosomal protein L35 
PA2743 infC   -4.0 translation initiation factor IF-3 
PA2761     -4.0 hypothetical protein 
PA2767     2.0 probable enoyl-CoA hydratase/isomerase 
PA2802     2.0 probable transcriptional regulator 
PA2853 oprI   -3.3 Outer membrane lipoprotein OprI precursor 
PA2857     2.0 probable ATP-binding component of ABC transporter 
PA2883     -2.8 hypothetical protein 
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PA2900     -12.1 probable outer membrane protein precursor 
PA2939   pepB  -3.0 probable aminopeptidase 
PA2960 pilZ   -2.8 type 4 fimbrial biogenesis protein PilZ 
PA3083 pepN   2.0 aminopeptidase N 
PA3095 xcpZ   3.7 general secretion pathway protein M 
PA3097 xcpX   2.6 general secretion pathway protein K 
PA3099 xcpV   2.8 general secretion pathway protein I 
PA3100 xcpU   2.8 General secretion pathway outer membrane protein H precursor 
PA3101 xcpT   2.5 general secretion pathway protein G 
PA3102 xcpS   2.8 general secretion pathway protein F 
PA3103 xcpR   2.0 general secretion pathway protein E 
PA3115 fimV   2.1 Motility protein FimV 
PA3129   yohI  2.0 conserved hypothetical protein 
PA3131   edaB  2.0 probable aldolase 
PA3140     2.0 hypothetical protein 
PA3196     2.0 hypothetical protein 
PA3198   ypuG  2.0 conserved hypothetical protein 
PA3207     2.0 hypothetical protein 
PA3209   ykgJ  2.0 conserved hypothetical protein 
PA3212     2.0 probable ATP-binding component of ABC transporter 
PA3222     2.0 hypothetical protein 
PA3225     2.0 probable transcriptional regulator 
PA3227 ppiA cypH  2.0 peptidyl-prolyl cis-trans isomerase A 
PA3303     2.0 probable major facilitator superfamily (MFS) transporter 
PA3364 amiC   2.0 aliphatic amidase expression-regulating protein 
PA3369     2.0 hypothetical protein 
PA3407 hasAp   2.3 heme acquisition protein HasAp 
PA3462     2.0 probable sensor/response regulator hybrid 
  
 
                                                                                                                                         2
0
1
 
PA3469   ywjB  2.0 conserved hypothetical protein 
PA3511     -10.6 probable short-chain dehydrogenase 
PA3533   ydhD  2.0 conserved hypothetical protein 
PA3540 algD   2.5 GDP-mannose 6-dehydrogenase AlgD 
PA3541 alg8   2.5 alginate biosynthesis protein Alg8 
PA3542 alg44   -2.6 alginate biosynthesis protein Alg44 
PA3543 algK   -2.8 alginate biosynthetic protein AlgK precursor 
PA3544 algE alg76  2.0 Alginate production outer membrane protein AlgE precursor 
PA3545 algG   3.3 alginate-c5-mannuronan-epimerase AlgG 
PA3546 algX   2.1 alginate biosynthesis protein AlgX 
PA3560 fruA   3.5 phosphotransferase system, fructose-specific IIBC component 
PA3561 fruK   2.5 1-phosphofructokinase 
PA3562   fruI  2.5 probable phosphotransferase system enzyme I 
PA3563 fruR   3.7 fructose transport system repressor FruR 
PA3564   yjjV  3.5 conserved hypothetical protein 
PA3566   ycnE  2.8 conserved hypothetical protein 
PA3567     3.3 probable oxidoreductase 
PA3585 glpM   2.5 membrane protein GlpM 
PA3586     2.0 probable hydrolase 
PA3590     2.0 probable hydroxyacyl-CoA dehydrogenase 
PA3628   yeiG  2.0 probable esterase 
PA3629 adhC   2.0 alcohol dehydrogenase class III 
PA3639 accA   2.0 acetyl-coenzyme A carboxylase carboxyl transferase (alpha subunit) 
PA3686 adk   2.0 adenylate kinase 
PA3699     2.0 probable transcriptional regulator 
PA3715     2.0 hypothetical protein 
PA3724 lasB   2 Elastase LasB 
PA3730     2.0 hypothetical protein 
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PA3742 rplS   -16.0 50S ribosomal protein L19 
PA3753   fbp  2.0 conserved hypothetical protein 
PA3754   yeaB  2.0 hypothetical protein 
PA3772     2.0 hypothetical protein 
PA3779     2.0 hypothetical protein 
PA3785     2.0 conserved hypothetical protein 
PA3787     2.0 conserved hypothetical protein 
PA3820 secF   2.0 secretion protein SecF 
PA3827   yjgQ  2.0 conserved hypothetical protein 
PA3832 holC   2.0 DNA polymerase III, chi subunit 
PA3910     2.3 hypothetical protein 
PA3912   yhbV  7.5 conserved hypothetical protein 
PA3913   yhbU  5.7 probable protease 
PA3914 moeA1   4.9 molybdenum cofactor biosynthetic protein A1 
PA3915 moaB1   2.6 molybdopterin biosynthetic protein B1 
PA3916 moaE   3.3 molybdopterin converting factor, large subunit 
PA3917 moaD   24.3 molybdopterin converting factor, small subunit 
PA3918 moaC   -2.0 molybdopterin biosynthetic protein C 
PA3974 ladS   2.0  Lost Adherence Sensor, LadS 
PA4015     2.0 conserved hypothetical protein 
PA4091 hpaA   2.0 4-hydroxyphenylacetate 3-monooxygenase large chain 
PA4121     2.3 conserved hypothetical protein 
PA4122     2.5 conserved hypothetical protein 
PA4123 hpcC hpaE 2.3 5-carboxy-2-hydroxymuconate semialdehyde dehydrogenase 
PA4124 hpcB hpaD 2.8 homoprotocatechuate 2,3-dioxygenase 
PA4125 hpcD   2.5 5-carboxymethyl-2-hydroxymuconate isomerase 
PA4134     2.0 hypothetical protein 
PA4161 fepG   2.0 ferric enterobactin transport protein FepG 
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PA4168 fpvB   2.0 Second ferric pyoverdine receptor FpvB 
PA4198     2.0 probable AMP-binding enzyme 
PA4221 fptA   2.5 Fe(III)-pyochelin outer membrane receptor precursor 
PA4333   fumA  2.0 probable fumarase 
PA4415 mraY  2.0 phospho-N-acetylmuramoyl-pentapeptide-transferase 
PA4418 ftsI pbpB 2.0 penicillin-binding protein 3 
PA4434     2.0 probable oxidoreductase 
PA4438   yhcM 2.0 conserved hypothetical protein 
PA4460   yhbN  -2.1 conserved hypothetical protein 
PA4461   yhbG  -2.1 probable ATP-binding component of ABC transporter 
PA4466     -2.1 probable phosphoryl carrier protein 
PA4467     -2.5 hypothetical protein 
PA4468 sodM Soda -7.5 superoxide dismutase 
PA4469     -4.3 hypothetical protein 
PA4470 fumC1   -4.9 fumarate hydratase 
PA4471   fagA  -2.8 hypothetical protein 
PA4481 mreB rodY 2.0 rod shape-determining protein MreB 
PA4482 gatC   2.0 Glu-tRNA(Gln) amidotransferase subunit C 
PA4483 gatA   2.0 Glu-tRNA(Gln) amidotransferase subunit A 
PA4527 pilC   2.8 Still frameshift fimbrial biogenesis protein PilC 
PA4528 pilD   3 Type 4 prepilin peptidase PilD 
PA4544 rluD yfiI  2.0 pseudouridine synthase 
PA4548   yfiT  2.0 probable D-amino acid oxidase 
PA4576     2.0 probable ATP-dependent protease 
PA4746   yhbC  2.0 conserved hypothetical protein 
PA4751 ftsH tolZ 2.0 cell division protein FtsH 
PA4846 aroQ1 aroD1  2.0 3-dehydroquinate dehydratase 
PA4917     -13.9 hypothetical protein 
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PA4973 thiC   3.5 thiamin biosynthesis protein ThiC 
PA4974   opmH  3.0 probable outer membrane protein precursor 
PA4976 aruH   2.3 Arginine:Pyruvate Transaminas, AruH 
PA4977 aruI   2.0 2-ketoarginine decarboxylase, AruI 
PA4982     2.0 probable two-component sensor 
PA5002     2.5 hypothetical protein 
PA5010 waaG rfaG 2.1 UDP-glucose:(heptosyl) LPS alpha 1,3-glucosyltransferase WaaG 
PA5011 waaC rfaC  2.8 heptosyltransferase I 
PA5018 msrA pmsR 2.0 peptide methionine sulfoxide reductase 
PA5019   yhiR  2.8 conserved hypothetical protein 
PA5024   ytnM  2.0 conserved hypothetical protein 
PA5028     2.0 conserved hypothetical protein 
PA5067 hisE   2.0 phosphoribosyl-ATP pyrophosphohydrolase 
PA5071     2.3 conserved hypothetical protein 
PA5241 ppx gppA  2.1 Exopolyphosphatase 
PA5242 ppk   3.0 polyphosphate kinase 
PA5245   yhbL  5.7 conserved hypothetical protein 
PA5247   yaiI  3.0 conserved hypothetical protein 
PA5250     2.5 conserved hypothetical protein 
PA5253 algP algR3  2.6 alginate regulatory protein AlgP 
PA5258   hemX  2.1 hypothetical protein 
PA5260 hemC popE  2.0 porphobilinogen deaminase 
PA5260 hemC popE  2.0 porphobilinogen deaminase 
PA5261 algR   4.9 alginate biosynthesis regulatory protein AlgR 
PA5262 algZ fimS  3.7 alginate biosynthesis protein AlgZ/FimS 
PA5279     2.6 conserved hypothetical protein 
PA5281   yigB  2.3 probable hydrolase 
PA5285     5.3 hypothetical protein 
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PA5286   yjbQ  4.3 conserved hypothetical protein 
PA5287 amtB   2.3 ammonium transporter AmtB 
PA5289     2.5 hypothetical protein 
PA5292 pchP   2.0 phosphorylcholine phosphatase 
PA5292 pchP   2.0 phosphorylcholine phosphatase 
PA5293     3.0 probable transcriptional regulator 
PA5296 rep   4.3 ATP-dependent DNA helicase Rep 
PA5297 poxB   2.5 pyruvate dehydrogenase (cytochrome) 
PA5320 coaC coaB  3.3 Phosphopantothenoylcysteine synthase/(R)-4'-phospho-N-
pantothenoylcysteine decarboxylase 
PA5321 dut   4.3 deoxyuridine 5'-triphosphate nucleotidohydrolase 
PA5327     2.1 probable oxidoreductase 
PA5329     3.5 conserved hypothetical protein 
PA5336 gmk   2.6 guanylate kinase 
PA5342     2.1 probable transcriptional regulator 
PA5347     2.1 hypothetical protein 
PA5348     2.0 probable DNA-binding protein 
PA5348     2.0 probable DNA-binding protein 
PA5350 rubA2   2.5 Rubredoxin 2 
PA5351 rubA1   3.3 Rubredoxin 1 
PA5352   glcG  2.5 conserved hypothetical protein 
PA5353 glcF   2.5 glycolate oxidase subunit GlcF 
PA5355 glcD   3.0 glycolate oxidase subunit GlcD 
PA5357   ubiC  2.8 hypothetical protein 
PA5358 ubiA   2.6 4-hydroxybenzoate-octaprenyl transferase 
PA5365 phoU   3.5 phosphate uptake regulatory protein PhoU 
PA5366 pstB   2.0 ATP-binding component of ABC phosphate transporter 
PA5366 pstB   2.0 ATP-binding component of ABC phosphate transporter 
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PA5367 pstA   3.5 membrane protein component of ABC phosphate transporter 
PA5378     2.3 hypothetical protein 
PA5383   yeiH  3.3 conserved hypothetical protein 
PA5394 cls   2.6 cardiolipin synthase 
PA5398 dgcA   3.3 DgcA, Dimethylglycine catabolism 
PA5405     2.5 hypothetical protein 
PA5407     2.0 hypothetical protein 
PA5559 atpE papH   3.5 atp synthase C chain 
PA5565 gidA   2.1 glucose-inhibited division protein A 
PA5566     2.5 hypothetical protein 
PA5569 rnpA   2.3 ribonuclease P protein component 
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Table III. Complete list of common genes differentially-expressed above the statistically significant cut-off fold change of 
4.0-fold (for the 50 µM NE array) and 2.0-fold (for the 500 µM NE array) in suspension cells of PA14 grown in serum-RPMI 
medium at 37 
o
C for 7 h with and without 50 µM NE. 
 
Locus 
tag 
Gene 
name 
Alt. gene 
name 
NE vs. control 
(50 µM) 
NE vs. control 
(500 µM) 
Description 
PA0510   nirE 6.1 3.0 probable uroporphyrin-III c-methyltransferase 
PA0512   nirH 6.5 2.0 conserved hypothetical protein 
PA0513   nirG 10.6 3.5 probable transcriptional regulator 
PA0514 nirL   9.2 3.0 heme d1 biosynthesis protein NirL 
PA0515   nirD  11.3 4.3 probable transcriptional regulator 
PA0516 nirF   6.1 2.0 heme d1 biosynthesis protein NirF 
PA0517 nirC   14.9 2.5 probable c-type cytochrome precursor 
PA0518 nirM   12.1 2.3 cytochrome c-551 precursor 
PA0519 nirS   16.0 4.0 nitrite reductase precursor 
PA0523 norC   45.3 3.7 nitric-oxide reductase subunit C 
PA0524 norB   39.4 4.0 nitric-oxide reductase subunit B 
PA0713     4.9 2.0 hypothetical protein 
PA0884   dctP  4.0 2.0 probable C4-dicarboxylate-binding periplasmic protein 
PA1174 napA   9.8 2.0 periplasmic nitrate reductase protein NapA 
PA1485     4.0 2.0 probable amino acid permease 
PA1919 nrdG   4.3 -13.0 class III (anaerobic) ribonucleoside-triphosphate 
reductase activating protein, 'activase', NrdG  
PA2399 pvdD   -8.6 2.3 Pyoverdine synthetase D 
PA2426 pvdS   -7.5 -2.1 Sigma factor PvdS 
PA3407 hasAp   -42.2 2.3 heme acquisition protein HasAp 
PA3785     13.9 2.0 conserved hypothetical protein 
PA3912   yhbV  27.9 7.5 conserved hypothetical protein 
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PA3913   yhbU  39.4 5.7 probable protease 
PA3914 moeA1   207.9 4.9 molybdenum cofactor biosynthetic protein A1 
PA3915 moaB1   64.0 2.6 molybdopterin biosynthetic protein B1 
PA3916 moaE   5.3 3.3 molybdopterin converting factor, large subunit 
PA3917 moaD   5.7 24.3 molybdopterin converting factor, small subunit 
PA3918 moaC   5.7 -2.0 molybdopterin biosynthetic protein C 
PA4134     22.6 2.0 hypothetical protein 
PA4467     -14.9 -2.5 hypothetical protein 
PA4468 sodM sodA  -12.1 -7.5 superoxide dismutase 
PA4469     -13.0 -4.3 hypothetical protein 
PA4470 fumC1   -16.0 -4.9 fumarate hydratase 
PA4471   fagA  -13.0 -2.8 hypothetical protein 
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